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i 
Abstract  
 
Design rationale is a methodology aimed at capturing and representing design decisions 
according to a designated structure. Additionally, these design decisions and their 
underlying arguments can be made available for examination at a later date. The 
literature review identified that there is currently a lack of information describing the 
use of design rationale methods and computational support tools with the medical 
device domain. Furthermore, the review of literature has also recognised that there are 
no existing guidelines available for medical device manufacturers and regulatory 
authorities to follow in order to capture and represent the design decisions in the case of 
medical devices.  
 
Medical devices are instruments which are used for diagnosis, screening, monitoring, or 
the treating of patients suffering from disease, injury, or disability. Medical devices are 
products that require rigorous regulation before they can be placed onto the market. If 
problems are encountered with a device once it has been placed onto the market, the 
device is recalled by the relevant regulatory authority. Device recalls can often result in 
the device manufacturers having to evaluate the design decisions that were made during 
the product development stages in order to address the reported problems and 
implement a solution. As a result, medical device manufacturers can incur unexpected 
rework and/or redesign costs, and in even more severe circumstances, incur high 
litigation costs.  
 
This research; reviews the state-of-the-art in design rationale and identifies its key 
capabilities, analyses design rationale’s feasibility for use with the medical device 
domain, identifies the regulatory approval processes for medical devices and compares 
them, analyses the possibilities of utilising design rationale with the regulatory approval 
of medical devices, and develops a set of guidelines. The guidelines detail the necessary 
steps that are required to capture and represent the design decisions for medical devices. 
The utility of this contribution has been verified through the process of validation with 
experts and researchers.  
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INTRODUCTION  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Design Rationale for the Regulatory Approval of Medical Devices  
 
 
1 
1. Introduction  
This chapter firstly provides the reader with a background to the research investigation 
and presents the research focus. The aim and objectives of the research are presented 
followed by a summary of the approach utilised for the research investigation. 
Following this, the novelty of the research and contribution to knowledge are outlined 
and the structure of the thesis is presented.  
 
1.1 Background to the Research Investigation  
Design rationale records designers’ knowledge of what issues should be addressed, how 
specific solutions are generated, as well as judgements as to why a particular solution 
should (or might not) work (Wang et al., 2012). Essentially, design rationale is a 
methodology directed towards problem solving and decision making in a design context 
which relies on understanding human cognitive processes and understanding the variety 
of design domains (Li et al., 2002).  
 
The research is interested in investigating the novel application of design rationale with 
the regulatory approval of medical devices. Having analysed the many definitions of 
design rationale that are available in the wider literature (Chapter 2), the author of this 
thesis considers the following definition appropriate for this research investigation: 
design rationale is a methodology aimed at capturing and representing design decisions 
according to a designated structure.  
 
Medical devices are instruments which are used for diagnosis, screening, monitoring, or 
the treating of patients suffering from disease, injury, or disability. The number and 
variety of medical devices is vast and incorporates most healthcare products other than 
medicines, this includes everything from lancets to implantable pacemakers and 
magnetic resonance imaging (MRI) scanners. Uniquely, medical devices are products 
that require rigorous regulation before they can be sold in the United States (U.S.) or 
countries that are member states of the European Union (EU). It is understood that 
manufacturers of medical devices are held to a higher standard than manufacturers of 
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many other products due to the potential severity of the consequences of introducing 
inferior or unsafe products to the market-place (McAllister and Jeswiet, 2003).  
 
Medical devices must be designed and manufactured according to the regulations and 
standards which are defined by the relevant regulatory authorities in the country in 
which the device is to be sold. In the U.S., medical devices are regulated by the Center 
for Devices and Radiological Health (CDRH) of the U.S. Food and Drug 
Administration (FDA). In the EU, the regulatory approval of medical devices relies on 
the use of notified bodies (NBs), which are independent commercial organizations that 
implement regulatory control over medical devices. It is understood that NBs have the 
ability to issue the CE mark, the official marking required for certain medical devices 
(Kaplan et al., 2004). Both the U.S. and EU regulatory approval systems classify 
medical devices pursuant to their inherent risks and accordingly assign different 
regulatory control mechanisms to each designated class of device (Chai, 2000).  
 
Currently, there is no available evidence in the published literature that reports on the 
application of design rationale methods and computational support tools with the 
medical device domain.  
 
The advantages of design rationale, in addition to the significant developments of 
methods and tools observed in recent years and the inherited knowledge from the 
philosophy of argumentation, make it an ideal candidate for capturing and representing 
the design decisions undertaken during the development of medical devices. These 
design decisions could be used in conjunction with the existing regulatory approval 
processes for medical devices in the U.S. and EU. As a result, this could potentially 
provide important benefits to both medical device manufacturers and regulatory 
authorities.  
 
Utilising design rationale with medical devices is challenging as it is currently uncertain 
as to what steps the device manufacturers and regulatory authorities should follow in 
order to apply and effectively utilise methods and tools in order to capture and represent 
the design decisions of medical devices.  
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Can Design Rationale be used with the regulatory approval of medical devices?  
This research is therefore necessary to provide enhanced knowledge and understanding 
of the incorporative and methodical process required to implement a solution whereby 
the design decisions of medical devices can be captured and represented according to a 
designated structure.  
 
1.2 Research Focus  
The literature review (Chapter 2) indicates that there has been recent advancement in 
the area of design rationale research including the utilisation of capture tools in different 
industrial locales such as; aerospace engineering design, civil engineering, artificial 
intelligence, knowledge management, human-computer interaction, and software 
development. At the beginning of the research, however, it was discovered that there 
were, among others, four significant gaps in knowledge. There was no literature 
available which addressed:  
1. The utilisation of methods and tools to capture and represent the design 
decisions of medical devices,  
2. The feasibility of design rationale for use with the regulatory approval of 
medical devices,  
3. How design rationale methods and tools could be utilised with the regulatory 
approval of medical devices and the benefits it could provide, and  
4. The steps required for medical device manufacturers and regulatory authorities 
in order to capture and represent the design decisions of medical devices.  
 
1.3 Primary Research Question, Aim and Objectives  
1.3.1 Primary Research Question  
In view of the need for the research and the gaps in knowledge that have been identified 
in Chapter 2, the following primary research question was established to guide the 
research presented in this thesis:  
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1.3.2 Research Aim  
The aim of this research is to develop a set of guidelines which detail the steps required 
to capture and represent the design decisions in the case of a medical device.  
 
1.3.3 Research Objectives  
In order to address the primary research question and the research aim, the following six 
research objectives were defined:  
1) To understand the state-of-the-art in design rationale research and medical 
device design.  
2) To compare the state-of-the-art in design rationale research with the current 
state-of-the-art in medical device design.  
3) To identify the individual activities that constitute the U.S. and EU regulatory 
approval processes for medical devices.  
4) To analyse the possibilities of utilising design rationale methods and tools with 
the U.S and EU regulatory approval process activities.  
5) To develop a set of descriptive guidelines.  
6) To validate the guidelines.  
 
1.4 Summary of the Research Approach  
Identification, collection, and analysis of data were conducted at a variety of stages of 
the research. The overall methodology for the research, described in Chapter 3, was 
guided by the primary research question and the ensuing research objectives. Since the 
focus of the research was to investigate the application of design rationale and its 
utilisation with the regulatory approval of medical devices, a flexible research approach 
was applied to the overall methodology which is comprised of individual methods 
detailed in Chapters 2 and 4 through to 9. Furthermore, due to the research being largely 
inductive in its approach, the research did not aim to prove or disprove any existing 
theories or generate hypotheses.  
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1.5 Contribution to Knowledge  
The research intends to generate new knowledge through an investigative analysis of 
how design rationale can be utilised with the regulatory approval of medical devices and 
the benefits it can provide. By executing a flexible research design, new knowledge is 
able to be identified directly from the data. There are several novel aspects of this 
research which will demonstrate a contribution to knowledge by:  
 Generating new knowledge within the area of design rationale research  
 Generating new knowledge within the area of medical device regulatory 
approval  
 Identifying the individual steps required to facilitate the utilisation of design 
rationale when regulating the approval of medical devices for the U.S. and EU 
markets  
 Conducting a study which focuses on the practical implications of utilising 
design rationale with the regulatory approval of medical devices  
As a result, the research provides a contribution to knowledge by presenting novel 
methods, findings, and conceptual models through the process of answering the primary 
research question.  
 
1.6 Thesis Structure  
In order to provide the reader with a coherent approach in understanding the process 
followed by the research, which has been meticulously designed and followed according 
to the methodology implemented for each individual chapter as described in Chapter 3, 
this thesis has been structured by following an investigational process from the 
preliminary research investigation to the conclusions. This process begins with an 
introduction to the background of the research and identification of the gaps in existing 
knowledge that need to be addressed. Following this, the state-of-the-art practices in the 
related research domains are identified. This is followed by the development, 
application and validation of a solution that addresses the identified research gaps. 
Finally, this thesis discusses the findings from the research, presents conclusions and 
recommendations for future research, and highlights the contribution to knowledge.  
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This section presents the structure of the thesis according to its content. It outlines the 
main activities and outcomes of each of the chapters. The interconnections between the 
chapters and the research objectives are described. The structure of this thesis is divided 
into nine chapters as follows.  
 
Chapter 1 – Introduction – presents the research background which includes the focus, 
aim and objectives. This chapter introduces the reader to the research investigation 
presented in this thesis and explains the rationale underlying the need for the 
investigation. In this chapter, a summary of the research approach is provided, 
contribution to knowledge is highlighted and the thesis structure is outlined. This 
chapter presents the interconnections between each of the chapters in this thesis.  
 
Chapter 2 – Literature Review – reviews literature on the state-of-the-art research in the 
areas of design rationale and medical device design. Literature relevant to this research 
investigation is reviewed and gaps in existing knowledge are identified. This chapter 
explores the context of the research and identifies the gaps in knowledge that the 
research is targeting. This chapter presents the fulfilment of the first objective of the 
research and provides the necessary foundation for the research activities presented in 
the following chapters.  
 
Chapter 3 – Research Design – defines the methodological approach that has been 
designed, developed and applied to fulfil the research objectives. This chapter presents 
the methods used to perform the research and provides the rationale for their selection 
and utilisation. This chapter explains the methodology used in conducting this research 
including the process followed to achieve the final outcome of the research – the 
guidelines which are presented in Chapter 7.  
 
Chapter 4 – Comparing the State-of-the-Art in Design Rationale with Medical Device 
Design – presents a comparison of the state-of-the-art in design rationale capabilities 
with the existing best practices that are available in the literature regarding medical 
device design. In this chapter, the current best practices in the medical device domain 
are compared with design rationale. The fulfilment of the second research objective is 
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presented in this chapter. This chapter defines the basis for a systematic research 
investigation.  
 
Chapter 5 – Regulatory Approval of Medical Devices – presents a detailed analysis of 
the U.S. and EU regulatory approval processes for medical devices. This chapter 
identifies the existing processes for medical device approval in the U.S. and EU. This 
chapter reveals the different process activities that are currently required for placing 
medical devices in the U.S. and EU markets. In this chapter, the accomplishment of the 
third research objective is presented. Regulatory approval process activities identified in 
this chapter are used in the following chapter.  
 
Chapter 6 – Utilising Design Rationale with the Regulatory Approval of Medical 
Devices – analyses the possibilities of utilising design rationale with the different 
activities that constitute both the U.S. and EU regulatory approval processes for medical 
devices as identified in the previous chapter. This chapter identifies the regulatory 
approval process activities where design rationale could be utilised and highlights the 
benefits it could provide. The activities identified in this chapter are used in the 
following chapter to form the basis for developing the guidelines. This chapter 
addresses the fulfilment of the fourth research objective.  
 
Chapter 7 – Guidelines for Utilising Design Rationale with the Regulatory Approval of 
Medical Devices – presents the guidelines that have been developed to address the 
identified gaps in existing knowledge. This chapter reports on the development and 
utilisation of the guidelines. The guidelines present a step-by-step approach for medical 
device manufacturers and regulatory authorities to follow in order to; capture and 
represent design decisions, review design decisions, and diagnose a problem and design 
a solution. This chapter addresses the fifth research objective.  
 
Chapter 8 – Validation – addresses the validity of the guidelines which are presented in 
Chapter 7. This chapter assesses how the guidelines have fulfilled the aim of this 
research investigation. Validation of the guidelines indicates that the developed 
guidelines provide guidance for medical device manufacturers and regulatory 
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authorities on the steps required to capture, represent and review the design decisions in 
the case of a medical device. This chapter presents the fulfilment of the final research 
objective.  
 
Chapter 9 – Discussion and Conclusions – provides a detailed discussion on the 
research findings as presented in the previous chapters. This chapter firstly explains 
how the findings from the research have answered the primary research question and 
then provides the authors perspective on the findings and the research process. This 
chapter analyses the key research findings, summarises the contribution to knowledge 
and presents recommendations for future work and further advancement based on the 
outcomes of the research.  
 
Figure 1-1 illustrates the thesis structure.  
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Figure 1-1: Thesis structure 
1 
• Introduction 
2 
• Literature Review 
3 
• Research Design 
4 
• Comparing the State-of-the-Art in Design 
Rationale with Medical Device Design 
5 
• Regulatory Approval of Medical Devices 
6 
• Utilising Design Rationale with the Regulatory 
Approval of Medical Devices 
7 
• Guidelines for Utilising Design Rationale with 
the Regulatory Approval of Medical Devices 
8 
• Validation 
9 
• Discussion and Conclusions  
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2 Literature Review  
This chapter provides grounding for the research by examining the state-of-the-art and 
relevant literature related to the design rationale research and medical device domains. 
Gaps in existing knowledge are identified and addressed as they form the basis for this 
research investigation.  
 
The review of literature presented in this chapter has taken the form of an examination 
of published literature that is explicitly associated with the design rationale research and 
medical device areas. Analysis and synthesis of the literature was performed primarily 
in this chapter and during the research activities. Therefore, literature applicable to this 
research investigation will also be presented in Chapters 4, 5, 6, 7 and 8 in conjunction 
with the findings from the research and discussion presented in Chapter 9. The review 
of the literature provides an essential grounding of the research in current and relevant 
knowledge. Gaps in existing knowledge and understanding are identified in this chapter 
and the first objective of the research is addressed.  
 
This chapter is presented in the following stages. Firstly, the methodology followed by 
this literature review is presented and described. This is followed by an examination of 
the key findings generated through the analysis of the literature. Following this, the 
findings from the literature reviewed are discussed. Finally, the research questions 
guiding this review are addressed and the identified gaps in knowledge are summarised 
and investigated further to provide the basis from which the research can develop.  
 
2.1 Review Methodology  
This section describes the stages that were methodologically followed for reviewing the 
current and relevant literature related to this research investigation. The methodology 
consists of four stages as follows. The scope and research questions guiding this review 
are initially defined. Secondly, the search strategy developed and implemented for 
identifying the relevant literature is detailed. This is followed by the approach 
developed for analysing the literature related to this review. Following this, the 
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methodology followed for answering the research questions is presented. These stages 
are described in the following subsections of this chapter.  
 
2.1.1 Review Scope and Research Questions  
In determining the scope of this literature review, the focus has been on published 
articles that are related to design rationale methods within a wider multidisciplinary 
context which includes literature related to medical device design. For example, the 
papers that have been considered relevant to this review are associated with design 
rationale methods and computational support tools including their applications, and 
existing best practices for medical device design.  
 
Some examples of publications that are within the scope of this review are those such as 
Moran and Carroll (1996) in which a collection of work describing the concepts of 
design rationale has been presented, and Bracewell et al. (2009) who have published 
articles on the utilisation of a prototype design rationale support tool in the aerospace 
industry.  
 
Outside the scope of this review are publications that focus on the technical 
architectures of computational support tools and contributions on topics that are related 
to design psychology. It has been noted that there are many similarities and connections 
between the design rationale and design psychology research communities. However, 
this review is concerned with structured methods and tools that enable the capture and 
communication of deliberated design decisions.  
 
Research questions have been posed to guide this literature review. It is intended that 
the following three questions will assist in ensuring a thorough and comprehensive 
review of literature: (1) what is what is meant by design rationale and how is it 
commonly defined; (2) what are the state-of-the-art in design rationale methods of 
representation and capture tools; and (3) what are the current capabilities of design 
rationale?  
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2.1.2 Literature Search Strategy  
Initially, the search strategy involved identifying the relevant data sources, keywords, 
and publication timeframe. However, some seminal papers outside of the timeframe 
(1990 - 2012) that were considered relevant were also cited in the review. Databases 
were used as part of the search strategy to identify a range of publications appropriate to 
the review. These were; SCOPUS, Science Direct, Cambridge Journals, Elsevier, 
Emerald, Design Society online repository, and also including the traditional library 
cataloguing systems. Internet searches were also used to identify publications and their 
corresponding databases. The keywords identified were associated with deliberating 
design decisions (design rationale, design history, design intent, design knowledge 
capture, knowledge management, design thinking, design process, decision-making, and 
design rationale capture tools). During the acquisition of appropriate and new articles, 
these keywords were refined.  
 
A large number of publications in the specified time period were discovered using the 
keyword search in the different databases. To remove any duplications of the published 
work and to ensure relevance to the review, the lists were edited and refined, and the 
titles and keywords of the articles were checked. Initially, a vast range of articles, 
reports, and books were identified using the search terms. Of the identified papers, the 
abstracts and introduction chapters were then read and if they were considered relevant, 
the paper was fully examined. From this selection process, the full papers relevant to 
this study have been established to be directly associated with this research 
investigation. During the literature search and acquisition, a number of objectives were 
defined with the purpose of addressing the three research questions. These included; to 
ascertain what researchers had focussed on within the design rationale research area, to 
identify what methods had been utilised and in what applications, and essentially how 
this informed the current investigation.  
 
2.1.3 Analysis of the Literature  
The literature reviewed covered a wide range of different topics. Therefore, the analysis 
itself involved clustering the papers into the main themes and contributions. These were 
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defined based on the papers that were reviewed in detail and grouped according to the 
ten key themes and the analysis of their coverage by the various authors. The key 
themes based on the total number of papers reviewed (101) in detail are presented 
(Table 2-1) including the number of papers covering each key theme and the percentage 
of the total papers.  
 
Table 2-1: Key themes and contributions of design rationale literature  
Design rationale literature – key themes based 
on total number of papers reviewed in detail  
No. of papers 
covering 
theme  
Percentage of 
total papers  
1. Capture and documentation techniques  16  16%  
2. Capture tools and development approaches  17 17%  
3. Empirical evaluations and case studies  10 10%  
4. Factors that undermine the widespread 
adoption of design rationale systems  
5  5%  
5. General concept and definition  12  12%  
6. Representations  14  14%  
7. Retrieval Strategies  6  6%  
8. Reuse  7  7%  
9. Reviews and surveys  7 7%  
10. Utility and usability  7  7%  
 
A large number of authors have covered representations for capturing deliberated design 
decisions (Lee and Lai, 1991; Moran and Carroll, 1996; Nomaguchi et al., 2004), 
capture tools and their development approaches (Karacapilidis and Papadias, 2001; 
Bracewell and Wallace, 2003; Burge and Brown, 2008), empirical evaluations and case 
studies (Burge, 2006; Falessi et al., 2006), and capture and documentation techniques 
including the reasoning of designers (Horner and Atwood, 2006; Aurisicchio et al., 
2007; Bracewell et al., 2009).  
 
It is interesting to note that authors have addressed the factors undermining the 
widespread adoption of design rationale systems for practical industrial application 
(Regli et al., 2000; Horner and Atwood, 2006; Burge, 2008). More recently, authors 
have been addressing the different strategies for effective retrieval and reuse of 
deliberated design decisions (Kim et al., 2005; Kim et al., 2007; Wang et al., 2009). 
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There are a variety of review and survey papers that have been published addressing the 
different aspects associated with design rationale research (Regli et al., 2000; Li et al., 
2002; Eng et al., 2009), and the general concept of design rationale providing 
definitions (Lee, 1997; Dutoit et al., 2006; Burge and Bracewell, 2008).  
 
2.1.4 Answering Research Questions  
Analysis of the published articles has formed the basis of the findings in this chapter in 
order to address the three research questions posed. Methods employed for analysing 
the literature to answer each of the three research questions are presented in the 
following subsections.  
 
2.1.4.1 Defining Design Rationale  
Literature was analysed with the purpose of understanding how the design rationale 
research community have defined what design rationale is. From the selected articles 
that were analysed, the definitions for design rationale that were provided by the authors 
were noted along with the article reference. Once all of the articles had been analysed, 
the popular definitions for design rationale were listed. These are provided in section 
2.2.1.1 of this chapter.  
 
2.1.4.2 Identifying the State-of-the-Art in Design Rationale 
Representations and Capture Tools  
Literature was analysed with the intentions of, firstly, identifying the most common 
methods that have been extensively used to represent design rationale, and secondly, 
discovering the design rationale representation frameworks that have been developed 
since the year 2000. The argument structures and methods for selecting and organising 
information as defined by the common frameworks are noted and a brief description of 
their background is provided. Methods for representing design rationale and capture 
tools based on these methods that have been developed since the year 2000 are 
presented and a brief description of their structures is given. These are provided 
respectively in sections 2.2.2 and 2.2.3 of this chapter.  
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2.1.4.3 Categorising the Current Capabilities of Design Rationale  
The term ‘capability’ is described to be “the power or ability to do something” (Oxford 
Dictionaries, 2010) whereby the ‘something’ can be performing an action for example. 
Literature was analysed with the goal of being able to categorise the current capabilities 
of design rationale (the ability of design rationale to perform specific actions). This 
analysis took the form of a two-stage process.  
 
In the first stage, descriptions of the actions that design rationale methods and tools are 
able to perform were taken from the literature. Each action was noted. The outcome 
(end result of the action) was noted in the form of what can be accomplished by design 
rationale. The verb describing the design rationale action was extracted from the 
statement of the action. This information was then used to derive an initial capability list 
composed of the following attributes: action, description in the literature, outcome, and 
verb.  
 
In the second stage, ‘higher-level’ design rationale capabilities were compiled by a 
process of grouping ‘similar’ capabilities together. The methodology for this grouping 
of initial capabilities used a two-stage process. Firstly, the similarity of the verbs that 
were extracted from the actions was assessed. Similarity was assessed using the 
‘synonym’ function of the Microsoft Word 2007 software (U.K. edition). Each category 
was then named after the appropriate verb. For example, the first capability category 
contained the verbs “answer” and “solve” which Microsoft Word stated “solve” as 
being a synonym of “answer.” Therefore, “answer” was selected as the capability name. 
For the capability named “communicate,” the following verbs were found to be 
synonyms of communicate: express, design, transmit, and note.  
 
Secondly, the capability sub-categories were derived. These capability sub-categories 
were defined by the subsequent noun in the defined action. For example, in the action; 
‘to capture design knowledge’, ‘answer was identified as a higher-level capability 
category (verb), and ‘design questions’ was defined as a capability sub-category of 
capture (nouns). The list of initial capabilities was then sorted and grouped by capability 
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and capability sub-categories to give the final list of the capabilities for design rationale. 
These are provided in section 2.2.4 of this chapter. The full list of capabilities which 
include the descriptions can be found in: Appendix A: List of Compiled Design 
Rationale Capabilities. A full listing of the capability names comprising of the verbs 
and synonyms is provided in Table 2-2. The synonyms column (Table 2-2) shows the 
verb or verbs that are synonymous to the action (verb) in the verb column. The arrow 
(>) symbol in the synonyms column indicates that the following verb after this symbol 
is synonymous to the previous verb. The tilde character (~) indicates that the verb is 
selected as the capability name. These capabilities were named, using the verb and 
synonym as the basis, and assigned a category identification letter (designated A to M).  
 
Table 2-2: List of the categorisation for the verbs and synonyms  
Verbs  Synonyms  Category name  
Answer   ~  Answer 
Solve  Answer  Answer  
Capture   ~  Capture  
Express  Communicate  Communicate  
Describe  Express > Communicate  Communicate  
Transmit  Convey > Communicate  Communicate  
Note  Communication > Communicate  Communicate  
Design   ~  Design  
Determine   ~  Determine  
Document   ~  Document  
List  Record > Documentation > Document Document  
Record  Documentation > Document  Document  
Explain   ~  Explain  
Justify   ~  Justify  
Provide   ~  Provide  
Represent   ~  Represent 
Illustrate  
Demonstrate > Reveal > Expose > Representation > 
Represent  
Represent  
Expose  Representation > Represent  Represent  
Structure   ~  Structure  
Support    ~  Support  
Assist  Support  Support  
Teach   ~  Teach  
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The following section of this chapter presents the key literature findings that were 
generated from the literature analysis.  
 
2.2 Results: Key Literature Findings  
The results are presented in the order of the research questions of this chapter. First of 
all, an overview of design rationale is provided which includes its associated 
definitions, the need for capturing a designs rationale, benefits provided by design 
rationale, and the challenges faced by the design rationale research community. 
Secondly, the state-of-the-art in design rationale representation frameworks and design 
rationale capture tools are presented and reviewed. Following this, the capabilities that 
design rationale currently has to offer are presented. Finally, an overview of medical 
device design is provided.  
 
2.2.1 An Overview of Design Rationale  
2.2.1.1 Definitions of Design Rationale  
The term ‘design rationale’ (DR) has been referred to in many different ways by the 
design rationale community representing a variety of meanings. There has been some 
interest by the DR research community in describing what constitutes DR, with authors 
presenting varied descriptions.  
 
Six different ways in which DR has been referred to as (Moran and Carroll, 1996) are 
summarised as follows: (1) an expression of the relationships between a designed 
artefact, its purpose, the designer’s conceptualisation, and the contextual constraints on 
realising the purpose; (2) the logical reasons given to justify a designed artefact; (3) a 
notation for the logical reasons for a designed artefact; (4) a method of designing an 
artefact whereby the reasons for it are made explicit; (5) documentation of the reasons 
for the design of an artefact, the stages or steps of the design process, and the history of 
the design and its context; and (6) an explanation of why the designed artefact is the 
way it is. It was identified (Lee and Lai, 1991) that the term ‘design-rationale’ was 
being used in the following three different ways: a historical record of the reasons for 
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the choice of an artefact (Yakemovic and Conklin, 1990), a set of psychological claims 
embodied by an artefact (Carroll and Rosson, 1990), and a description of the design 
space (MacLean et al., 1989).  
 
Table 2-3 lists the popular definitions for DR available in the literature.  
 
Table 2-3: List of popular definitions for design rationale  
Authors (date) Definitions of design rationale  
Wang et al. (2012)  
“DR is an effective way of capturing the missing part 
of an integrated representation of design knowledge, 
and can be viewed as a valuable intellectual asset of an 
enterprise”  
Kannengiesser and Gero 
(2011)  
“DR can be understood either as a passive and fixed 
description of the history of designing, or as a dynamic 
act that constructs the assumptions underpinning the 
design decisions as they are needed in a current 
situation” 
Mix et al. (2010)  
“DR is the combination of specifications, motivations 
and actions for the purpose of creating designs”  
Nkwocha et al. (2010)  
“DR bridges the information gap between the need a 
system fulfils and its final design”  
Wang et al. (2009)  
“DR can offer designers useful information about how 
previous designs evolved and in what context such 
evolution happened”  
Haynes et al. (2008)  
“DR can answer questions about why a given design 
takes the form that it does”  
Burge and Bracewell 
(2008)  
“DR provides a history of the design process as well as 
capturing the intent behind the decisions made”  
Atwood and Horner (2007)  
“DR is a potential solution to help designers identify 
issues that they may have otherwise left unconsidered”  
Dutoit et al. (2006)  
“DR is the reasoning that goes into determining the 
design of the artefact”  
Tang et al. (2006)  
“DR is a method of capturing the knowledge and 
reasoning that justify the resulting design”  
Kim et al. (2005)  “DR is the result of complex reasoning and decisions” 
Li et al. (2002)  
“DR is a methodology for problem solving and 
decision making in a design context”  
Lee (1997)   
“DR can include not only the reasons behind a design 
decision but also the justification for it, the other 
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alternatives considered, the trade-offs evaluated, and 
the argumentation that led to the decision”  
Shum (1996)  
“DR is a representation of the reasoning behind the 
design of an artefact”  
McKerlie and MacLean 
(1994)  
“DR is an approach to design which emphasises 
working with explicit representations not only of 
possible design solutions, but also of the reasons and 
processes behind them”  
 
It has been explained (Haynes et al., 2008) that the purpose of DR was intended to 
capture the reasons why designers make the design decisions that they do, how they 
moved through a design space to identify questions and the answers to solutions to 
those questions, and the criteria they used to determine that a particular solution will 
work, or will work better than other possible alternatives. It has also been expressed 
(Burge and Brown, 2008) that rationale differs from other types of documentation 
because it documents more than the results of each decision; it documents what the 
decisions were, what alternatives were considered and rejected, and what arguments 
were used in making the alternative selections.  
 
It has been highlighted that DR is essentially a methodology directed towards problem 
solving and decision making in a design context which relies on understanding human 
cognitive processes and understanding the variety of design domains (Li et al., 2002). In 
this context, it is described that a design rationale capture (DRC) tool intends to let 
designers think and discuss design within a certain knowledge representation 
framework (Regli et al., 2000).  
 
The definitions for DR have presented various analogous descriptions of what 
constitutes a DR but they do not explain what a DR does not include. The descriptions 
showed a general consensus of what DR is based on similar interpretations by 
researchers. As pointed out by Li et al. (2002) some of the definitions are generic and 
could be accepted by everyone nevertheless some of the definitions were defined with a 
specific purpose and based on the current understanding of research in the DR domain. 
This view is echoed by Atwood and Horner (2007) who also state that DR may mean 
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different things to the different researchers and practitioners within the DR research 
community.  
 
It has been argued (Medeiros and Schwabe, 2008) that there is no agreement in the 
literature regarding the definition of design, although different definitions were 
available (Simon, 1981; Schön, 1983; Goel and Pirolli, 1989; Hubka and Eder, 1996; 
Winograd, 1996). In the context of design, it is understood by researchers within the 
wider design community that there is no single, universally accepted concise definition 
of design although several classifications have been proposed (Atwood et al., 2002). It 
is also understood that design is concerned with the construction of artefacts and 
artefacts are systems produced by people to help them meet their goals (Simon, 1981). 
This therefore raises some important questions as to what DR actually is and whom it is 
intended for other than the designer who captures and uses it.  
 
2.2.1.2 The Need for Capturing a Design’s Rationale  
It is understood that large amounts of knowledge and experience are seldom captured 
and are stored in the minds of individuals (Wallace et al., 2005). It was identified by 
Wallace et al. (2005) that when individuals leave an organisation or a particular part of 
it, they take their knowledge with them, and in such instances this knowledge is lost 
forever. More importantly, addressing the issues of how to capture, store and retrieve 
design knowledge independently of human sources has been identified as a requirement 
for industrial organisations (Wallace et al., 2005).  
 
It has been explained by Burge (2008) that there is an increasing acknowledgement of 
the importance of knowledge to organisations and rationale has the potential to make a 
key contribution to capturing and retaining that knowledge. This is further iterated by 
Medeiros and Schwabe (2008) who consider DR to have a potential value for 
supporting design reuse, because it prevents the experience and the knowledge invested 
in a design from being lost. Hooey and Foyle (2007) have stated that the need for a 
DRC tool is prevalent in a wide array of NASA’s design projects including 
Constellation, small satellites, air traffic control automation, and robotics. They have 
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argued that if DR could have been captured in an efficient and effective manner during 
the Apollo Era in the 1960’s, NASA would be able to take advantage of this design 
knowledge and applied the lessons learned to existing projects.  
 
Aurisicchio et al. (2007; 2008) have recognised that aerospace engineering design relies 
heavily on the use of past experience, and engineering designers are frequently required 
to revisit previous design solutions and understand the rationale for their generation. 
Additionally, Bracewell et al. (2009) have explained that engineering designers cannot 
retain all the information they require in order to solve complex design problems in 
their heads, therefore retrieval of information is externally sourced from colleagues, 
documents, models, engineering drawings and databases. In particular, it is considered 
that the expert knowledge of an experienced designer is invaluable and DR can help to 
capture this knowledge (Burge and Kiper, 2008). The re-use of previous design 
knowledge is considered to be a potentially important way to improve the design 
efficiency (Brissaud et al., 2003).  
 
Burge and Brown (2008) have acknowledged that there are many ways that rationale 
can be used in the development and maintenance of software. They have explained that 
rationale can serve as documentation by capturing knowledge of the original developers 
for use by new people joining the team, since the software maintainers are not often the 
developers. As software evolves over time, the original reasons or rationale behind the 
design and implementation decisions may be lost.  
 
Burge et al. (2008) have described that the general goal of rationale research was to use 
records of rationale to improve the processes of creating various physical artefacts, also 
including software and governmental policies. They have explained that in order to 
support the aforementioned goal, rationale research has sought to develop methods and 
software that enable: the elicitation of useful rationale from its authors; the recording of 
useful rationale; the structuring and indexing of rationale to aid its retrieval; retrieval of 
rationale when it is useful; delivery of that rationale to those for whom it is useful; and 
use of the rationale by those people.  
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A survey on architecture DR conducted by Tang et al. (2006) revealed that 85% of 
architects that they had surveyed agreed that the use of DR was important in justifying 
design decisions, and 80% of the respondents are said to have failed to understand the 
reasons of a design decision without the support of DR. Additionally, it was discovered 
that 74% of the respondents had a tendency to forget their own design decisions. 
According to the Tang et al. (2006), the results from the survey had clearly indicated the 
need in capturing the DR for system maintenance.  
 
2.2.1.3 Benefits of Utilising Design Rationale  
Many claims have been made by DR researchers regarding the benefits provided by 
using DRC tools to capture and represent rationale, and about the consequences of not 
documenting DR. One such claim is that, DR helps to expose the underlying 
propositions and mechanics of a given theoretical position by exposing the otherwise 
invisible reasoning that unifies a theoretical construct with a constructed object (Haynes 
et al., 2008). Additionally, one of the potentially most promising roles for DR 
representations and tools according to Haynes et al. (2008), is to act as a repository for 
design knowledge and cases, and one of the strengths of DR is that it makes explicit 
how design criteria are applied to influence a given design decision.  
 
Researchers have argued that by capturing DR, knowledge that is usually implicit is 
made explicit, additionally, this knowledge becomes available for re-examination at a 
later date, for example, if and when the requirements change (Dutoit and Paech, 2000). 
Moran and Carroll (1996) have suggested that DR would seem to be a helpful aid for 
teaching students or inexperienced designers; because it provides an explanation for 
why particular design components or features were chosen.  
 
Lee and Lai (1991) have declared that an explicit representation of design rationales can 
bring many benefits; however, this depended largely on the computational language 
used for representing design rationales. MacLean et al. (1991) listed two major benefits 
from DR representation which were aiding in reasoning and aiding in communication. 
These were further elaborated in terms of enabling the designers to envisage the 
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available design alternatives in a more structured way including arguments for and 
against.  
 
Jarczyk et al. (1992) have provided an example of the potential benefit of recording DR 
for large software systems. They have explained that a significant amount of time and 
money could be saved on future releases of software providing the rationale was 
recorded for the initial version. This was considered to be where DRC tools seemed to 
promise to be the most useful, and even the modest success of such tools could provide 
substantial benefits.  
 
Lee (1997) classified common services into the following four major groups according 
to the user group who was considered to benefit from the services provided by a DR 
system: (1) better design (designers); (2) better maintenance (system maintainers); (3) 
learning (new trainee, students, learning programs); and (4) documentation (to be used 
by future designers and maintainers). It was also considered that well-structured design 
rationales could help designers follow the issues and alternatives being explored 
including their evaluations, which in turn clarified the overall structure of the reasoning 
process and supported decision making.  
 
It has been argued by Burge et al. (2008) that rationale matters because it useful for 
creating artefacts in general and particularly software engineering. There are two ways 
defined by Burge et al. (2008) in which rationale documentation methods can be useful 
for artefact creation. The first way is by providing a record of the reasoning associated 
with decision-making, and the second is by actively shaping the process of reasoning 
about decisions. Two further ways are also described in which a record of the decision-
making process can be useful to serve as a memory aid for those who have participated 
in the decision-making, and the other is to inform those who did not participate in the 
decision-making process but are affected by the decisions. In addition to the value of 
simply recording DR, rationale can be useful by aiding decision-making.  
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2.2.1.4 Challenges Currently Faced by the Design Rationale Research 
Community  
As well as the suggested benefits of capturing DR and using DRC tools, researchers 
have also commented on the challenges currently facing researchers in the DR 
community. One of the challenges described for DR research was to discover the most 
helpful and accessible representations for design reasoning (Shum and Hammond, 
1994). Lee and Lai (1991) explained how each DR representation must consider the 
costs and benefits involved in trade-offs among the following three general dimensions: 
expressiveness, human usability, and computational tractability.  
 
Jarczyk et al. (1992) have highlighted an important issue for the application of DRC 
tools and identified a difficult problem which was how to integrate the DRC tool into 
the overall design process and into the designer’s natural working environment without 
disrupting the design process. Bracewell et al. (2009) identified that a hindrance to the 
adoption of rationale capture tools in industry was the need of previous DR tools for a 
dedicated Database Management System (DBMS) to store the rationale. According to 
Bracewell et al. (2009), this did not fit well with the designers’ regular working 
practices and IT support systems.  
 
Fischer et al. (1996) have pointed out that documenting the decisions could hinder the 
design process if it is viewed as a separate process and that there were fundamental 
obstacles to the effective documentation and use of DR that needed to be considered. It 
was also claimed by Fischer et al. (1996) that DR served design if it helped designers: 
(a) to improve their work; (b) to cooperate with other people holding stakes in the 
design; and (c) to understand existing artefacts (learn from past designs). Additionally, 
the change of working practice to capture DR could result in low designer participation 
since the benefits of DR were not always demonstrated immediately (Myers et al., 
1999).  
 
Regli et al. (2000) have argued that a DRC tool was not effective as an individual 
system. They elucidated that together with other design support systems, such as 
Computer-Aided Design (CAD) or Computer-Aided Software Engineering (CASE) 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
28 
tools, a DRC tool could contribute to the design process by providing designers with a 
knowledge representation framework, including the tools to capture DR, design 
reasoning and communication during the design process.  
 
Horner and Atwood (2006) have explained that the inherent problem of identifying the 
impact of rationale across different design problems added a net cost to the utilisation of 
rationale, which in turn, decreased the overall utility in the design process. They have 
also stated that one problem with DRC tools was that there was no absolute measure of 
effectiveness. This posed a difficulty for the designers to understand which rationale 
would be the most useful. Burge and Brown (2000) have also commented on problems 
with DR by firstly stating; capturing, or recording DR was a particularly difficult 
problem. Secondly, the recording of all decisions made, including those rejected could 
be a time consuming and expensive process.  
 
A study conducted by Conklin and Yakemovic (1991) found that there was a nearly a 
universal intuitive notion that DR would be beneficial in the long term, however, the 
immediate cost of capturing DR discouraged the practice. There was also a strong 
consensus that rationale was very valuable, but there was an equally strong concern that 
the costs of its capture may be too high, and in order to justify the costs, it’s essential to 
establish ways in which the rationale could be useful (Burge and Bracewell, 2008).  
 
One of the major stumbling blocks in rationale research has been the fear that rationale 
may not be worth the costs of its capture (Burge et al., 2008). Several key issues that 
impeded the application of argumentation-based DR methods were highlighted by Tang 
et al. (2007). Firstly, it was considered to be a cognitive burden in capturing complete 
explanations and secondly, there was a lack of traceability when changes to the design 
occurred.  
 
Burge (2008) has listed the numerous proposed uses for rationale and the barriers to its 
capture and use. The proposed uses included: providing additional documentation; 
assisting new personnel in learning about the design; and supporting software 
maintenance. The barriers identified to DR capture and uses included: the effort 
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involved in capturing it; potential liability issues if decisions can be tracked; and the 
potential for disrupting design.  
 
Burge and Brown (2008) have argued that while capture and representation are 
important for DR, the real value of a DRC tool is how well the rationale can be put to 
use. They continue to state that capturing DR was not useful if it was never looked at 
again, and if rationale was to be useful to the designers, the designers generally tended 
to assist with the capture and recording of DR particularly if they could put it to 
immediate use. The use of DR depended on its representation format and content, and 
rationale was only useful if software developers actually used it (Burge and Brown, 
2008).  
 
A summary of the challenges currently facing the DR community are summarised in 
Table 2-4. Comments made by the authors are noted and the date is referenced.  
 
Table 2-4: Summary of the challenges for design rationale  
Authors (date)  Challenges  
Aurisicchio and Bracewell 
(2009)  
Recognised that a key challenge in engineering 
design research was that of enabling designers to 
capture, in a digital way, design information of the 
type that was generally documented in personal 
design journals.  
Burge (2008)  
Identified two major obstacles that need addressing: 
(1) need to understand the requirements and problems 
of the practitioners DR is intending to support; and 
(2) need to provide evidence of the value of DR 
solutions through formal empirical evaluations of 
existing and new DR approaches.  
Billa et al. (2007)  
Commented on issues that may prevent a DR model 
from being used in healthcare settings as being due to 
legal value of the patient record. The physician may 
be held accountable for their action (diagnosis and 
specified treatment).  
Atwood and Horner (2007) 
Identified essential barriers and problems that inhibit 
the success of DR systems. These were: cognitive 
barriers, capture barriers, retrieval barriers, usage 
barriers, and organisational barriers.  
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Dutoit et al. (2006)  
Discussed the intrusiveness of the effort required for 
DR capture which required designers to write up their 
rationale in a given framework. This required a great 
deal of additional work to the normal design process. 
Other challenges included political and legal factors.  
Horner and Atwood (2006)  
Classified DR challenges into four categories: 
cognitive limitations; capture limitations; retrieval 
limitations; and usage limitations.  
Regli et al. (2000)  
Presented challenges for representations and capture. 
The challenge for representations was to find the best 
method to assist designers in decision-making and to 
possess three qualities: ease of input, effective view 
and activeness. Challenges for capture included 
devising a method to capture process knowledge with 
minimal overhead and with least interference of 
design activities.  
 
This section has provided an overview of DR which includes its associated definitions, 
its need, the benefits of utilising design rationale and the challenges currently faced by 
researchers. The following subsection presents the state-of-the-art in DR representation 
frameworks.  
 
2.2.2 Design Rationale Representation Frameworks  
A DR representation framework is described to explicitly document the reasoning and 
argumentation occurring in a design (MacLean et al., 1991). It is understood that the 
representation determines the methods used to capture and retrieve the rationale, but 
more importantly, a good representation schema is described to be vital in enabling 
effective design rationale capture, retrieval and reuse (Regli et al., 2000). Dutoit and 
Paech (2000) have described that DR can be represented in several different ways which 
include: natural language justifications, as rules in knowledge-based systems (KBS), or 
as arguments that were structured in rhetorical steps.  
 
The importance of selecting an appropriate representation framework has been 
emphasised by numerous authors (Lee and Lai, 1991; Shum, 1991; Moran and Carroll, 
1996; Lee, 1997; Regli et al., 2000; Li et al., 2002; Dutoit et al., 2006; Medeiros and 
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Schwabe, 2008; Wang et al., 2012). According to Lee and Lai (1991), the choice of 
representation is considered to be especially important when a human is the user of the 
representation. DR is also considered to be an important part of the integrated 
knowledge representation as it is able to describe the complex reasoning used (Wang et 
al., 2012). A DR representation should be able to explain the design reasons and also to 
describe the artefact (Liang et al., 2009).  
 
Lee (1997) has explained how it was impossible to represent an entire DR explicitly 
however, whatever was represented must be accessible, and it must have some form of 
structure. The choice of representation is considered to be especially important when a 
human is the user of the representation (Lee and Lai, 1991).  
 
Fundamentally, DR must have a method for capture, representation, and construction in 
order for it to be used (Moran and Carroll, 1996). Most approaches to representing DR 
include the notion of criteria that are used in design decisions as a basis for evaluating, 
comparing, and selecting alternative solutions (Kannengiesser and Gero, 2011). The 
most common argument structures and methods for selecting and organising 
information, and that have been extensively used to represent DR are; Issue-Based 
Information System (Kunz and Rittel, 1970), Procedural Hierarchy of Issues (McCall, 
1991), Questions, Options, and Criteria (MacLean et al., 1991), and Decision 
Representation Language (Lee and Lai, 1991). An overview of these and other 
representation approaches that have been developed since the year 2000 is provided in 
the following sub-sections.  
 
2.2.2.1 Issue-Based Information System  
The issue-based information system method (IBIS) uses an issue-based approach and 
was originally applied to large-scale projects in planning and policy making for the 
United Nations, the Commission of European Communities and the former West 
German Government (Dutoit et al., 2006). Since IBIS was proposed and applied in the 
1970s and 1980s (Kunz and Rittel, 1970), it has become the dominated method in the 
DR community and it has been studied, improved and applied in many areas such as; 
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architecture and planning, environmental design and planning, engineering design, 
computer system design, group meetings, and individual brain storming (Li et al., 
2002).  
 
IBIS consists of three node types (Issue, Positions, and Arguments) and eight link types 
(supports, objects-to, replaces, responds-to, generalizes, specializes, questions, and 
suggested-by). Issues can have numerous counter positions which are prospective 
responses to the issue raised. A position can have a single or multiple arguments to 
either support or object-to it. Issues can also generalize or specialize other issues, and 
can be suggested-by or question other issues, positions, or arguments. Figure 2-1 
illustrates the gIBIS (graphical IBIS) notation (Conklin, 1989) which has been adapted 
from the IBIS method for use in the software engineering domain by extending its 
vocabulary and adding a graphical representation by displaying each IBIS as a directed 
graph (Shum, 1991). Relationships among the three elements (issues, position and 
argument) in gIBIS are displayed (Figure 2-1).  
 
 
Figure 2-1: Legal argumentation moves in gIBIS (Shum, 1991)  
 
The following eight features of IBIS that are commonly shared by most other 
argumentative approaches to DR have been identified by Burge et al. (2008): (1) Using 
a fixed conceptual schema of elements and relationships between pairs of them; (2) 
Dividing rationale into the reasoning about individual decision-making tasks (referred 
to as issues in IBIS); (3) Representing decision-making tasks as questions to be 
answered; (4) Proposing decision alternatives for each decision-making task (referred to 
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as positions in IBIS); (5) Evaluating the proposed decision alternatives by stating and 
considering pros and cons of these alternatives (referred to as arguments on positions in 
IBIS); (6) Evaluating the evaluations by stating and considering pros and cons (referred 
to as arguments on arguments in IBIS); (7) Deciding a decision task by selecting one 
decision alternative on the basis of its evaluation; and (8) Using several relationships to 
link the separate decision-making processes (referred to as inter-issue relationships in 
IBIS).  
 
A study conducted by Bracewell and Wallace (2003) suggested that the practical use of 
the existing IBIS DRC tools were hampered by various problems. It was described that 
for every issue, solution or argument captured, the user was required to summarise it 
meaningfully into no more than five or six words, which was likely to prove an 
intolerable burden to the designer. It was also identified that the DRC tools had no clear 
and consistent way of representing the element status, so the user was forced to adopt 
textual conventions in labels in order to represent the status information. This resulted 
in the loss of clarity of the design arguments.  
 
In order to address the recognised problems of existing IBIS tools, Bracewell and 
Wallace (2003) have introduced a graph-based IBIS DRC tool called the Design 
Rationale editor (DRed) which is understood to allow a much clearer view of the 
rationale structure and content than has previously been possible. An evaluation of the 
DRed tool in industry was shown to make the design process faster overall and more 
rigorous, and the rationale structure was clear to see and understand both by users and 
others. According to Bracewell and Wallace (2003), the tunnelling links in DRed 
simplified the preparation and presentation of large rationale structures in a way that no 
other DR system provided. Another particular advantage of the IBIS-based DRed DRC 
tool was the natural and intuitive interface which indicated that the system was easy to 
learn, easy to use and clear as an archival method (Bracewell and Wallace, 2003).  
 
DRed is a graphical software tool for design rationale capture that, despite essentially 
still being a research prototype, has proved robust and useful enough gradually to 
achieve use in an international aerospace company and like Compendium (Shum et al., 
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2006), both of these DRC tools are developments of the IBIS concept (Bracewell et al., 
2007). Figure 2-2 shows the links available in DRed (Kim et al., 2007). It is described 
by Kim et al. (2007) that a DRed path is the list of the links starting from a specific 
element and finishing at a specific element.  
 
 
Figure 2-2: An overview of different link types among the DRed elements (Kim et al., 
2007)  
 
2.2.2.2 Procedural Hierarchy of Issues  
The procedural hierarchy of issues (PHI) (McCall, 1991) method extends the original 
IBIS structure by introducing a quasi-hierarchical issue-serves-issue structure as 
illustrated in Figure 2-3. PHI is described to be a system of question-answering 
processes in which the question-answering processes are related to each other by inter-
issue dependencies called ‘serve relationships’.  
 
PHI has altered the IBIS structure by simplifying the relations among issues by use of 
the ‘serve’ relationship. It provides two methods that assess design issues which are 
known as deliberation and decomposition. The deliberation process is similar to that of 
IBIS whereby an argumentative approach is used. However, the decomposition process 
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includes the incorporation of a hierarchical structure and the introduction of a second 
argumentative process for solving issues.  
 
A central point of the PHI method is the ‘Prime Issue’ which should be explicitly raised 
and resolved. The end-point of using this method is that the prime issue is resolved. 
McCall (1991) has commented on how IBIS focuses on the argumentative processes 
associated with debate and disagreement. However, it is understood that PHI advances 
this and generalises the concept of argumentation as basing conclusions on premises 
(McCall, 1991).  
 
 
Figure 2-3: A quasi-hierarchical structure of sub-issues in PHI (McCall, 1991)  
 
Regli et al. (2000) have explained that a major advantage of PHI is that associated 
elements (issues, sub-issues, answers, and arguments) can be presented in the format of 
outlined text using indentations. In PHI, design is represented in a tree like-structure of 
nested issue-resolution process (Figure 2-3).  
 
In comparison to IBIS, PHI is described to provide dependency relationships between 
issue resolutions, and it also takes into consideration the pros and cons of alternative 
answers. The PHI concept has generated the development of a number of issue-based 
hypermedia systems which include; MIKROPLIS (McCall, 1989), ViewPoints (Fischer 
et al., 1989), AAA (Schuler and Smith, 1990), JANUS (McCall et al., 1990a), and 
PHIDIAS (McCall et al., 1990b).  
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2.2.2.3 Design Space Analysis: Questions, Options, and Criteria  
Design Space Analysis is described to be an argumentative-based approach for 
representing DR. It uses a semi-formal notation called questions, options, and criteria 
(QOC), to represent the design space surrounding an artefact (MacLean et al., 1991). It 
incorporates six types of elements (Questions, Options, Criteria, Assessments, 
Arguments, and Decisions) and includes relationships between the elements (inter-
question relationships).  
 
MacLean et al. (1991) have explained that a design space analysis did not produce a 
record of the design process but was rather a co-product of design which had to be 
constructed in conjunction with the artefact. By using the design space analysis, an 
artefact is placed in the space of different possibilities and explanations are sought as to 
why certain characteristics of the artefact or artefact were chosen from the identified 
possibilities. The QOC notation is illustrated in Figure 2-4.  
 
 
Figure 2-4: QOC notation (Shum and Hammond, 1994)  
 
The systematic development of a space of design options which are structured by 
questions is emphasised by the QOC representation (Figure 2-4). This is described as 
being different from IBIS-derived systems, whereby the aim of these are to capture the 
history of the design deliberation process (Regli et al., 2000). The design space is 
represented in QOC using three components (questions, options, and criteria) as 
illustrated by the QOC notation in Figure 2-4. The questions are used to discover the 
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main issues to structure the space of alternatives, whereas the options are used to offer 
possible answers to the questions. The criteria are then used as a basis for the evaluation 
and selection from the different options.  
 
One of the advantages highlighted by Regli et al. (2000) was that QOC could be used to 
‘reverse-engineer’ a part of a system or artefact whereby the information could be 
preserved for future use. Another advantage pointed out by Dutoit et al. (2006) was that 
QOC did not allow the designer to ignore questions regarding the features of an artefact. 
Li et al. (2002) have mentioned that the QOC representation brings the design 
objectives into explicit focus and as a result is able to overcome one the limitations 
identified in the IBIS structure. However, Dutoit et al. (2006) have highlighted that the 
authors of the QOC approach (MacLean et al., 1991) did not create software to support 
the framework although other researchers have incorporated QOC into some systems.  
 
2.2.2.4 Decision Representation Language  
Decision representation language (DRL) was developed for representing and managing 
the qualitative elements of decision making which includes; the alternatives considered, 
their existing evaluations, the arguments underlying those evaluations, and the 
evaluation criteria used (Lee and Lai, 1991). The term ‘decision rationale’ has been 
defined by Lee and Lai (1991) as being the representation of the qualitative elements 
(decision problems, alternatives, goals, claims, and groups). It has been mentioned that 
many of these qualitative elements and relationships correspond to certain aspects of 
IBIS and QOC (Dutoit et al., 2006).  
 
A ‘decision rationale management system’ is described to provide an environment for 
capturing decision rationale and the computational systems which uses it (Lee and Lai, 
1991). It has been acknowledged that DRL was proposed as an explicit representation 
of DR which focussed on the deliberation leading to a decision (Li et al., 2002). The 
object vocabulary in DRL consists of the following five design spaces; argument space, 
criteria space, alternative space, evaluation space, and the issue space. Figure 2-5 
provides an illustration of the DRL graphical notation.  
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Figure 2-5: DRL notation (Shum, 1991)  
 
The DRL model (Figure 2-5) has been embedded in the SIBYL system (Lee, 1990). 
SIBYL has been described to be a system that supports decision making by representing 
and managing qualitative aspects of decision making processes which include the 
alternatives, goals to be satisfied, and the arguments that evaluate the alternatives of the 
desired goals (Li et al., 2002). In SIBYL, the user does not have interaction with the 
graphs that display the entire DRL model. However, numerous views operating on 
subsets of the entities are available to the user (Shum, 1991). It is understood that 
SIBYL is able to computationally manipulate DR data in order to explore the 
implications of different aspects of design before finally making a commitment (Li et 
al., 2002).  
 
2.2.2.5 Other Design Rationale Representation Frameworks  
Since the year 2000, there has been some considerable development in design rationale 
representation frameworks. Table 2-5 lists the representation frameworks that have been 
identified from the available literature. Details such as the names of the authors 
including the date of publication, name of the representation framework, knowledge 
representation method and the design domain in which the representation framework 
has been applied to is provided (Table 2-5).  
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Table 2-5: List of design rationale representation frameworks  
Authors 
(date) 
Representation 
name / acronym 
Knowledge 
representation  
Design domain  
Schubanz et 
al. (2012)  
EvoPL  Extending QOC  
Product line 
evolution planning 
– software 
engineering  
Kannengiesser 
and Gero 
(2011)  
Function-Behaviour-
Structure (FBS) 
FBS Ontology  Generic  
Galvao et al. 
(2010)  
Eclipse Modelling 
Framework (EMF)  
N/A  
Modelling of 
architecture 
variability in 
software product 
lines  
Liang et al. 
(2009)  
DR Representation in 
Patent Documents  
N/A  
Patent 
documentation  
Bracewell et 
al. (2009)  
Design Rationale 
editor (DRed)  
Extending IBIS  
Aerospace 
engineering design  
Burge and 
Brown (2008)  
RATSpeak  Extending DRL  
Software 
development  
Medeiros and 
Schwabe 
(2008)  
Kuaba  Extending IBIS  Generic  
Billa et al. 
(2007)  
DR based model for 
the representation of a 
patient’s medical 
record  
Extending IBIS/QOC  
Medical patients 
records  
Tang et al. 
(2007) 
AREL  
Rationale-based 
architecture model  
Software design  
Boehm and 
Kitapci (2006)  
WinWin  Extending IBIS/DRL  
Software 
architecture  
Lacaze et al. 
(2006)  
Traceability, 
Exploration and 
Analysis Model 
(TEAM)  
Extending QOC  
Safety critical 
systems  
Nomaguchi et 
al. (2004)  
Hierarchical model of 
DR  
Extending IBIS  Generic products  
Brissaud et al. 
(2003)  
Design process 
rationale capture and 
support  
Conjectures and 
criteria  
Engineering design  
Kato et al. 
(2002)  
Integrated Design 
Information 
Management System 
(IDIMS)  
N/A  
Email 
communication  
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Table 2-5 shows that IBIS is the most popular choice for representing design knowledge 
within the DR research community. From the frameworks that are listed (Table 2-5), 
IBIS has been used more than any other method as the basis to represent design 
knowledge in a variety of design domains. This is followed by QOC and then DRL as 
the most popular methods to represent DR.  
 
2.2.3 Design Rationale Capture and Capture Tools  
2.2.3.1 Design Rationale Capture  
The task of eliciting, recording, and organising design knowledge is called DR capture, 
or DRC as it is more commonly abbreviated (Gruber, 1990). It has been described that 
the primary requirement of the DRC process is that it captures design descriptions in a 
form that supports the communication and reuse of design knowledge (Regli et al., 
2000).  
 
During the design process, DR is captured by recording the reasoning and by creating a 
structure (formal or semi-formal) in order for the DR to be used in the decision-making 
process during the design of an artefact. The DRC process is described to generally 
consist of two phases which are defined as knowledge recording and DR construction 
(Regli et al., 2000). Knowledge recording requires the capture of vast amounts of raw 
information during the design process, and DR construction involves the extraction, 
organisation, and storage of rationale knowledge based on the DR representation 
framework.  
 
One common way of documenting rationale has been described to use the structure of a 
designed artefact instead of the structure of an argumentative schema to organize 
rationale (Burge et al., 2008). Lee and Lai (1991) affirmed that this was one of the 
simplest and least labour-intensive ways to record rationale. When designing physical 
artefacts, this could be achieved by linking textual rationale to a digital model of the 
artefact being designed (Burge et al., 2008).  
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It has been pointed out by Regli et al. (2000) that the main aim of the DRC process was 
to capture design descriptions in a form that supported the reuse and communication of 
deliberated design knowledge. It was further recognised by Regli et al. (2000) that DRC 
methods could be divided into the following two categories: user-intervention based 
capture (user manually records and documents design information as it is generated 
during the design process), and automatic rationale capture (DRC tool automatically 
captures rationale). The user-intervention approach to DR capture often required the use 
of design documentation (documentation method) regarding the designed artefact. More 
than often, these were in the form of design reports that were created by individual 
designers or design teams at the end of a design process. This type of documentation 
recorded the design decisions that were taken during the artefacts development. 
However, this did not always include the argument for or against the decisions taken.  
 
To capture DR using the automatic capture method required the presence of a method to 
capture the communication of designers and design teams. Systems such as Computer-
Supported Co-operative Work Tools (CSCW) could be used for communication 
amongst designers and included a variety of tools such as; telephone, tape recorders, 
video camera, other shared applications, or email in order to capture oral discussions 
(Regli et al., 2000). Using the automatic capture method, DR could be determined from 
digital archives. However, there was a limitation using this method because there was 
no structure to the communication captured this way. This in turn, made retrieving the 
desired design knowledge difficult to obtain due to the lack of structure.  
 
2.2.3.2 Capture Tools  
A key goal of DRC tools is to provide an external design argument representation in 
order for users, generally designers, to create, direct, and review arguments. DR 
representation frameworks are the critical interface between the user and the DRC tool. 
Since the emergence of the first argumentation-based approach taken to capture 
rationale, there has been a growing interest in developing DRC tools to assist designers 
from different domains to record and reuse DR. It has been described that a DRC tool 
needs to record the analysis of various alternatives so that designers could easily make 
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their decision, and after the design is completed, be able store its rationale for future use 
(Regli et al., 2000). It is further explained by Regli et al. (2000) that DRC tools are 
intended to support communication, reflection, and analysis in design.  
 
The main approaches to developing DRC tools are either process-orientated (PO) or 
feature-orientated (FO). Regli et al. (2000) have explained that the FO approaches were 
frequently used in areas where a relatively high degree or standardisation occurred, and 
focussed on the representation of the artefact and the established rules which governed 
the design process. The PO approach was often used to create historical representations 
of the design process in dynamic domains where design principles were not well 
established (Shum and Hammond, 1994; Conklin and Yakemovic, 1991). The PO 
approach originated from the IBIS argumentation framework by Kunz and Rittel 
(1970).  
 
The main difference between the FO and PO approach is that the FO approach 
constructs DR as a logical structure whereas in the PO approach the DR is descriptive. 
As pointed out by Regli et al. (2000), the different approaches (PO and FO) were based 
on the different stages of the design process whereby the design could be either process-
orientated or feature orientated. The DR using the PO approaches were usually 
represented using graph-based notations which included; the use of nodes and links 
whereby the nodes indicated issues (questions), positions (options), and arguments. The 
links were indicated the different relationships among the nodes. This type of 
representation framework was described to provide a flexible structure and ease in 
recording the DR.  
 
Figure 2-6 shows the flow of information in most DRC tools (Atwood and Horner, 
2007). It is described that designers initially consider alternatives to design issues that 
they are faced with during the design of an artefact. Following this, they capture and 
store the rationale for their design decisions using a DRC tool. After this, another 
designer can browse the DRC tool to review the earlier decisions made and potentially 
apply these to current or new designs. This is described to take place in an 
organisational context.  
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Table 2-6 lists the commercial and prototype DRC tools from the year 2000 to date that 
have been identified in this review. The DRC tools have been categorised according to; 
the name of the computational system including the author and year of publication, 
knowledge representation framework used, knowledge capture method (semi-automatic 
- ‘Semi’; user-intervention – ‘UI’; automatic – ‘Auto’), knowledge retrieval (query or 
navigate), and design domain that the tool is being or has been developed for.  
 
 
Figure 2-6: Flow of information in most design rationale capture tools (Atwood and 
Horner, 2007)  
 
Table 2-6: List of prototype and commercial design rationale capture tools  
DRC tool 
acronym / 
name and 
authors  
(date)  
Knowledge 
representation  
Knowledge 
capture  
Knowledge 
retrieval  
Design 
domain  
Year  
DRC in PLM 
Systems 
(Pavkovic et 
al., 2010)  
Extending IBIS UI  Query Generic  2010 
Kuaba 
(Medeiros 
and Schwabe, 
2008) 
Extending IBIS Semi Query Generic 2008 
SEURAT 
(Burge and 
Brown, 2008) 
RATSpeak/ 
Extending DRL 
UI Query 
Software 
Development 
2008 
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AREL (Tang 
et al., 2007) 
N/A UI Query 
Software 
Design 
2007 
DREAM 
(Lacaze et al., 
2006) 
TEAM/Extendi
ng QOC 
UI 
Query or 
Navigate 
Safety Critical 
Systems 
2006 
WinWin 
(Boehm and 
Kitapci, 
2006) 
Extending 
IBIS/DRL 
UI N/A 
Software 
Architecture 
2006 
Sysiphus 
(Dutoit et al., 
2005) 
Extending 
QOC 
UI Navigate 
Software 
Engineering 
Courses 
2005 
Design 
Process 
Rationale 
(Brissaud et 
al., 2003) 
Conjectures 
and Criteria 
UI N/A 
Engineering 
Design 
2003 
CodeLink 
(Zaychik and 
Regli, 2003) 
N/A Auto N/A 
Software 
Development 
2003 
DRed 
(Bracewell 
and Wallace, 
2003) 
Graph-based 
IBIS 
UI 
Query or 
Navigate 
Aerospace 
Engineering 
2003 
IDIMS (Kato 
et al., 2002) 
Integrated 
Design 
Information 
Management 
System 
UI Navigate 
Satellite 
Development 
2002 
R-Objects 
Pepper (Ernst, 
2002) 
IBIS Meta-
Model 
UI Navigate Generic 2002 
HERMES 
(Karacapilidis 
and Papadias, 
2001) 
Extending IBIS UI Query Generic 2001 
Compendium 
(Conklin et 
al., 2001) 
IBIS UI Navigate 
Meeting 
Facilitation 
2001 
 
As can be observed from Table 2-6, there have been many DRC tools that have been 
developed since the year 2000 and the majority of these either use the IBIS structure or 
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have extended it. The design domains covered include: meeting facilitation (Conklin et 
al., 2001); satellite development (Kato et al., 2002); aerospace engineering (Bracewell 
and Wallace, 2003); software design and development (Zaychik and Regli, 2003; Dutoit 
et al., 2005; Boehm and Kitapci, 2006; Palyagar and Richards, 2006; Tang et al., 2007; 
Burge and Brown, 2008); engineering design (Brissaud et al., 2003); safety critical 
systems (Lacaze et al., 2006); and generic activities (Karacapilidis and Papadias, 2001; 
Ernst, 2002; Medeiros and Schwabe, 2008).  
 
This section has presented the state-of-the-art in prototype and commercially available 
DRC tools that have been developed since the year 2000. The following section 
presents the capabilities that DR currently has to offer.  
 
2.2.4 Design Rationale Capabilities  
The compiled list of capabilities for DR is provided in Table 2-7. Listed (Table 2-7) are; 
the actions that design rationale can perform, reference to indicate where the action was 
obtained from, outcomes of those actions, the extracted verb from the action, capability 
name of which the action is assigned to, capability sub-category name based on the 
noun of the action, and the capability identifier (labelled A to M) to denote the category 
of which the action is assigned to. The thirteen categories of DR capabilities that were 
identified from the literature reviewed and listed in Table 2-7 are: (A) Answer, (B) 
Capture, (C) Communicate, (D) Design, (E) Determine, (F) Document, (G) Explain, (H) 
Justify, (I) Provide, (J) Represent, (K) Structure, (L) Support, and (M) Teach.  
 
The capability sub-categories are: (Capability | A) design questions and design 
problems; (Capability | B) design knowledge and designers decisions; (Capability | C) 
design relationships, design space, information and logical reasoning; (Capability | D) 
artefact; (Capability | E) reasoning; (Capability | F) design decisions, design history, 
decision-making processes, design reasoning and logical reasoning; (Capability | G) 
design and reasoning; (Capability | H) argument; (Capability | I) historical evidence; 
(Capability | J) design reasoning, rationale and reasoning; (Capability | K) designers 
decisions; (Capability | L) designers; and (Capability | M) design.  
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Table 2-7: List of identified design rationale capabilities  
Reference  Actions  Verbs  Outcomes  
Capability 
names  
Capability sub-
category names  
Categories  
Haynes et al. 
(2008)  
To answer design 
questions.  
Answer  
Questions concerning a 
particular design are 
answered.  
Answer  Design Questions  A  
Li et al. (2002)  
To solve design 
problems.  
Solve  
Available method for 
problem solving in a design 
context.  
Answer  Design Problems  A  
Tang et al. 
(2006)  
To capture design 
knowledge.  
Capture  
Design knowledge and 
reasoning captured.  
Capture  Design Knowledge  B  
Haynes et al. 
(2008)  
To capture designers 
decisions.  
Capture  
Designer’s decisions and 
reasoning are captured.  
Capture  
Designers 
Decisions  
B  
Moran and 
Carroll (1996)  
To express the design 
relationships.  
Express  
Design relationships are 
expressed.  
Communicate  
Design 
Relationships  
C  
MacLean et al. 
(1989)  
To describe the design 
space.  
Describe  
Description of the design 
space is provided.  
Communicate  Design Space  C  
Atwood and 
Horner (2007)  
To transmit information.  Transmit  
Information transmitted 
from one designer to 
another.  
Communicate  Information  C  
Moran and 
Carroll (1996)  
To note logical 
reasoning.  
Note  Logical reasoning is noted.  Communicate  Logical Reasoning  C  
Moran and 
Carroll (1996)  
To design an artefact 
with explicit reasoning.  
Design  
Reasoning behind the design 
is made explicit.  
Design  Artefact  D  
Dutoit et al. To determine the Determine  Reasoning underlying a Determine  Reasoning  E  
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(2006)  reasoning behind a 
design.  
design is determined.  
Burge and Brown 
(2008)  
To document the design 
decisions.  
Document  
Design decisions are 
documented.  
Document  Design Decisions  F  
Jarczyk et al. 
(1992)  
To list the design 
decisions and reasoning.  
List  
Design decisions are 
explicitly listed.  
Document  Design Decisions  F  
Yakemovic and 
Conklin (1990)  
To record the design 
history.  
Record  
Historical evidence of the 
reasoning is provided.  
Document  Design History  F  
Moran and 
Carroll (1996)  
To document the design 
history.  
Document  
Historical evidence of the 
design process is provided 
Document  Design History  F  
Burge et al. 
(2008)  
To document the 
decision-making 
processes.  
Document  
Decision-making processes 
are documented.  
Document  
Decision-Making 
Processes  
F  
MacLean et al. 
(1991)  
To document the design 
reasoning.  
Document  
Design reasoning is 
documented.  
Document  Design Reasoning  F  
Moran and 
Carroll (1996)  
To record logical 
reasoning.  
Record  
Logical reasoning of a 
designed artefact is 
recorded.  
Document  Logical Reasoning  F  
Moran and 
Carroll (1996)  
To explain the reasoning 
behind the designed 
artefact. 
Explain  
Explanation of the designed 
artefact is provided.  
Explain  Design  G  
Gruber and 
Russell (1996)  
To explain the reasoning 
behind the design. 
Explain  
Explanation of the designed 
artefact is provided. 
Explain  Reasoning  G  
Lee (1997)  
To justify the argument 
behind the design 
decisions made.  
Justify  
Justification of the design 
decisions is provided.  
Justify  Argument  H  
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Burge and 
Bracewell (2008)  
To provide historical 
evidence.  
Provide  
Historical evidence of the 
design process is provided.  
Provide  Historical Evidence  I  
Shum (1996)  
To represent the design 
reasoning.  
Represent  
Reasoning underlying the 
designed artefact is 
represented.  
Represent  Design Reasoning  J  
Carroll and 
Rosson (1990)  
To illustrate rationale 
behind the artefact.  
Illustrate  
Rationale is embodied 
within the artefact.  
Represent  Rationale  J  
McKerlie and 
MacLean (1994)  
To represent the 
reasoning of design 
solutions.  
Represent  
Representation of the design 
solutions.  
Represent  Reasoning  J  
Haynes et al. 
(2008)  
To expose the reasoning 
underlying an artefact.  
Expose  
Rationale for a constructed 
artefact is exposed.  
Represent  Reasoning  J  
Regli et al. 
(2000)  
To structure designers 
decisions.  
Structure  
Designer’s decisions 
structured to a given 
framework.  
Structure  
Designers 
Decisions  
K  
Dutoit et al. 
(2006)  
To structure designers 
decisions.  
Structure  
Designer’s decisions 
structured to a given 
schema. 
Structure  
Designers 
Decisions  
K  
Lee (1997)  
To assist designers in 
decision-making.  
Assist  
Structured decision-making 
process.  
Support  Designers  L  
Atwood and 
Horner (2007)  
To support designers.  Support  
Reasoning and 
argumentation 
communication support 
system is established.  
Support  Designers  L  
Moran and 
Carroll (1996)  
To teach others about 
design.  
Teach  
Explanation of the designed 
artefact is provided. 
Teach  Design  M  
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
49 
2.2.5 An Overview of Medical Device Design  
2.2.5.1 Medical Devices  
The term medical device has been defined by the FDA to be; “an instrument, apparatus, 
implement, machine, contrivance, implant, in vitro reagent, or other similar or related 
article, including a component part, or accessory which is: intended for use in the 
diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or 
prevention of disease, in man or other animals, or intended to affect the structure or any 
function of the body of man or other animals, and which does not achieve any of its 
primary intended purposes through chemical action within or on the body of man or 
other animals and which is not dependent upon being metabolized for the achievement 
of any of its primary intended purposes” [1]1.  
 
In comparison, the European Commission (EC) have defined a medical device to mean; 
“any instrument, apparatus, appliance, software, material or other article, whether used 
alone or in combination, including the software intended by its manufacturer to be used 
specifically for diagnostic and/or therapeutic purposes and necessary for its proper 
application, intended by the manufacturer to be used for human beings for the purpose 
of: diagnosis, prevention, monitoring, treatment or alleviation of disease, diagnosis, 
monitoring, treatment, alleviation of or compensation for an injury or handicap, 
investigation, replacement or modification of the anatomy or of a physiological process, 
control of conception, and which does not achieve its principal intended action in or on 
the human body by pharmacological, immunological or metabolic means, but which 
may be assisted in its function by such means” [2].  
 
2.2.5.2 The Infusion Pump  
An example of a medical device is the infusion pump. The FDA has defined an infusion 
pump to be a medical device that is used in a healthcare facility to pump fluids into a 
patient in a controlled manner (CDRH: FDA, 2010a). The device may use a piston 
                                                 
1
 Numbers in the square brackets [n] indicate the citing of internet resources. A full list of the resources 
used can be found in the References: Internet Resources.  
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pump, a roller pump, or a peristaltic pump and may be powered electrically or 
mechanically. The device may also operate using a constant force to propel fluid 
through a narrow tube which determines the flow rate. The device may include means to 
detect a fault condition, such as air in, or blockage of, the infusion line and to activate 
an alarm. Figure 2-7 provides an illustrative example of an infusion pump.  
 
 
Figure 2-7: An example of an infusion pump (image obtained from: http://gzhuaxi.com/)  
 
The FDA has defined the infusion pump system to include the following (CDRH: FDA, 
2010a):  
 Infusion pump;  
 Fluid infusion set for the complete fluid pathway from, and including, the drug 
reservoir or fluid source container (e.g., bag cassette, vial, syringe), infusion set, 
extension sets, filter and valves, clamps, up to and including patient connection;  
 Components and accessories (e.g., power cord, wireless controller);  
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 Network (i.e., any device or system physically or wirelessly connected to the 
infusion pump);  
 Patient;  
 Environment of use (e.g., clinical setting, temperature, humidity); and  
 User (physician or lay user).  
There are many different types of infusion pumps, which are used for a variety of 
purposes and in a variety of environments. The FDA has described [20] that infusion 
pumps may be capable of delivering fluids in large or small amounts, and may be used 
to deliver nutrients or medications – such as insulin or other hormones, antibiotics, 
chemotherapy drugs, and pain relievers. The FDA continues to describe that some 
infusion pumps are designed mainly for stationary use at a patient’s bedside. Others, 
called ambulatory infusion pumps, are designed to be portable or wearable. The number 
of commonly used infusion pumps that are designed for specialised purposes have been 
identified by the FDA as follows [20]:  
 Enteral pump - A pump used to deliver liquid nutrients and medications to a 
patient’s digestive tract.  
 Patient-controlled analgesia (PCA) pump - A pump used to deliver pain 
medication, which is equipped with a feature that allows patients to self-
administer a controlled amount of medication, as needed.  
 Insulin pump - A pump typically used to deliver insulin to patients with 
diabetes. Insulin pumps are frequently used in the home.  
The FDA has also identified that different infusion pumps operate in the following 
different ways [20]:  
 In a syringe pump, fluid is held in the reservoir of a syringe, and a moveable 
piston controls fluid delivery.  
 In an elastomeric pump, fluid is held in a stretchable balloon reservoir, and 
pressure from the elastic walls of the balloon drives fluid delivery.  
 In a peristaltic pump, a set of rollers pinches down on a length of flexible tubing, 
pushing fluid forward.  
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 In a multi-channel pump, fluids can be delivered from multiple reservoirs at 
multiple rates.  
 A "smart pump" is equipped with safety features, such as user-alerts that activate 
when there is a risk of an adverse drug interaction, or when the user sets the 
pump's parameters outside of specified safety limits.  
The FDA has explained how clinicians and patients rely on pumps for safe and accurate 
administration of fluids and medications [21]. However, the FDA has identified 
problems that can compromise the safe use of infusion pumps. These problems are 
presented in the following subsection.  
 
2.2.5.3 Reported Infusion Pump Problems  
As with other medical devices, infusion pumps are not without risks. Significant safety 
issues related to infusion pumps have recently been reported by the FDA (CDRH: FDA, 
2010b). The FDA has stated that it has witnessed an increase in the number and severity 
of infusion pump recalls (CDRH: FDA, 2010a). A recall is when a product is removed 
from the market or a correction is made to the product because it is either defective or 
potentially harmful [22]. Analyses of medical device reporting regulations (MDRs) by 
the FDA have revealed device problems that appear to be the result of faulty design 
(CDRH: FDA, 2010a).  
 
Between January 2005 and December 2009, the FDA received over 56,000 MDRs 
associated with the use of infusion pumps, including numerous injuries and deaths. Of 
these reports, it is stated that approximately 1% were reported as deaths, 34% were 
reported as serious injuries, and 62% were reported as malfunctions (CDRH: FDA, 
2010a). These adverse event reports and device recalls have not been isolated to a 
specific manufacturer, type of infusion pump, or use environment; rather, they have 
occurred across the board (CDRH: FDA, 2010b).  
 
The FDA has explained how it has evaluated a broad spectrum of infusion pumps across 
manufacturers and has concluded that there are numerous, systemic problems with 
device design, manufacturing, and adverse event reporting (CDRH: FDA, 2010a). Many 
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of the reported events are related to deficiencies in device design and engineering, 
which can either create problems themselves or contribute to user error. In come 
reports, the manufacturer was unable to determine or identify the problem and reported 
the problem as “unknown.” It has been noted by the FDA (CDRH: FDA, 2010a) that 
subsequent root cause analyses revealed that many of the design problems were 
foreseeable and, therefore, preventable.  
 
According to the FDA (CDRH: FDA, 2010b), the most common types of reported 
problems have been associated with software defects, user interface issues, and 
mechanical or electrical failures. Examples of these types of problems are provided as 
follows [23]:  
 Software problems:  
o A software error message is displayed, stating that the pump is 
inoperable. This occurs in the absence of an identifiable problem.  
o The infusion pump interprets a single keystroke as multiple keystrokes (a 
problem called a “key bounce”). For example, the user programs an 
infusion rate of 10 mL/hour (millilitres per hour), but the device registers 
an infusion rate of 100 mL/hour.  
 Alarm errors:  
o The infusion pump fails to generate an audible alarm for a critical 
problem, such as an occlusion (e.g., clamped tubing) or the presence of 
air in the infusion tubing.  
o The infusion pump generates an occlusion alarm in the absence of an 
occlusion.  
 Inadequate user interface design (human factors issues):  
o The design of the infusion pump screen confuses the user, or the infusion 
pump does not respond as it should (i.e., with a warning or alarm) when 
inappropriate data is entered.  
o The infusion pump screen doesn’t make clear which units of 
measurement the user is expected to enter. For example, the user may 
enter weight in pounds when the infusion pump requires it in kilograms.  
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o Pump labels or components become damaged under routine use. For 
example, cleaning the pump, as the user-maintainer believes is 
acceptable practice, may damage the pump, making it unreliable for 
clinical use. Users with long fingernails may damage the print on the 
pump keys, making them unreadable.  
 Broken components:  
o The infusion pump may have been dropped or damaged during use, 
which may result in an over-infusion or an under-infusion if the pump 
continues to be used without being repaired.  
o The plastic casing of an insulin pump, although promoted as waterproof, 
is prone to cracking, allowing water to enter the case and to cause the 
pump to malfunction. See Figure 2-8.  
o Slight misalignment of tubing places stress on the pump door, resulting 
in eventual cracking of pump case. See the following figures: Figure 2-9, 
Figure 2-10 and Figure 2-11.  
 Battery failures:  
o A design issue causes over-heating of the battery and leads to premature 
battery failure. See Figure 2-12.  
o A patient returns from ambulating and forgets to plug in the infusion 
pump. The infusion pump alarms with a low battery message, but the 
speaker volume is set too low, and the alarm goes unnoticed. The 
infusion pump powers off after the battery is depleted.  
o The battery is not replaced during the recommended end of life routine 
maintenance.  
 Fire, sparks, charring, or shocks:  
o The user plugs in or unplugs the device from an electrical outlet and 
receives a shock, and/or sparks are seen.  
o A burning smell or flames are noted on the infusion pump. See Figure 
2-13.  
Figure 2-8 shows an image of the cracks between the operating buttons that allow water 
to get inside of the case.  
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Figure 2-8: Image showing the cracks between the operating buttons which allow water 
inside [23]  
 
Figure 2-9, Figure 2-10 and Figure 2-11 respectively show images of the; proper 
positioning of the tubing set, a close up of the tubing set out of alignment (the bump in 
the door will catch on the lower flange of the tubing set instead of fitting between the 
lower and upper flanges as intended), and the cracked door hinge resulting from stress 
caused by the misaligned tubing.  
 
 
Figure 2-9: Image showing the proper position of the tubing set [23]  
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Figure 2-10: Close up image of the tubing set out of alignment [23]  
 
 
Figure 2-11: Image showing a cracked door hinge resulting from stress caused by 
misaligned tube [23]  
 
Figure 2-12 shows an image of a design issue with the sealed lead-acid battery of the 
infusion pump. As shown (Figure 2-12), the damage to the battery is caused by over-
heating which, in turn, is the result of overcharging.  
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Figure 2-12: Image showing sealed lead-acid battery damage [23]  
 
Figure 2-13 shows two images linked together, the photomicrograph on the right 
illustrates the charring and melting of failed connectors after a fire that occurred when 
pump modules were attached to a running unit [23].  
 
 
Figure 2-13: Image showing the charring and melting of failed connectors [23]  
 
Based on the design issues which have been identified with the infusion pump, the FDA 
has announced (CDRH: FDA, 2010b) that it is taking steps to address infusion pump 
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problems through the Infusion Pump Improvement Initiative [24]. Details on the 
infusion pump improvement initiative are provided in the following subsection.  
 
2.2.5.4 Infusion Pump Improvement Initiative  
The FDA has recently launched the infusion pump improvement initiative (CDRH: 
FDA, 2010b) to address infusion pump safety problems. The FDA has explained how 
better infusion pump design and engineering could prevent recurrence of many of the 
problems that have been observed. It has been stated by the FDA (CDRH: FDA, 2010b) 
that is has taken actions to respond to the issues that have arisen on a largely case-by-
case basis; however, many of the same problems continue to occur.  
 
By launching the infusion pump improvement initiative, the FDA is taking a more 
proactive and comprehensive approach to prevent safety problems by fostering the 
development of safer, more effective infusion pumps, and supporting the safer use of 
these vital medical devices. Through the infusion pump improvement initiative, the 
FDA has stated [24] that it is taking the following steps to prevent infusion pump 
problems:  
1. Establishing additional requirements for infusion pump manufacturers;  
2. Proactively facilitating device improvements; and  
3. Increasing user awareness.  
In order to provide greater assurance that the design deficiencies are identified and 
corrected before they lead to safety issues, the FDA has described how manufacturers of 
infusion pumps are now required to include additional design and engineering 
information as part of their premarket submissions and conduct additional testing of 
their devices (CDRH: FDA, 2010b). The FDA has issued a new, total product life cycle 
(TPLC) draft guidance document for infusion pump manufacturers (CDRH: FDA, 
2010a). The guidance document has been developed to assist manufacturers of infusion 
pumps in preparing premarket notification submissions and to identify device features 
that manufacturers should address throughout the total product life cycle. By issuing 
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new guidance to manufacturers, the FDA intends to improve the quality of infusion 
pumps in order to reduce the number of device recalls and infusion pump MDRs.  
 
It has been explained by the FDA (CDRH: FDA, 2010b) that the draft guidance 
recommends that manufacturers are to provide detailed design and engineering 
information to the FDA during premarket review, and that each infusion pump 
premarket submission should include a comprehensive discussion of steps the 
manufacturer has taken to mitigate the risks involved at each stage of the device’s life 
cycle. The stages include; design, manufacture, servicing and maintenance, and use. The 
draft guidance also recommends that manufacturers are to conduct validation testing 
specific to the setting where the device is intended to be used. This is to account for the 
real-life environmental or user interface issues. When manufacturers are demonstrating 
the substantial equivalence of a new infusion pump intended for the U.S. market, the 
FDA has recommended that manufacturers submit information using a framework 
known as the assurance case or assurance case report (CDRH: FDA, 2010a). Details on 
the assurance case report are provided in the following subsection.  
 
2.2.5.5 Assurance Case Practice for Medical Devices  
An assurance case is described as a formal method for demonstrating the validity of a 
claim by providing a convincing argument together with supporting evidence (CDRH: 
FDA, 2010a). An assurance case structures arguments to help ensure that the top-level 
claims are credible and supported. The FDA has further described that in an assurance 
case, many arguments, with their supporting evidence, may be grouped under one top-
level claim. The FDA has stated that it believes the methodology will be particularly 
useful for presenting and reviewing information about infusion pumps (CDRH: FDA, 
2010a).  
 
An assurance case that addresses safety has been defined as a safety case (CDRH: FDA, 
2010a). A top-level claim (infusion pump is comparably safe) is supported by 
arguments that demonstrate how and why the evidence (performance data) supports the 
top-level claim. In a safety case, the arguments are typically organised in a hierarchical 
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manner with multiple layers of sub-claims, each supported by the appropriate evidence. 
It is intended that these arguments are to be used to convince a qualified reviewers that 
the top-level claim (infusion pump is comparably safe) is valid (CDRH: FDA, 2010a). 
Weinstock and Goodenough (2009) have stated that much like a legal case; the 
assurance case lays out an argument and supporting evidence to show that safety claims 
are valid. The FDA has identified the following three main elements of an assurance 
case:  
1. Claim: Statement about a property of the system or some subsystem.  
2. Evidence: Information that demonstrates the validity of the claim. This can 
include facts (based on observations or established scientific principles), 
analysis, research conclusions, test data, or expert opinions.  
3. Argument: Links the evidence to the claim. Arguments can be deterministic, 
probabilistic, or qualitative. The argument will describe what is being proved or 
established (the claim(s)), identify the items of evidence the manufacturer is 
appealing to, and the reasoning (inference, rationale) that the evidence is 
adequate to satisfy the claim. Arguments many also introduce sub-claims or 
assumptions which require further exposition.  
It is argued by Weinstock and Goodenough (2009) that a goal-structured assurance case 
holds promise to make the regulatory approval process less daunting by providing a 
means for the regulatory authority to understand just what beneficial properties the 
manufacturer is claiming for the device and how the evidence shows that the device is 
safe and effective. A goal structured assurance case specifies a claim regarding a 
property of interest, provides evidence that supports that claim, and provides a detailed 
argument explaining how the evidence supports the claim. Rather than having to work 
through piles of evidence with little to no guidance, an assurance case provides the 
examiner with a structure that is easier to follow (Weinstock and Goodenough, 2009).  
 
Weinstock and Goodenough (2009) have developed an assurance case for a generic 
infusion pump by adopting the GSN (Kelly, 1998). Figure 2-14 provides an example of 
a short assurance case developed in GSN.  
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Figure 2-14: An example of a GSN argument (Weinstock and Goodenough, 2009)  
 
2.2.5.6 Regulating the Approval of Medical Devices  
Uniquely, medical devices are products that require rigorous regulation before they can 
be sold in the U.S. or countries that are member states of the EU. It is understood that 
manufacturers of medical devices are held to a higher standard than manufacturers of 
many other products due to the potential severity of the consequences of introducing 
inferior or unsafe products to the market-place (McAllister and Jeswiet, 2003). 
 
In the U.S., medical devices are regulated by the Center for Devices and Radiological 
Health (CDRH) of the U.S. Food and Drug Administration (FDA). In the EU, the 
regulatory approval of medical devices relies on the use of notified bodies (NBs), which 
are independent commercial organizations that implement regulatory control over 
medical devices. It is understood that NBs have the ability to issue the CE mark, the 
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official marking required for certain medical devices (Kaplan et al., 2004). Both the 
U.S. and EU regulatory approval systems classify medical devices pursuant to their 
inherent risks and accordingly assign different regulatory control mechanisms to each 
designated class of device (Chai, 2000).  
 
In the U.S. approval system, medical devices are classified by the FDA into the 
following classes based on the intended use and risk the device presents to the patient 
[9]: Class I (low risk); Class II (medium risk); and Class III (high risk). In the EU, 
medical devices are grouped into the following classes (MHRA, 2009): Class I 
(generally regarded as low risk); Class IIa (generally regarded as medium risk); Class 
IIb (generally regarded as medium risk); and Class III (generally regarded as high risk). 
Examples of medical devices are for each of the aforementioned classes based on their 
risk are provided as follows: low risk (tongue depressors); medium risk (x-ray systems); 
and high risk (replacement heart valves).  
 
Regulatory approval practices for the U.S. and EU have been described by Kaplan et al, 
(2004). It is understood that there are many similarities between the U.S. and EU 
regulatory processes, and there are important differences that impact the time and cost 
associated with the introduction of a new medical device in the U.S. and EU. It was 
noted that the main differences between the two processes were; the use of notified 
bodies in the EU, criteria for approval, and the process required in obtaining approval.  
 
A comparative study of the medical device regulations in the U.S. and EU has been 
reported by Chai (2000). The study firstly reviews the U.S. and EU medical device 
classification systems and the requirements applicable to each class. Secondly, the U.S. 
and EU medical device regulations have been compared and contrasted according to 
their goals, implementation, and outcome. There were reported differences and 
similarities in the goals and implementation of the two regulatory approval systems, 
however it was also reported that it proved difficult to compare the outcome of the two 
approval systems’ due to the lack of data. It was noted that due to the differences in the 
U.S. and EU regulatory systems, medical device manufacturers had to meet both sets of 
regulatory requirements in order for the device to be placed in the U.S. and EU markets.  
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2.3 Discussion  
The discussion is presented in the order of the three research questions considered in 
this chapter. The following subsections discuss; how the definitions of design rationale 
have changed over the past ten years, the advancement in the state-of-the-art in design 
rationale representation frameworks; the capture tools that have been emerged since the 
seminal paper published by Regli et al. (2000), and the current capabilities of design 
rationale categorised in this chapter.  
 
2.3.1 Definitions of Design Rationale  
Before the year 2000, the design rationale research community have defined design 
rationale to include the reasons behind why design decisions regarding an artefact were 
made, the alternatives that were considered, a historical record of the reasons for 
making design decisions and representing the reasoning behind the design of an artefact. 
These definitions show that researchers in the design rationale community have 
considered design rationale to be notation for representing the design decisions that 
were undertaken during the development of an artefact.  
 
More recently, since the year 2000, the design rationale research community have 
defined design rationale to be a potential solution to help designers identify issues with 
a design, a method for capturing design knowledge, a methodology for problem solving 
and decision-making in a design context and that design rationale can answer questions 
regarding the design of an artefact.  
 
The more recent definitions of design rationale provided by the research community 
suggest that design rationale has evolved over the past ten years from a notation for 
representing design decisions to now being a methodological tool for problem solving 
and decision-making in a design context.  
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2.3.2 Representing and Capturing Design Rationale with the State-
of-the-Art Methods of Representation and Computational 
Support Tools  
Prior to the paper published by Regli et al. (2000), much attention had been focused on 
developing methods, notations and tools for recording rationales, the space or history of 
arguments surrounding the actual decision made. The prominent methods for 
representing design rationale were IBIS, PHI, QOC, and DRL.  
 
From the year 2000 onwards, IBIS and QOC have become the basis for many new 
methods for representing design rationale. Methods such as Kuaba, TEAM and the 
design rationale model applied to health care have extended the original capabilities of 
these two prominent methods. IBIS remains as the prominent method for representing 
design rationale and is the methodological basis of many computational support tools. 
Many design rationale capture tools that have been developed since the year 2000 have 
adopted the IBIS structure or have extended it to apply it to the chosen application 
domain.  
 
2.3.3 Current Capabilities of Design Rationale  
The discussion on capabilities that design rationale currently has to offer follows the 
structure of a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis 
framework. Firstly the strengths and weaknesses of the DR capabilities are considered 
and compared to each other using a quantitative analysis approach. The frequency of 
occurrences that DR researchers have mentioned a particular capability in peer reviewed 
journals has been used as this measure. Conversely, weaknesses are derived from the 
small frequency of mention by the DR research community in peer reviewed journal 
publications.  
 
Secondly, the opportunities for new research that could further advance the 
understanding of the capabilities that DR currently offers are investigated. These 
opportunities have been derived from identifying whether the current DR capabilities 
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characterised as weaknesses could be translated into future strengths and whether the 
capabilities could include other types of actors than they currently serve.  
 
Following this, the potential threats to the existing DR capabilities and continued 
advancement in DR research are presented. The potential threats have been identified by 
considering whether the current weaknesses constitute long term threats to DR research.  
 
2.3.3.1 Strengths  
Capabilities identified from the literature reviewed indicate that the major strengths of 
DR are communication, documentation, and representation. The capability ‘document’ 
has a frequency of seven occurrences. This is followed by the capabilities 
‘communicate’ and ‘represent’ which both have four occurrences. These three sum to 
half the total capabilities.  
 
2.3.3.2 Weaknesses  
The remaining capabilities comprise of one or two occurrences. The capabilities which 
occur twice are; ‘answer’, ‘capture’, ‘explain’, ‘structure’, and ‘support’. Capabilities 
that occur once are; ‘design’, ‘determine’, ‘justify’, ‘provide’, and ‘teach’. These low 
numbers of occurrences may reflect that the DR research community do not consider 
them to be particularly important, or as not well served by DR, or as only served by a 
small part of DR.  
 
Another weakness concerns the actors or users who utilise DR. Five out of the thirteen 
capabilities (‘capture’, ‘communicate’, ‘structure’, ‘support’ and ‘teach’) have identified 
designers to be the only actors concerned with the utilisation of DR. The remaining 
eight capabilities have no defined actors associated with the use of DR. This seems to 
be a weakness as there are other potential users of DR that are currently not mentioned 
in the literature which could benefit from using DR methods and tools. This is also 
emphasised by Carroll (2011) who explains that it is necessary for design rationale to be 
articulated by and accessible to anyone and everyone.  
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2.3.3.3 Opportunities  
The preceding discussion on the frequency of capabilities leads to the question of 
whether low frequency capabilities could contribute to future opportunities for DR. A 
way to examine this question would be by being able to demonstrate a need for these 
capabilities inside and outside the DR community. However, these needs have not been 
categorised within the DR literature itself. Therefore, it is suggested that this is a gap 
which constitutes an important future research opportunity for DR practitioners.  
 
Another opportunity for future research includes the targeting of new potential users of 
DR other than designers and the wider research and industrial communities in 
developing methods and tools that could be of benefit to the wider communities. If DR 
methods and tools could be utilised by users others than designers, this may expand the 
opportunities of receiving funding for future research and development. The DR 
community could perform an assessment of the types of actors involved in product 
development including who would potentially use the rationale and who would benefit 
from using it.  
 
2.3.3.4 Threats  
Despite over thirty years of research contribution and researchers efforts to develop DR 
methods and tools, the DR capabilities presented in this chapter have strongly 
emphasised only three capabilities (‘document’, ‘communicate’, and ‘represent’) out of 
the thirteen that were identified.  
 
The main threat to future DR research and advancement that is faced by the DR 
community is the limited number of potential users who utilise DR. This suggests that 
the DR research domain could wither due to lack of future interest from funding bodies. 
The DR community need to address potential users and assess how these actors could 
benefit from using DR. DR methods and tools should be made available to a variety of 
users other than designers. For example, DR could be used in diverse industrial settings 
by manufacturers, regulatory bodies, and policy-makers.  
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By not demonstrating the capabilities of DR outside of the DR research community, DR 
will remain only useful to designers and not to others who may also benefit from using 
DR methods and tools.  
 
This section has presented a discussion, using a SWOT analysis framework, on the 
capabilities that DR currently has to offer. The following sections in this chapter are as 
follows. A description of how the literature has answered the research questions is 
provided. Following this, gaps in existing knowledge that have been identified from the 
review of literature are outlined. Finally, a summary of the chapter is presented.  
 
2.4 How the Literature Informed the Research Questions  
This section presents answers to the three questions that were guiding this review of 
literature.  
 
Firstly, this review sought to answer the questions; what is meant by design rationale, 
and how is it commonly defined? This review of literature has presented various 
definitions of design rationale and it is understood that design rationale is inherently 
linked to the explanation of a set of reasons or a logical basis for a course of action in 
the generic context of design. It is also understood that the term ‘design’ has various 
definitions but more importantly, there is no agreed definition of design in the literature 
therefore it poses some difficulty in concisely defining what design rationale is.  
 
The second question posed was; what are the state-of-the-art in design rationale 
methods of representation and capture tools? There are four main methods for 
representing design rationale which are IBIS, PHI, QOC, and DRL. New frameworks 
for representing design rationale have been developed incorporating and extending the 
aforementioned methods to address their limitations. Many design rationale capture 
tools that have been developed since the year 2000 have adopted the IBIS structure or 
have extended it. Most recently, design rationale capture tools have been utilised for; 
meeting facilitation, satellite development, aerospace engineering, software design and 
development, engineering design, and safety critical systems.  
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The third and final question posed was; what are the current capabilities of design 
rationale? There were thirteen listed categories of design rationale capabilities that were 
identified from the literature reviewed. The thirteen categories of design rationale 
capabilities were; answer, capture, communicate, design, determine, document, explain, 
justify, provide, represent, structure, support, and teach. The design rationale 
capabilities presented in this chapter were analysed using a SWOT analysis framework. 
The SWOT analysis indicated that design rationale is strong on communication, 
documentation, and representation of design decisions. One of the weaknesses 
identified from the analysis highlighted that there are other potential users of design 
rationale that are currently not mentioned in the literature which could benefit from 
using design rationale. This presents an opportunity for the design rationale research 
community to assess the types of users who could potentially use design rationale and 
the benefits that it could provide. By not demonstrating the capabilities of design 
rationale to other potential users, design rationale will remain only useful to designers 
and not to others who may also benefit from its utilisation.  
 
2.5 Research Gaps  
The literature review has identified that there is currently a lack of published literature 
describing the use of design rationale with the medical device application domain. 
Sections 2.2.2 and 2.2.3, and in particular, Table 2-5 and Table 2-6, signify that design 
rationale representation frameworks and computational support tools have not been 
used to capture the design decisions of medical devices. It is intended that this 
significant gap in existing knowledge will provide the design rationale research and 
medical device communities with new incentives and insight into the possible 
integration of design rationale methods and tools with the regulatory approval of 
medical devices.  
 
The review of literature has also recognised that currently there are no existing 
guidelines or recommendations for manufacturers of medical devices and regulatory 
approval authorities in order to utilise design rationale methods and support tools. 
Furthermore, there is an evident gap in knowledge surrounding how design rationale 
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could be utilised with the regulatory approval of medical devices. This gap has been 
derived from reviewing the published literature in this chapter and identifying that 
design rationale methods and tools have not been applied to the medical device domain, 
specifically with the regulatory approval of medical devices. The review of literature 
has indicated, among others, four significant gaps in existing knowledge that this 
research investigation is dedicated to addressing:  
1. The utilisation of design rationale methods and tools with medical devices,  
2. The feasibility of design rationale for use with the regulatory approval of 
medical devices,  
3. How design rationale could be utilised with the development of medical devices 
for regulatory approval and the benefits it could provide, and  
4. The steps required for medical device manufacturers and regulatory authorities 
to capture and represent the design decisions of medical devices.  
 
2.6 Chapter Summary  
This chapter has presented a review of literature in the domain of design rationale and 
particularly reviewed the capabilities which design rationale has to currently offer. The 
capabilities presented in this chapter were derived from the literature and compiled 
based on the similarity of the extracted verbs from the actions which describe what 
design rationale can do. This has provided the researcher with a basis for understanding 
the different actions that design rationale can perform and the prospect of utilising the 
capabilities during the succeeding stages of this research investigation.  
 
The design rationale capabilities presented in this chapter were analysed using a SWOT 
analysis framework. The SWOT analysis indicated that design rationale methods and 
tools are strong on communication, documentation, and representation of rationale.  
Additionally and significantly, several gaps in existing knowledge have been identified, 
the three research questions guiding this literature review have been answered, and the 
first objective of the research has been addressed. The following chapter details the 
research design through by which the primary research question shall be addressed.  
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3 Research Design  
This chapter identifies pertinent research approaches and provides the rationale 
underlying the selected research design and data collection techniques.  
 
Based on the research questions and gaps in existing knowledge that were informed by 
the literature review in Chapter 2, this chapter presents the methodological approach 
utilised throughout this research to address the gaps and fulfil the objectives and aim of 
the research.  
 
This chapter identifies the pertinent research approaches and provides the rationale 
behind the selected research design and data collection techniques. Available research 
approaches are discussed and the selected methodology is presented. The applicable 
research methods employed by the researcher have been outlined together with the 
rationale underlying the selected research design.  
 
This chapter is structured as follows. Firstly, the designing of a research methodology is 
introduced. Secondly, the available research approaches and methods are presented and 
their applicability to the research investigation is assessed. Thirdly, the selection of the 
relevant methods and approaches are presented. This is followed by a description of the 
development of the research methodology which includes its initial development and 
detailed development stages. Following this, the strengths and weaknesses of the 
research design are discussed. Finally, this chapter summarises the research design and 
the methodology applied to the research investigation.  
 
3.1 Research Methodology Design  
During the initial phase of the research, the researcher considered it to be important to 
develop a structured and logical approach to conduct the research. In turn, this will 
provide further validation of the research. Furthermore, documenting the development 
of the research methodology and justifying the rationale underlying its development 
enhances its repeatability and reproducibility.  
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Robson (2002) has identified the following components that constitute a framework for 
research design: purpose (what is the study trying to achieve); theory (what theory will 
guide and inform the study); research questions (what questions is the research geared 
to providing answers); methods (what specific techniques will be used to collect data); 
and sampling strategy (where will the data be collected from). The relationship between 
these aspects is illustrated in Figure 3-1.  
 
The framework (Figure 3-1) shows that there is some directionality regarding the whole 
process. The purposes and theory lead into, and help specify the research questions. 
Once details appear concerning the research questions, decisions regarding the methods 
that need to be used and sampling strategy can be made.  
 
 
Figure 3-1: Framework for research design (Robson, 2002)  
 
It has been suggested by Robson (2002) that when conducting research, there is a 
propensity for researchers to assume that there is no other option to their preferred 
approach.  
 
Even though the applied research methods are determined by the research questions to 
some degree, there are still many ways to developing the research methodology. Robson 
(2002) has recognised that the methods or techniques employed must be appropriate for 
the research questions that require answering.  
 
research 
questions   
purpose(s) 
sampling  
strategy 
methods  
theory 
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3.2 Research Approaches  
There are two general approaches to research which are described as being either 
quantitative or qualitative (Robson, 2002).  
 
It is understood that quantitative research assumes that everything in the social world 
can be described or numerically measured (McQueen and Knussen, 2002). One of the 
main advantages of quantitative research is that data can be collected and analysed in a 
rational manner that can be repeated. Quantitative research and quantitative data is more 
commonly gathered in laboratory experiments and surveys, represented in tables, 
graphs, charts, as in many of the social and all of the natural sciences (Booth et al., 
2008). Robson (2002) likens this approach to a ‘fixed’ research design strategy whereby 
data are almost always in the form of numbers.  
 
Qualitative research is more commonly associated with behavioural and social studies 
in which precise outcomes from the studies cannot be anticipated, therefore ways in 
which to measure data are undetermined. This research approach originates from the 
area of anthropology and is an investigative approach which utilises methods and tools 
such as; observations, surveys, structured interviews, semi-structured interviews, 
unstructured interviews, and analysis of documents and materials (Creswell, 2003).  
 
Robson (2002) likens qualitative research to a ‘flexible’ research design strategy 
whereby the research design evolves during the data collection phases. This strategy 
shows substantial flexibility in anticipation that the design will emerge and develop 
during the collection of data. This is in contrast to the quantitative research approach 
which calls for a tight pre-specification of the design prior to data collection. Data 
collected using the flexible approach is described to be typically non-numerical (usually 
in the form of words); hence this type of approach is often referred to as a qualitative 
strategy. A comparison of the methods used in both the qualitative and quantitative 
research approaches is provided in Table 3-1 (Burns, 2000).  
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Table 3-1: Comparison of qualitative and quantitative research approaches (Burns, 2000)  
 Qualitative  Quantitative  
Assumptions  
- Reality socially constructed. 
- Variables complex and 
interwoven; difficult to 
measure. 
- Events viewed from 
informant’s perspective. 
- Dynamic quality to life. 
- Facts and data have an 
objective reality. 
- Variables can be measured 
and identified. 
- Events viewed from 
outsider’s perspective. 
- Static reality to life. 
Purpose  
- Interpretation. 
- Contextualisation. 
- Understanding the 
perspectives of others. 
- Prediction. 
- Generalisation. 
- Casual explanation. 
Method  
- Data collection using 
observation and interviews. 
- Concludes with hypothesis 
and grounded theory. 
- Emergence and portrayal. 
- Inductive and naturalistic. 
- Data analysis by themes 
from informant’s 
descriptions. 
- Descriptive write-up. 
- Testing and measuring. 
- Commences with hypothesis 
and theory. 
- Manipulation and control. 
- Deductive and experimental. 
- Statistical analysis. 
- Statistical reporting. 
- Abstract impersonal write-
up. 
Researchers role  
- Researcher as instrument. 
- Personal involvement. 
- Empathic understanding. 
- Researcher applies formal 
instruments. 
- Detachment. 
- Objective. 
 
Robson (2002) has described that in the flexible design research approach, rigorous data 
collection procedures are used, and multiple data collection techniques are typically 
employed. The data is then adequately summarised usually in tabular form and details 
of how the data are collected is provided. This approach includes detailed methods, a 
rigorous approach to data collection, data analysis, and report writing. Data can be 
collected from multiple sources such as documents, archival records, interviews, 
observations, and physical artefacts.  
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3.3 Research Methods  
The following three influential design traditions within qualitative research have been 
identified by Robson (2002): grounded theory, ethnography, and case study. It has been 
recommended by Robson (2002) that the researcher should keep within one research 
tradition, however as the research investigation evolves, features from other research 
traditions may also be useful and incorporated into the research design. Additionally, 
the flexible research design strategy incorporates the use of multiple techniques to 
collect and analyse data.  
 
A comparison of the key features of the grounded theory, ethnography, and case study 
methods is provided in Table 3-2. Descriptions of these methods are provided in the 
following subsections.  
 
Table 3-2: Comparing research traditions in qualitative research (Robson, 2002)  
 Grounded theory  Ethnography  Case study  
Focus  
Developing a 
theory grounded in 
data from the field  
Describing and 
interpreting a 
cultural and social 
group  
Developing an in-
depth analysis of a 
single case or 
multiple cases  
Discipline origin  Sociology  
Cultural 
anthropology, 
sociology 
Political science, 
sociology, 
evaluation, urban 
studies, many other 
social sciences  
Data collection  
Typically 
interviews with 20-
30 individuals to 
‘saturate’ 
categories and 
detail a theory  
Primarily 
observation and 
interviews during 
extended time in 
the field  
Multiple sources – 
documents, 
archival records, 
interviews, 
observations, 
physical artefacts  
Data analysis  
Open, coding, 
axial coding, 
selective coding, 
conditional matrix  
Description, 
analysis, 
interpretation  
Description, 
themes, assertions  
Narrative form  
Theory or 
theoretical model  
Description of the 
cultural behaviour 
of the group  
In-depth study of a 
‘case’ or ‘cases’  
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
78 
3.3.1 Grounded Theory  
The central aim of the grounded theory study is to generate theory from data collected 
during the study (Robson, 2002). According to Robson (2002), grounded theory is 
particularly useful in new, applied areas where there is a lack of theory and concepts to 
describe and explain what is going on. Data collection, analysis and theory development 
and testing are interspersed throughout the study. The typical features of grounded 
theory are as follows (Robson, 2002):  
1. applicable to a wide variety of phenomena;  
2. commonly interview-based; and  
3. a systematic but flexible research strategy which provides detailed prescriptions 
for data analysis and theory generation.  
It has been suggested by Strauss and Corbin (1998) that by adopting the grounded 
theory approach, it is likely to offer insight, enhance understanding, and provide a 
meaningful guide to action. However, during the commencement of the research 
investigation, the researcher had not generated a theory or hypotheses. The areas of 
design rationale research and medical device regulatory approval are well established 
and there is available and accessible data. Therefore, the grounded theory method will 
not provide any substantial guidance during the course of the research investigation.  
 
3.3.2 Ethnography  
It has been described by Robson (2002) that the ethnographic study seeks to capture, 
interpret and explain how a group, organisation, or community live, experience and 
make sense of their lives and their world. Typically, it tries to answer questions about 
specific groups of people, or about specific aspects of the life of a particular group. 
Robson (2002) has listed the following typical features of ethnography to include:  
1. selection of a group, organisation or community of interest or concern;  
2. immersion of the researcher in that setting; and  
3. use of participant observation.  
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The ethnography method is not applicable to the research investigation. The focus of the 
current study is on capturing and representing the design decisions of medical devices 
so that it can be used for regulatory approval. The research does not seek to capture, 
interpret, and explain how a group, organisation, or community live and experience 
their surroundings.  
 
3.3.3 Case Study  
It has been described by Huberman and Miles (2002) that the case study method is 
focussed on understanding the dynamics that are present in a single setting by utilising a 
combination of data collection methods. A case study is also strategy for doing research 
which involves an empirical investigation of a particular contemporary phenomenon 
within its real life context using multiple sources of evidence (Robson, 2002). The 
following typical features of the case study method have been outlined by Robson 
(2002):  
1. selection of a single case (or a small number of related cases) of a situation, 
individual or group of interest or concern;  
2. study of the case in its context; and  
3. collection of information via a range of data collection techniques including 
observation, interview, and documentary analysis.  
Robson (2002) has explained that case studies can follow an ethnographic or grounded 
theory approach, but are not required to. According to Huberman and Miles (2002), the 
case study method provides a more realistic and focussed view as compared to 
ethnography and the grounded theory approach. Gill and Johnson (1997) have also 
argued that the case study is relevant if there is a need to combine research with practice 
in the real world.  
 
Case studies can be performed on a group, on an institution, on a neighbourhood, on an 
innovation, on a decision, on a service, on a programme and on many other things 
(Robson, 2002). A list of the different types of case studies is presented in Table 3-3.  
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Table 3-3: List of the types of case studies (Robson, 2002)  
Case study type  Description  
Individual case study  
Detailed account of one person.  
 
Tends to focus on antecedents, contextual 
factors, perceptions and attitudes preceding a 
known outcome (e.g. drug use; immigrant 
status).  
 
Used to explore possible causes, determinants, 
factors, processes, experiences, etc., 
contributing to the outcome.  
Set of individual case studies  
As above, but a small number of individuals 
with some features in common are studied.  
Community study  
Study of one or more local communities. 
 
Describes an analyses the pattern of, and 
relations between, main aspects of community 
life (politics; work; leisure; family life; etc.).  
Commonly descriptive, but may explore 
specific issues or be used in theory testing.  
Social group study  
Covers studies of both small direct contact 
groups (e.g. families) and larger, more diffuse 
ones (e.g. occupational groups).  
 
Describes and analyses relationships and 
activities.  
Studies of organisations and 
institutions  
Studies of firms, workplaces, schools, trade 
unions, etc.  
 
Many possible foci, e.g. best practice; policy 
implementation and evaluation; industrial 
relations; management and organisational 
issues; organisational cultures; processes of 
change and adaptation; etc.  
Studies of events, roles and 
relationships  
Focus on a specific event.  
 
Very varied; includes studies of police-citizen 
encounters; doctor-patient interactions; 
specific crimes or ‘incidents’ (e.g. disasters); 
studies of roles conflicts; stereotypes, 
adaptations.  
 
The case study method is considered by the researcher to be the most appropriate 
method for utilisation with the current study. The rationale underlying this selection is 
presented in the following section.  
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3.4 Research Strategy Selection  
Consequential to comparing both the quantitative and qualitative research approaches, a 
qualitative research approach has been selected by the researcher and is to be adopted 
within the current research investigation. This selection is largely based on the empirical 
datasets required for the research investigation. It is anticipated that data will be 
emergent therefore a qualitative (flexible) research approach will offer the ‘flexibility’ 
needed to make any necessary modifications within the research design itself as and 
when required.  
 
Based on the comparison of the research traditions that are available in qualitative 
research, utilisation of the case study method was found to be the most applicable 
research strategy for the research investigation. The case study method is used to answer 
the primary research question and fulfil the aim and objectives of the research. This 
selection is mainly based on the exploratory nature of the research, the empirical 
datasets required for the research such as information regarding the regulatory approval 
processes for medical devices, the research setting, and research focus. Robson (2002) 
likens the use of case studies to exploratory work.  
 
The research will be conducted by utilising multiple analytical studies with the purpose 
of utilising them to develop the guidelines (Chapter 7). It is anticipated that the 
analytical case studies will provide insight into the development and implementation of 
the guidelines. The research investigation presented in this thesis is reporting on an in-
depth analysis of multiple cases. These cases consist of collecting data from a variety of 
sources and analysing documentation in order to address the objectives of the research.  
 
Based on the researcher’s selection of the flexible research design strategy and the case 
study method, the methodology developed and followed for the research investigation is 
presented in the following section of this thesis.  
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3.5 Research Methodology Development  
After considering the different research design approaches and methods and selecting 
the flexible research design strategy, this section presents the methodology that has been 
developed for the current study. The sequence of steps used in the initial development 
and detailed development stages of the methodology are illustrated and descriptions of 
each of the stages are provided.  
 
3.5.1 Methodology Representation  
The sequence of steps used to develop the initial and detailed stages of the methodology 
is represented using a set of descriptive process models. These models illustrate the 
initial and detailed stages as a set of linear and sequential activities.  
 
The IDEFØ process modelling tool was chosen to illustrate the research methodology, 
as it possesses a clear definition and graphical representation, and has been successfully 
used as both and analysis tool and as a communication tool in a number of application 
areas (Sagoo et al., 2009; Mayer et al., 1992). The software used to create the models 
illustrating both the initial and detailed stages of the methodology was the ‘BPwin 
Business Process Design Tool version 4.0’.  
 
The IDEFØ modelling technique consists of five constituents to model the process; 
activity name, input, control, and mechanism. Details regarding the graphical syntax of 
these constituents can be found in Chapter 5 of this thesis, Sagoo et al. (2009) and 
Mayer et al. (1992). Creating a descriptive process model using the IDEFØ process 
modelling tool, as a rule, commences with the definition of the top level or context 
activity. This is followed by identification of the proceeding functions or activities 
(decomposition) which are grouped depending on their relationship or similarity. It is 
this process which constructs the hierarchy of the model.  
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3.5.2 Methodology Development: Initial Stage  
The initial development stage of the research methodology is targeted at chapters 1, 2 
and 3. These three chapters provide a vital foundation for the research investigation. 
Figure 3-2 illustrates the context activity for the steps used for modelling the initial 
stages of methodology developed for the research investigation. The input into the 
context activity is the research context. This is converted into the output – selected 
research design strategy. To convert the input into the required output, physical 
resources such as data collection and data analysis are required. Controlling the initial 
methodology is the availability of published literature.  
 
 
Figure 3-2: Initial development of the research methodology – context activity  
 
The decomposition of the methodology (Figure 3-3) details the lower level activities 
that were undertaken in developing the initial methodology for the research 
investigation. Each of the individual activities from M1 to M5 has separate outputs 
signifying the results from each of the activities performed. These are direct inputs into 
the subsequent activities. Activity M6 converts this sequence of outputs into the final 
specified output, the selected research design strategy.  
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Figure 3-3: Initial development of the research methodology – decomposed activities  
 
As illustrated in Figure 3-3, there are six activities (M1 to M6) that comprise the initial 
research methodology. These are: Identify Research Issues (M1); Perform Initial 
Review (M2); Define Research Focus (M3); Perform Critical Review (M4); Identify 
Research Approaches (M5); and Assess Research Approaches (M6).  
 
Initial development of the research methodology firstly commences with identifying the 
research issues to be investigated by the research investigation (activity – M1). Input 
into the first activity (M1) is the research context. The output from this activity is the 
definition of the problem statement. This is a direct input into the following activity 
‘Perform Initial Review’ (M2).  
 
At activity M2, an initial review of literature is performed. Controlling this activity is 
the availability of published literature. Literature is searched, collected, and analysed 
and an initial set of research gaps are identified. As an output from activity M2, the 
initial research gaps identified from this initial literature review are a direct input into 
defining the focus of the research (M3).  
 
At activity M3, the focus of the research investigation is defined based on the research 
context (primary input) and identification of the initial research gaps (output from M2). 
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The main outputs from this activity (M3) are the definition of the primary research 
question, research aim and research objectives. These are a direct input into the 
following activity (M4).  
 
A critical review of literature on the state-of-the-art design rationale research is 
performed at the activity M4. Controlling this activity is the availability of published 
literature on design rationale research. Published literature is searched, collected, and 
analysed, and a set of comprehensive research gaps are defined. There are two outputs 
from this activity that are direct inputs into the following activity (M5) and the 
preceding activity (M3). As illustrated in Figure 3-3, the output returning to activity M3 
(labelled refine research focus and shown as a dashed line) acts as an iterative loop to 
refine the research objectives.  
 
Based on the defined research gaps from activity M4, at activity M5 the research design 
approaches are identified. The availability of published literature on research design 
approaches control this activity (M5). Data regarding the available research design 
approaches are collected from the available literature. This data details the available 
research approaches, methods and strategies, and is an output from this activity. This 
output is as a direct input into the final activity (M6).  
 
At the final activity (M6), the available research approaches, methods, and strategies are 
assessed for application with the current research investigation. The advantages and 
applicability of the different approaches are identified from the published literature 
which controls this activity. The output from this activity is the selection of the research 
design strategy.  
 
3.5.3 Methodology Development: Detailed Stage  
The detailed development stage of the research methodology is targeted at chapters 4, 5, 
6, 7, 8, and 9.  
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Figure 3-4 illustrates the context activity for the steps used for modelling the detailed 
methodology developed for the research investigation. The input into the context 
activity is the selected research design. This is converted into the output – verified 
research investigation. To convert the input into the required output, physical resources 
such as; data capture, data analysis, process modelling tool, and design rationale 
methods and tools are required. Controlling the detailed methodology is; the U.S. and 
EU medical device regulatory approval authorities, the availability of the medical 
device experts and researchers required for ensuring that validation can be undertaken, 
design rationale capabilities to identify the ability of design rationale to perform specific 
actions, and the availability of published literature to capture the necessary data required 
at the different stages of the research.  
 
 
Figure 3-4: Detailed development and implementation of the research methodology – 
context activity  
 
Decomposition of the methodology (Figure 3-5) details the lower level activities that 
are undertaken in developing the detailed methodology for the research investigation. 
Each of the individual activities from M1 to M5 represented in Figure 3-5 has separate 
outputs indicating the results from each of the activities performed. These are direct 
inputs into the following activities. Activity M6 converts this sequence of outputs into 
the final specified output, the verified research investigation.  
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Figure 3-5: Detailed development and implementation of the research methodology – decomposed activities  
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The detailed development stage of the methodology (Figure 3-5) commences with a 
comparison of the state-of-the-art in design rationale research with the state-of-the-art in 
medical device design (M1). The activities following this are: Analyse Approval 
Processes for Medical Devices (M2); Analyse Utilisation Possibilities (M3); Develop 
Guidelines (M4); Validate Guidelines (M5); and Discuss Research Findings (M6).  
 
The initial step of developing and implementing the detailed methodology for the 
research investigation (activity – M1) begins by comparing the state-of-the-art in design 
rationale research with the current state-of-the-art in medical device design. The initial 
input into activity M1, and the detailed methodology, itself is the selected research 
design strategy. At this activity (M1), data regarding the state-of-the-art in design 
rationale methods and existing best practices in the medical device domain are captured 
from the available published literature. The comparative analysis performed at this 
activity identifies the differences between the current best practices in medical device 
design and design rationale, establishes the vital benefits that design rationale could 
offer to the medical device community, and as an output from this activity, proposes the 
utilisation of design rationale with the regulatory approval of medical devices in 
addition to the existing best practices. This output is a direct input into the following 
activity (M2) and also acts as a control on the final activity (M6).  
 
The second step of methodology (activity – M2) involved analysing the existing U.S. 
and EU regulatory approval processes for medical devices. Data regarding the current 
regulatory approval practices for placing medical devices in the U.S. and EU markets is 
captured from the websites and documentation provided by the U.S. and EU regulatory 
authorities for medical devices. Availability of the regulatory approval data for medical 
devices provided by the U.S. and EU regulatory authorities acts as a primary control on 
activity M2. The comparative analysis performed at this activity (M2) is dependent on 
the current regulatory approval information made available by the U.S. and EU 
regulatory authorities. To perform the analysis, a process modelling tool is used to 
transform the data obtained from the regulatory authorities into a set of descriptive 
models which represent the current regulatory approval processes for placing medical 
devices into the U.S. and EU markets. These models are then analysed and compared 
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with each other to identify the differences and similarities between the regulatory 
approval processes for medical devices in the U.S. and EU. The output from activity M2 
is the classification of the U.S. and EU medical device regulatory approval process 
activities. This output is an input into the following activity (M3) and also controls the 
successful outcome of activity M6 (Discuss Research Findings).  
 
At activity M3, an analysis of the possibilities of utilising design rationale with the U.S. 
and EU medical device regulatory approval process activities is performed. The output 
from activity M2 is a direct input into activity M3. At this activity (M3), the U.S. and 
EU medical device regulatory approval process activities (output from activity – M2) 
are mapped with the design rationale capabilities that were identified from the critical 
literature review in Chapter 2. These capabilities specify the ability of design rationale 
to perform designated actions, thereby controlling the different possibilities of how 
design rationale could be used with the individual activities that constitute both the U.S. 
and EU medical device regulatory approval processes. The mapping of the design 
rationale capabilities with the U.S. and EU regulatory approval process activities 
identifies the regulatory approval activities where design rationale could be utilised. 
These activities are then analysed to identify how the capabilities of design rationale 
could be utilised and what benefits design rationale could provide. The analysis 
performed at activity M3 identifies a set of possibilities for utilising design rationale 
with the key activities of the U.S. and EU regulatory approval processes that were 
identified from the analysis as an output from this activity.  
 
Activity M4 develops the guidelines for utilising design rationale with the regulatory 
approval process activities for medical devices. The output from activity M3 is a direct 
input into this activity (M4) and provides the necessary basis for developing the 
guidelines. Data concerning the application of design rationale is captured and analysed 
from activity M3. The availability of published literature in the areas of; design 
rationale, medical device development, and regulatory approval control this particular 
activity (M4). The output from activity M4 is the guidelines for utilising design 
rationale with the regulatory approval of medical devices.  
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Once the guidelines have been developed (M4), medical device experts, and researchers 
are required for validating their utility and applicability at activity M5. The number of 
experts and researchers and the range of their expertise with respect to medical device 
development and regulatory approval control this activity (M5). Data concerning the 
validation is captured from the participating experts and researchers and analysed 
identifying the results from the validation activity. The output from activity M5 is the 
validated guidelines. This is a direct input into the final activity – discuss research 
findings (M6).  
 
The final activity in the detailed methodology is to discuss the findings from the 
research investigation (M6). The input into activity M6 derives from activity M5 
(validated guidelines), however the outputs from the previous activities (M1 to M4 and 
including M5) all control this final activity (M6). At this activity (M6), the findings 
from the different stages of the research (outputs from activities M1 to M5) are analysed 
in order to address the fulfilment of the research question, aim, and objectives. Once the 
findings from the different stages of the research are analysed and discussed, the final 
output from the detailed methodology developed for the research investigation (M6) is – 
a verified research investigation.  
 
Detailed methods that have been developed and followed for the different stages of the 
research as illustrated in Figure 3-5 (activities M1 to M6) are presented in the following 
chapters of this thesis: M1 (Compare State-of-the-Art) – Chapter 4 (Comparing the 
State-of-the-Art in Design Rationale with Medical Device Design); M2 (Analyse 
Approval Processes) – Chapter 5 (Regulatory Approval of Medical Devices); M3 
(Analyse Utilisation Possibilities) – Chapter 6 (Utilising Design Rationale with the 
Regulatory Approval of Medical Devices); M4 (Develop Guidelines) – Chapter 7 
(Guidelines for Utilising Design Rationale with the Regulatory Approval of Medical 
Devices); M5 (Validate Guidelines) – Chapter 8 (Validation); and M6 (Discuss 
Research Findings) – Chapter 9 (Discussion and Conclusions). The reasoning behind 
this is so the individual methods and results can be repeated and reproduced, thereby 
validating the research findings.  
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3.6 Strengths and Weaknesses of the Research Design  
The methodology developed and implemented for this research possesses both strengths 
and weaknesses in its design. These strengths and weaknesses are inherently linked to 
the available research approaches and methods selected which form the basis of the 
methodology developed for the current study. Strengths and weaknesses of the research 
design are discussed as follows.  
 
3.6.1 Strengths  
One of the major strengths of the selected and adopted research design approach is the 
specificity of the research investigation which addresses significant research gaps in two 
domains namely design rationale and medical device regulatory approval. The 
flexibility of the chosen research design allows the methodology to be developed and 
refined during the course of the research investigation. The development and refinement 
process also takes into account the results obtained from the different stages of the 
research, therefore assisting in the detailed methodology’s development. Flexibility of 
the research design has provided the opportunity to develop the detailed methodology as 
the data emerges throughout the course of the research investigation. This ensures that, 
as the data emerges, it can be captured, analysed and methodically synthesised so that it 
can be used as an input into developing detailed methods for the following research 
activities.  
 
The detailed methodology which incorporates the case studies, presented in the 
following chapters of this thesis, contains detailed methods that can be repeated, and as 
a consequence, the results can be reproduced accordingly. The adoption and use of the 
flexible research design approach has led to the emergence of data which consequently 
has reduced the amount of time that would have been spent in attempting to identify and 
capture the diverse datasets. As a result, this emergent data has alleviated time spent on 
data collection itself therefore presenting the researcher with the opportunity to 
capitalize on the time gained to analyse and synthesise data.  
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The research methodology implemented for this research investigation has been 
developed based on existing recognised approaches to research design. Due to the 
flexibility of the adopted research design approach and its limitations, data collection 
and analysis techniques from other research traditions may need to be incorporated into 
the methodology to provide a comprehensive understanding of the emergent data.  
 
3.6.2 Weaknesses  
The detailed methodology that has been specifically developed for the research 
investigation is based on the case study method and, as a result, has inherited some of 
its limitations. As with many qualitative research techniques, the case study method has 
been subject to criticism regarding its subjectivity, verification, and validity. However, 
the case study method can be more rigorous if all of the evidence is gathered and 
reported in an unbiased manner. In order to eliminate bias, the researcher has 
comprehensively documented the methods for data collection and analysis in an 
unbiased manner whereby these methods can be repeated thus ensuring the validity of 
the findings from the research.  
 
Due to the specificity and novelty of the methodology developed for the research 
investigation, external validation of the detailed methodology has not been performed 
prior to its implementation. The detailed methodology has been specifically developed 
by the researcher based on data which has emerged throughout the course of the 
research therefore validation of the detailed methodology prior to its implementation 
proved difficult to perform.  
 
A lack of collaboration with medical device manufacturers and regulatory authorities in 
identifying the requirements for the existing regulatory approval processes for medical 
devices in the U.S. and EU led to an increase in the amount of time spent searching and 
analysing the literature and documentation on the WWW.  
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3.7 Research Design Summary  
Following the definition of the primary research question, aim, objectives, and research 
gaps presented in Chapters 1 and 2, this chapter has identified the approaches that are to 
be followed in order to accomplish these goals. The decision to adopt and implement a 
flexible approach to the research design through the use of the case study method has 
been justifiably discussed.  
 
As illustrated at the detailed stage of the research methodology (decomposed activities) 
in Figure 3-5, the methodology will follow a sequential process in order to validate the 
research findings. This will be accomplished through:  
 analysis of current literature to address and validate the research findings;  
 continuous involvement with the case studies via documentary analysis and 
literature analysis; and  
 workshops with medical device experts and researchers to validate the research 
findings.  
Subsequent to the selection and definition of the research design presented in this 
chapter, the following chapters provide details of the research design’s implementation.  
 
  
 
 
 
  
CHAPTER 4  
 
 
 
 
 
 
 
 
 
 
COMPARING THE STATE-OF-THE-ART 
IN DESIGN RATIONALE WITH  
MEDICAL DEVICE DESIGN  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
97 
4 Comparing the State-of-the-Art in Design Rationale 
with Medical Device Design  
This chapter presents a comparative analysis of the state-of-the-art in design rationale 
with the state-of-the-art in medical device design.  
 
Literature concerning the state-of-the-art in design rationale research and medical 
device design were identified and reviewed in Chapter 2. The findings from the 
literature review are used to form the basis of the comparison presented in this chapter. 
This chapter compares the current capabilities of design rationale with the existing best 
practices in medical device design. This comparison establishes whether or not design 
rationale could be considered for utilisation with the medical device domain. This 
chapter addresses the second objective of the research. This chapter is structured as 
follows. Firstly, the methodology followed in order to perform the comparison is 
presented and described. Following this, the results obtained from the comparison are 
presented and analysed. Finally, this chapter concludes by summarising the findings 
from the analysis.  
 
4.1 Comparison Methodology  
The methodology followed for comparing the state-of-the-art in design rationale with 
the state-of-the-art in medical device design is presented in two stages as follows. 
Firstly, the ability of design rationale and assurance case practices to perform specific 
actions is identified and classified respectively. Secondly, an explanation of how the 
comparison was conducted is provided.  
 
4.1.1 Classifying the Capabilities of Design Rationale and 
Assurance Case Practices  
The design rationale capabilities (thirteen unique capabilities) that were identified from 
the literature reviewed in Chapter 2 (see section 2.2.4) are used in this chapter as a basis 
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for comparison. The capabilities for assurance case practices have been identified and 
captured from the seminal document published by Weinstock and Goodenough (2009). 
This is described as follows.  
 
The process of identifying the capabilities offered by the assurance case practice 
involved reading the entire document and analysing it with the goal of being able to 
classify the capabilities (the ability to perform specific actions). Descriptions of the 
actions that assurance case practices are able to perform were taken directly from the 
document (Weinstock and Goodenough, 2009).  
 
The actions were noted and compared with each other to distinguish them from one 
another in order to ensure that one action was not a synonym of another which was 
identified from the document. The outcome (end result of the action) was noted in the 
form of what can be accomplished by assurance case practices. The verb describing the 
action performed by the assurance case practice was extracted from the statement of the 
action. The verb was then used as the basis to derive the name of the capability. This 
information was then used to develop a list of capabilities for the assurance case 
practice.  
 
4.1.2 Comparing the Design Rationale and Assurance Case 
Practices Capabilities  
In order to conduct the comparison, the ability to perform specific actions of design 
rationale (design rationale capabilities identified and categorised in Chapter 2) is 
compared with the actions that assurance case practices have the ability to perform 
(assurance case practice capabilities presented in section 4.2.1). These capabilities of 
design rationale are compared with the identified capabilities of the assurance case 
practice. A matrix is used to list and compare the capabilities of both design rationale 
and assurance case practices as shown in Table 4-1.  
 
Capabilities for design rationale are listed at the top of the table using the capability 
identification label (A to M to denote the thirteen capabilities) that was defined in 
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Chapter 2. At the left side of the table (Table 4-1), the capabilities for assurance case 
practices are listed according to the name of the capability. The star symbol (*) in the 
table (Table 4-1) indicates that the capabilities are represented by both design rationale 
and assurance case practices.  
 
Table 4-1: Matrix for comparing the design rationale and assurance case capabilities  
  Design rationale capability identification label (A to M) 
  A  B  C  D  
A
ss
u
ra
n
ce
 c
a
se
 c
a
p
a
b
il
it
y
  A *    
B  *   
C   *  
D    * 
 
The analysis of the results involves identifying the similar, same, or different 
capabilities that assurance case practices have to offer as compared to the capabilities of 
design rationale that have been previously identified (Chapter 2). The results from the 
comparison are presented and analysed in the following section of this chapter.  
 
4.2 Results  
Results obtained from the comparison of the design rationale capabilities and the 
capabilities for assurance case practices are presented as follows. First of all, the 
capabilities that have been identified for assurance case practices are presented. Second 
of all, these capabilities are compared with the design rationale capabilities.  
 
4.2.1 Assurance Case Practice Capabilities  
Capabilities for assurance case practices (the ability of assurance cases to perform 
specific actions) have been identified from Weinstock and Goodenough (2009) and are 
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listed in Table 4-2. Listed in the table (Table 4-2) are the actions that assurance case 
practices have the ability to perform, the extracted verb that has been used to define the 
action, the outcome of what that actions leads to, the name of the capability based on the 
verb, and an alphabetic capability identifier for each unique capability.  
 
Table 4-2: List of identified assurance case practice capabilities  
Actions  Verbs  Outcomes  
Capability 
names  
Capability 
identifier 
To represent 
safety 
requirements.  
Represent  
Safety 
requirements are 
represented.  
Represent  A  
To document 
the device being 
manufactured.  
Document  
Device being 
manufactured is 
documented.  
Document  B  
To structure 
generic safety 
arguments.  
Structure  
Generic safety 
arguments are 
structured.  
Structure  C  
 
As shown in Table 4-2, there are currently three capabilities that assurance case 
practices have to offer which have been identified from the seminal document published 
by Weinstock and Goodenough (2009). These capabilities have been identified as: 
represent, document, and structure. The capabilities for assurance case practices 
identified and listed in Table 4-2 are used in the following subsection for the 
comparison.  
 
4.2.2 Comparison of the Design Rationale Capabilities and 
Assurance Case Practice Capabilities  
The capabilities that have been identified for assurance case practices in the previous 
subsection (represent, document, and structure) are compared with the thirteen 
capabilities of design rationale that were identified in Chapter 2. The thirteen 
capabilities of design rationale are presented in Table 4-3. The capabilities of design 
rationale are compared with the capabilities of assurance case practices in Table 4-4.  
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Table 4-3: List of design rationale capabilities  
Capability names  
Design rationale capability 
identifier 
Answer  A  
Capture  B  
Communicate  C  
Design  D  
Determine  E  
Document  F  
Explain  G  
Justify  H  
Provide  I  
Represent  J  
Structure  K  
Support  L  
Teach M  
 
Table 4-4: Comparing the design rationale and assurance case practice capabilities  
 
 Design rationale capabilities  
 
 A  B  C  D  E F G H I J K L M 
A
ss
u
ra
n
ce
 c
a
se
 
ca
p
a
b
il
it
ie
s 
A          *    
B      *        
C           *   
 
The comparison of the capabilities of design rationale and assurance case practice 
capabilities presented in Table 4-4 shows that the assurance case practice has three 
capabilities that are identical with three of the design rationale capabilities. These 
identical capabilities are; represent, document, and structure. However, the assurance 
case practice does not have any other capabilities that are unique. In comparison, design 
rationale has ten other capabilities that are unique in which they describe the ability of 
design rationale to be able to perform ten more specific actions than compared to 
assurance case practices. These ten capabilities consist of: Answer, Capture, 
Communicate, Design, Determine, Explain, Justify, Provide, Support, and Teach.  
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4.3 Chapter Summary  
This chapter has presented a comparison of the state-of-the-art in design rationale with 
the state-of-the-art in medical device design.  
 
The comparison consisted of comparing the design rationale capabilities that were 
identified from the literature reviewed in Chapter 2 with the capabilities identified from 
the existing best practices in medical device design, the assurance case practice for 
medical devices. Capabilities for the assurance case practices were identified and 
defined in this chapter in order to conduct the comparison.  
 
Results from the comparison have highlighted that design rationale and assurance case 
practices for medical devices share the ability to perform three generic actions, although 
the differ in their specific outcomes.  
 
Design rationale and assurance case practices both share the ability to represent, 
document and structure information that could be used to communicate the knowledge 
underlying the development of a medical device. In contrast, design rationale has the 
ability to perform an additional ten actions which signifies that it is further advanced 
than the current state-of-the-art in medical device design.  
 
This chapter has addressed the second objective of the research.  
 
  
CHAPTER 5  
 
 
 
 
 
 
 
 
 
 
REGULATORY APPROVAL OF  
MEDICAL DEVICES  
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5 Regulatory Approval of Medical Devices  
This chapter identifies the individual activities that constitute the U.S. and EU 
regulatory approval processes for medical devices and provides a comparative analysis 
of the two processes highlighting their similarities and differences.  
 
Currently, there is a lack of models available in the published literature which represents 
the U.S. and EU medical device regulatory approval processes. In this chapter, 
descriptive models illustrating the U.S. and EU medical device regulatory approval 
processes have been constructed using a recognised process modelling tool. These 
models are derived from publicly available data obtained from the U.S. and EU 
regulatory authorities, individually analysed and compared with each other. The models 
illustrate the different stages that constitute the U.S. and EU regulatory approval of 
medical devices.  
 
Individual activities that comprise the existing processes for regulating the approval of 
medical devices in the U.S. and EU are identified in this chapter. The third objective of 
the research is addressed in this chapter by revealing the individual process activities 
that are currently required for placing medical devices in the U.S. and EU markets.  
 
This chapter is presented in the following stages. Firstly, the methodology followed for 
modelling and comparing the U.S. and EU medical device regulatory approval 
processes is described. This is followed by the results from the individual analysis of the 
two descriptive models, each representing the U.S. and EU medical device regulatory 
approval process respectively. Following this, the descriptive models are compared with 
each other and the findings from the comparison are discussed. Finally, the research 
questions guiding this chapter are addressed and a summary of the findings is provided.  
 
5.1 Methodology  
The methodology followed for modelling and comparing the U.S. and EU regulatory 
approval processes for medical devices is presented a follows.  
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Firstly, the research questions guiding the comparative analysis presented in this chapter 
are defined. Secondly, the selection and rationale underlying the process modelling tool 
is presented. This is followed by the methodology used for modelling and analysing 
both U.S. and EU regulatory approval process. Following this, the identification of data 
sources and data collection and analysis techniques are described. This is followed by 
an explanation of how the models are to be compared with each.  
 
5.1.1 Defining the Research Questions  
Each regulatory approval process presented in section 5.2 has been mapped in order to 
identify the main activities, analysed, and then compared with reference to the following 
questions:  
1) What do the U.S. and EU regulatory approval processes for medical devices 
entail?  
2) What are the different stages that constitute the U.S. and EU regulatory approval 
of medical devices?  
3) What are the differences and similarities between the U.S. and EU regulatory 
approval processes?  
 
5.1.2 Process Modelling Tool Selection  
The IDEFØ modelling tool was chosen to model the regulatory approval processes. The 
justification for this choice can be found in section 5.1.3.3.  
 
The IDEFØ process modelling technique consists of five constituents to model the 
process, as shown in Figure 5-1. These are: activity name (clarifies the objective of the 
activity), input (represents the information to be converted by a particular activity into 
an output), control (applies rules to regulate the imposing constraints of an activity), 
output (direct result of the information produced by an activity), and mechanism 
(physical resources required to perform the activity which can include people, 
equipment and software tools).  
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Figure 5-1: IDEFØ constituents  
 
Creating a process model usually begins with raw data obtained from identified sources 
of information for a particular area of interest followed by identification of the activities 
performed.  
 
A process model includes a set of activities arranged in a specific order, with clearly 
identified inputs and outputs (Zakarian and Kusiak, 2000). The top level or context 
activity (activity - A0 or M0) is primarily defined followed by identification of the 
proceeding functions or activities (decomposition). These are then grouped depending 
on their relationship or similarity. It is this process that constructs the hierarchy of the 
model to be analysed.  
 
5.1.3 Modelling and Analysing the U.S. and EU Medical Device 
Regulatory Approval Processes  
The steps for modelling and comparing the U.S. and EU medical device regulatory 
approval processes in this chapter have themselves been illustrated using the IDEFØ 
tool (Figure 5-2 and Figure 5-3). They are described in detail in the following 
subsections. Figure 5-2 illustrates the higher-level context activity (M0) and Figure 5-3 
shows the lower-level decomposed activities (M1 to M6).  
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The inputs into the context activity were the descriptions of the existing U.S. and EU 
practices for the regulatory approval of medical devices. This was converted into the 
output – comparison of the U.S. and EU medical devices regulatory approval processes. 
To convert the input into the required output, physical activities, and resources such as 
data capture, data analysis and process modelling tool were required. Controlling the 
overall methodology were the availability of the required data and the modelling tool 
selection criteria for selecting the most appropriate process modelling tool.  
 
 
Figure 5-2: Context activity of the methodology (M0) – steps for modelling and comparing 
the U.S. and EU regulatory approval processes  
 
The decomposition of the methodology (Figure 5-3) details the lower-level activities 
that were performed to create and compare the U.S. and EU medical devices regulatory 
approval process models.  
 
Each of the individual activities from M1 to M6 had separate outputs signifying the 
results from each of the activities performed. These were direct inputs into the 
subsequent activities. Activity M6 converted this sequence of outputs into the final 
specified output, comparison of the U.S. and EU medical devices regulatory approval 
processes.  
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Figure 5-3: Decomposed activities of the methodology (M1 to M6) – steps for modelling 
and comparing the U.S. and EU regulatory approval processes  
 
5.1.3.1 Identifying Data Sources  
The sources of information that were identified (M1) and considered to be of direct 
relevance in providing the necessary data concerning the activities and requirements for 
the regulatory approval of medical devices in the U.S. and EU, are the output from 
activity M1 (Figure 3). These are listed in Table 5-1. Abbreviations listed throughout 
the chapter are specified in the appendix (Appendix B: Tabulation of Activities and 
Their Controls, Mechanisms and Outputs for the U.S. and EU Processes).  
 
Table 5-1: List of identified data sources for medical device regulations in the U.S. and 
EU  
Organisation Abbreviation 
Geographic 
Area 
Role Reference 
World Health 
Organisation 
WHO International 
Directing and 
coordinating 
authority for 
health within 
the United 
(WHO, 2003)  
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Nations 
system 
U.S. Food and 
Drug 
Administration 
FDA 
United States 
of America 
Responsible 
for protecting 
the public 
health in the 
U.S. 
[3]  
European 
Commission 
EC Europe 
Concerned 
with the 
regulatory 
framework of 
medical 
devices for 
market access 
[4]  
Medicine and 
Healthcare 
products 
Regulatory 
Agency 
MHRA 
United 
Kingdom 
Responsible 
for the 
regulation of 
medicines and 
medical 
devices in the 
EU 
[5]  
British 
Standards 
Institute 
BSi 
United 
Kingdom 
Inspection and 
certification of 
medical 
products 
[6-7]  
Intertek - International 
Inspection and 
certification of 
medical 
products 
[8]  
 
5.1.3.2 Data Collection  
Data was collected (M2) from the sources identified in the preceding activity (M1). 
Table 5-2 presents a list of the source documents collected. Data collected and directly 
referenced from the websites of the U.S. and EU regulatory authorities for medical 
devices can be found in section 5.1.3.4.  
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Table 5-2: List of documents containing data for medical device regulations in the U.S. 
and EU  
Document Name Organisation Date Reference 
Medical Devices: Guidance 
Document, Classification of 
Medical Devices 
EC 2010 
European 
Commission 
(2010)  
Bulletin No.17: Medical 
Devices and Medicinal 
Products 
MHRA 2009 MHRA (2009)  
Medicines & Medical Devices 
Regulation: What you need to 
know 
MHRA 2008 MHRA (2008a)  
Bulletin No.4: Conformity 
Assessment Procedures 
(Medical Device Regulations) 
MHRA 2008 MHRA (2008b) 
Bulletin No.2: The CE Mark MHRA 2007 MHRA (2007) 
Council Directive 93/42/EEC 
on Medical Devices (MDD) 
EC 2007 
European 
Commission 
(2007) 
Guidance Notes for 
Manufacturers of Class I 
Medical Devices (EC Medical 
Devices Directives) 
MHRA 2006 MHRA (2006a)  
Bulletin No.8: Information 
About the EC Medical Devices 
Directives 
MHRA 2006 MHRA (2006b)  
Bulletin No.10: The 
Classification Rules 
MHRA 2006 MHRA (2006c)  
Bulletin No.18: The Medical 
Devices Regulations: 
Implications on Healthcare and 
Other Related Establishments 
MHRA 2006 MHRA (2006d) 
Design Control Guidance for 
Medical Device Manufacturers 
FDA 1997 
CDRH:FDA 
(1997)  
Medical Device Quality 
Systems Manual: A Small 
Entity Compliance Guide. 
FDA 1996 
[9]; CDRH:FDA 
(1996) 
Certification for Medical 
Devices 
BSi - [6]  
CE Marking for Medical 
Devices 
BSi - [7]  
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5.1.3.3 Modelling Tool Selection  
Modelling tools were considered and assessed for constructing the two regulatory 
approval process models (M3) in order to graphically illustrate the U.S. and EU 
regulatory approval processes. Controlling this activity was the modelling tool selection 
criteria (definition, concept, motivation, theory, graphical representation, and analysis 
tool).  
 
5.1.3.4 Data Analysis  
On completion of the data collection activity (M2) and modelling tool selection (M3), 
the outputs from activities M2 and M3 were direct inputs into activity M4 – ‘Analyse 
Data’.  
 
In M4, a detailed analysis of the qualitative data was performed in order to define the 
individual activities performed by the device manufacturers and regulatory authorities in 
the two processes that are required for medical device approval in the U.S. and EU.  
 
The activities that constituted the U.S. and EU regulatory approval processes were 
primarily identified from the data sources (Table 5-1 and Table 5-2). The sequence of 
steps required for the regulatory approval of medical devices in the U.S. and EU was 
noted. This information was then used to define the activities (Table 5-3 and Table 5-4).  
 
Having defined these activities, for each activity the inputs, outputs, factors controlling 
the regulatory approval activities (controls), and the physical resources required to 
undertake those activities (mechanisms) were defined.  
 
Table 5-3 shows the data sources used for each defined activity for the U.S. regulatory 
approval process.  
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Table 5-3: List of the U.S. data sources used in the data analysis  
IDEFØ 
Activity 
Name 
Inputs Controls Outputs Mechanisms 
A1 – Define 
Device [10]  
Medical 
Device 
Intended for 
Human Use 
[11]  
Device 
Definition [14] 
(contained in 21 
CFR 862-892) 
Defined 
Medical 
Device [10]  
FDA Website 
[14]; 
Device 
Manufacturer 
[10]  
A2 - Classify 
Device [10] 
Defined 
Medical 
Device [10]  
Device 
Classification 
Criteria [14]; 
Regulatory 
Controls [15]  
Classified 
Device: Class I 
[14]; 
Classified 
Devices: 
Classes II and 
III [14]  
CDRH 
Classification 
Database [14]; 
Device 
Manufacturer 
[10]  
A3 – Select 
Marketing 
Process [14]  
Classified 
Devices: 
Classes II and 
III [14]  
Device 
Classification 
Criteria [14]; 
Regulatory 
Controls [15]; 
Marketing 
Clearance 
Requirements 
[10]  
Premarket 
Notification 
510(k) 
Requirements 
and Premarket 
Approval 
Application 
(PMA) 
Requirements 
[10]  
FDA Website 
[11]; 
Device 
Manufacturer 
[10]  
A4 – Prepare 
Marketing 
Application 
[10]  
Premarket 
Notification 
510(k) 
Requirements 
and Premarket 
Approval 
(PMA) 
Requirements 
[10]  
Marketing 
Clearance 
Requirements 
[10]; 
Quality System 
Regulations 
(QSR) [16]  
Device Data 
and 
Documentation 
[10]  
Device 
Manufacturer 
[10]; 
Clinical Trials 
[10]; 
Clinical 
Performance 
Data [10]; 
Quality 
Management 
System (QMS) 
[16, 19]  
A5 - Submit 
Marketing 
Application 
[10]  
Device Data 
and 
Documentation 
[10]  
Application 
Submission 
Requirements 
[11]  
Device 
Marketing 
Application 
[10]  
FDA Website 
(MHRA, 
2008b); 
Device 
Manufacturer 
[10]  
A6 – Review 
Device 
Application 
Device 
Marketing 
Application 
PMA 
Regulations (21 
CFR 814; 
Device 
Approvable 
Letter [13]  
FDA 
Personnel [13]  
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[11-13]  [10]  510(k) 
Regulations 
FD&C Act; 
Refuse to File 
policy) [13]  
A7 – Register 
Device 
Details [10]  
Device 
Approvable 
Letter [13]; 
Classified 
Device: Class I 
[14]  
Marketing 
Clearance 
Requirements 
[10]; 
Premarket 
Requirements 
[10]  
Medical 
Device 
Registered for 
Intended Use 
in the U.S. 
with the FDA 
[10]  
Device 
Manufacturer 
[10]; 
FDA Website 
[11]  
A8 – Market 
Device [10]  
Medical 
Device 
Registered for 
Intended Use 
in the U.S. 
[10]  
Marketing 
Clearance 
Requirements 
[10]; 
Post market 
Requirements 
[10]; 
Quality System 
Regulations 
(QSR) [10]; 
Medical Device 
Reporting 
(MDR) 
Regulations 
[10]  
Medical 
Device 
Registered and 
Approved for 
Intended Use 
in the U.S. [10]  
Device 
Manufacturer 
[10]; 
FDA 
Personnel [13]  
 
Table 5-4 shows the data sources used for each defined activity for the EU regulatory 
approval process.  
 
Table 5-4: List of the EU data sources used in the data analysis  
IDEFØ 
Activity Name 
Inputs Controls Outputs Mechanisms 
A1 – Classify 
Device [6-8]  
Intended 
Purpose of 
Medical Device 
(European 
Commission, 
2010) 
Classification 
Rules in 
Annex IX of 
Medical 
Device 
Directive 
(MDD) 
93/42/EEC 
(European 
Commission, 
2007; 2010)  
Classified 
Device: Class I 
(ns/nm) [7] 
(European 
Commission, 
2007); 
Classified 
Devices: 
Classes I (s/mf), 
IIa, IIb and III 
[7] (European 
Device 
Manufacturer 
(European 
Commission, 
2010); 
EU 
Competent 
Authority 
Website (such 
as MHRA for 
UK Notified 
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Commission, 
2007)  
Bodies Listed 
Under the 
Medical 
Devices 
Directives) 
[17]  
A2 – 
Implement 
Quality 
Management 
System (QMS) 
[6-7]  
Classified 
Devices: 
Classes I 
(s/mf), IIa, IIb 
and III [7] 
(European 
Commission, 
2007)  
Annex II or V 
of Medical 
Device 
Directive 
(MDD) 
93/42/EEC 
[9]; ISO 
Standard 
13485:2003 
[7] 
QMS 
Compliance [7]  
Device 
Manufacturer 
(European 
Commission, 
2010)  
A3 – Prepare 
Technical 
Documentation 
[6-7]  
Classified 
Device: Class I 
(ns/nm) [7] 
(European 
Commission, 
2007); 
QMS 
Compliance [7]  
Medical 
Device 
Directive 
(MDD) 
93/42/EEC 
[7]; 
Risk 
Management 
Requirements 
[7]  
Technical File 
or Design 
Dossier (Device 
Data and 
Documentation) 
[6-8]  
Device 
Manufacturer 
(European 
Commission, 
2010); 
Clinical Data 
[7]  
A4 – Select 
and Appoint 
EU Notified 
Body [6-7]  
Technical File 
(Device Data 
and 
Documentation) 
[6-8]  
Located in EU 
[7]  
Appointed EU 
REP [7] for 
Classified 
Device: Class I 
(ns/nm); 
Appointed EU 
REP [7] for 
Classified 
Devices: 
Classes I (s/mf), 
IIa, IIb and III 
Device 
Manufacturer 
[7]; 
EU 
Competent 
Authority 
Website such 
as MHRA for 
U.K. Notified 
Bodies Listed 
Under the 
Medical 
Devices 
Directives) 
[17]  
A5 – Audit: 
QMS, 
Technical File 
and Dossier [6-
7]  
Appointed EU 
REP [7] for 
Classified 
Devices: 
Classes I 
(s/mf), IIa, IIb 
and III 
Medical 
Device 
Directive 
(MDD) 
93/42/EEC [6, 
17] (European 
Commission, 
CE Certificate 
[7] for Class I 
Devices (s/mf); 
CE Certificate 
[7] for Class 
IIa, IIb and III 
Devices 
EU Notified 
Body [7]  
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2010)  
A6 – Register 
Device Details 
[6-7]  
CE Certificate 
[7] for Class I 
Devices (s/mf); 
Appointed EU 
REP [7] for 
Classified 
Device: Class I 
(ns/nm) 
Medical 
Device 
Directive 
(MDD) 
93/42/EEC [6, 
17] (European 
Commission, 
2010) 
Registered All 
Class I Medical 
Devices [7]  
Device 
Manufacturer 
[6-7]; 
EU 
Competent 
Authority [7]  
A7 – Market 
Device [6-7]  
Registered All 
Class I Medical 
Devices [6]; 
CE Certificate 
[6] for Class 
IIa, IIb and III 
Devices 
Medical 
Device 
Directive 
(MDD) 
93/42/EEC [6-
7, 17]; 
CE Mark 
(MHRA, 
2008a; 
European 
Commission, 
2010); 
Declaration of 
Conformity 
[6-7]; 
Post Market 
Surveillance 
(MHRA, 
2006a)  
Medical Device 
Certified and 
Approved for 
Intended 
Purpose in the 
EU (MHRA, 
2008a)  
EU Notified 
Body [7]; 
Device 
Manufacturer 
[6-7]  
 
5.1.3.5 Process Model Development  
The process models illustrating the U.S. and EU regulatory approval processes for 
medical devices presented in this chapter were developed (M5) using the IDEFØ 
modelling tool which was selected at activity M3 (Figure 5-3).  
 
The software used to create the models (methodology for developing the models and the 
actual U.S. and EU regulatory approval process models) was the ‘BPwin Business 
Process Design Tool version 4.0’. The models were developed by firstly creating the 
context activity followed by the decomposition of activities.  
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5.1.3.6 Comparison of U.S. and EU IDEFØ Models  
The final activity in the methodology (M6) compared the developed U.S. and EU 
regulatory approval process models constructed in the previous activity (M5).  
 
Two methods were utilised to form an overall comparison of the U.S. and EU 
regulatory approval processes for medical devices.  
 
Firstly, the IDEFØ process models for each of the aforementioned regulatory approval 
processes were analysed, described, and compared with reference to each of the 
individual activities performed.  
 
Secondly, the IDEFØ constituents (inputs, controls, outputs, and mechanisms) were 
described and compared. The comparison was the final output from the sequence of 
activities in the methodology as illustrated in Figure 5-3 (M1 to M6).  
 
5.2 Results: U.S. and EU Medical Devices Regulatory Approval 
Process Models  
The following subsections present the U.S. and EU medical devices regulatory approval 
process models that have been created using the IDEFØ process modelling technique.  
 
5.2.1 Higher Level Context Activity of the U.S. Medical Devices 
Regulatory Approval Process Model  
The higher level context activity, represented by the IDEFØ technique, of a process 
model for regulating the approval of medical devices for the U.S. market is shown in 
Figure 5-4.  
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Figure 5-4: Context activity of the U.S. medical devices regulatory approval process  
 
The direct input into the context activity (A0) was a medical device intended for human 
use. This input was converted into the output – ‘Medical Device Registered and 
Approved for Intended Use in U.S’. As illustrated in Figure 5-4, there are seven 
mechanisms or physical resources, and ten constraints (controls) required to regulate the 
approval of medical devices for the U.S. market. The context activity is shown 
decomposed in Figure 5-5.  
 
5.2.2 Decomposition of the U.S. Medical Devices Regulatory 
Approval Process Model  
The U.S. medical devices regulatory approval process (Figure 5-5) commences with the 
definition of the medical device (A1). The activities that follow this are; classify device 
(A2), select marketing process (A3), prepare marketing application (A4), submit 
marketing application (A5), review device application (A6), register device details (A7), 
and market device (A8). These activities are described in detail in the following 
subsections using the IDEFØ modelling tool constituents (inputs, controls, outputs, and 
mechanisms).  
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Figure 5-5: Decomposition of the U.S. medical devices regulatory approval process  
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5.2.2.1 Define Device  
Figure 5-6 shows activity A1 and illustrates the input, control, output, and mechanisms. 
Activity A1 – ‘Meets Device Definition’ is defined by the FDA [10] to be the primary 
step in the medical device marketing process in the U.S. According to the FDA [10], 
this is to ensure that the manufactured medical device intended for human use (input 
into activity A1) conforms to the definition of a medical device provided in section 
201(h) of the FD&C Act. The FDA states that the definition [14] provides a clear 
distinction between a medical device and other FDA regulated products such as drugs. 
In order to market a device, the device manufacturers’ are required to ensure that their 
intended product for the medical device market meets with the definition of a medical 
device. 
 
 
Figure 5-6: Activity A1 – define device  
 
5.2.2.2 Classify Device  
Figure 5-7 illustrates the second activity in the process (A2). This activity identifies 
how the FDA determines the classification of the medical device to be placed on the 
market. The FDA classifies medical devices into three different classes (I, II and III), 
whereby the regulatory control increases from class I medical devices to class III. Class 
I devices are restricted by general controls; class II devices are restricted by special 
controls; class III devices require premarket approval.  
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General controls are described by the FDA to be the basic provisions that provide the 
FDA with the means of regulating devices to ensure their safety and effectiveness [15]. 
They include provisions that relate to adulteration; misbranding; device registration and 
listing; premarket notification; banned devices; notification, including repair, 
replacement, or refund; records and reports; restricted devices; and good manufacturing 
practices. It is further described that the general controls apply to all three classes of 
medical devices; however, they are the only level of controls that apply to class I 
devices [15].  
 
The FDA has stated that class II devices are those for which general controls alone are 
insufficient [15]. In addition to the general controls, the special controls include special 
labelling requirements, mandatory performance standards, and post market surveillance. 
The FDA considers that the device classification identifies the level of regulatory 
control that is necessary to assure the safety and effectiveness of a medical device [10]. 
In order to identify the device classification of a medical device to be placed on the U.S. 
market, device manufacturers’ are advised by the FDA to use the CDRH (Center for 
Devices and Radiological Health) Classification Database [14] to search for similar 
products that are regulated by the FDA. The product classification database is described 
to contain products that the FDA considers to be devices, and contains medical device 
names and associated information developed by the CDRH.  
 
 
Figure 5-7: Activity A2 – classify device  
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5.2.2.3 Select Marketing Process  
Figure 5-8 illustrates the select marketing process activity (A3). At this activity, the 
device manufacturers are required by the FDA to select the appropriate marketing 
approval process in order to obtain market approval for the device. A major control on 
this particular activity (A3) is the marketing clearance requirements for both class II and 
III devices.  
 
The FDA has highlighted [12] that for most class II devices, a premarket notification 
510(k) is required, and for most class III devices, a premarket approval application 
(PMA) is required for obtaining market clearance. It is further explained by the FDA 
[14] that most class I devices and a few class II devices are exempt from the premarket 
notification [510(k)] requirements subject to the limitations on exemptions. However, it 
is also noted that these devices are not exempt from other general controls. According to 
the FDA, all medical devices must be manufactured under a quality assurance program, 
be suitable for the intended use, be adequately packaged and properly labelled, and have 
establishment registration and device listing forms on file with the FDA [14]. The FDA 
has listed the devices by class that are exempt from the 510(k) and Good Manufacturing 
Practices (GMP)/Quality Systems [19].  
 
 
Figure 5-8: Activity A3 – select marketing process  
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5.2.2.4 Prepare Marketing Application  
At activity A4, (Figure 5-9) the device manufacturers’ are required to prepare the 
marketing application based on the selected marketing process. The type of marketing 
application (510(k) or PMA) is based on the class of device (class II or III).  
 
The device manufacturers’ are required to develop the necessary documentation 
containing the device data and information which is needed to submit the application for 
device approval in the following activity A5 – ‘Submit Marketing Application’.  
 
The FDA state that for some 510(k) submissions and most PMA applications, clinical 
performance data is required to obtain marketing clearance [10]. If the device is 
classified as class I or II, and if it is not exempt, a 510k will be required for marketing 
[14].  
 
The FDA also state that products requiring PMA’s are class III devices and are high risk 
devices that pose a significant risk of illness or injury, or devices found not substantially 
equivalent to class I and II predicate through the 510(k) process [16]. The PMA process 
is described to be more involved and includes the submission of clinical data to support 
claims made for the device.  
 
The clinical trials are to be conducted by the device manufacturers. These must conform 
to the FDA's Investigational Device Exemption (IDE) regulation (marketing clearance 
requirements). Additionally, the device manufacturers’ are required to implement a 
quality management system (QMS) that is in accordance to the FDA’s quality systems 
regulation (QSR).  
 
The QSR includes requirements related to the methods used in and the facilities and 
controls used for: designing, purchasing, manufacturing, packaging, labelling, storing, 
installing, and servicing of medical devices [16]. The manufacturing facilities of the 
device manufacturers’ must undergo inspections by the FDA to assure compliance with 
the requirements of the QSR [16].  
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Figure 5-9: Activity A4 – prepare marketing application  
 
5.2.2.5 Submit Marketing Application  
Activity A5 is illustrated in Figure 5-10. At this activity, the device manufacturers are 
required to submit the applicable marketing application to the FDA using the FDA 
website. The FDA has specified three types of 510(k) submissions for marketing 
clearance: Traditional, Special, and Abbreviated [12]. For PMA submissions, the FDA 
has defined the following five methods; Traditional PMA, Modular PMA, Streamlined 
PMA, Product Development Process, and Humanitarian Device Exemption (HDE).  
 
 
Figure 5-10: Activity A5 – submit marketing application  
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5.2.2.6 Review Device Application  
Activity A6 is shown in Figure 5-11. This activity requires the reviewing of the medical 
device marketing application by the FDA. The device application is reviewed at this 
stage by personnel in the CDRH department at the FDA. The review of the application 
by the FDA is performed in conformance to the regulations found in 21CFR814 [13].  
 
The application review process consists of the following four steps: (1) administrative 
and limited scientific review by FDA staff to determine completeness (filing review); 
(2) an in-depth scientific, regulatory, and quality system review by the appropriate FDA 
personnel; (3) a review followed by the recommendations of the appropriate advisory 
committee (panel review); and (4) the final deliberations, documentation, and 
notification of the decision made by the FDA.  
 
If the application is considered successful by the FDA, the application is then filed for 
review. The filing of an application means that FDA has made a threshold 
determination that the application is sufficiently complete to begin an in-depth review 
[13].  
 
 
Figure 5-11: Activity A6 – review device application  
 
5.2.2.7 Register Device Details  
Figure 5-12 shows activity A7 – ‘Register Device Details’. Activity A7 requires the 
device manufacturer to register the manufacturing company and list the type of device 
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they plan to market with the FDA [10] using the FDA website. The FDA states that all 
registration and listing information (annual, initial or updates) are to be submitted 
electronically unless a waiver is granted to the device manufacturer.  
 
Before marketing clearance can be obtained, the device manufacturer has to assure that 
the device is properly labelled in accordance with the FDA's labelling regulations.  
 
 
Figure 5-12: Activity A7 – register device details  
 
5.2.2.8 Market Device  
The final activity requires the device manufacturers to place the medical device in the 
U.S. market. (A8). Once the device is on the market, there are post market requirements 
(surveillance controls) with which a medical device manufacturer as well as other firms 
involved in the distribution of devices must conform to [10]. These requirements 
include the QSR and medical device reporting regulations (MDR).  
 
MDR regulation is an adverse event reporting program for medical devices [10]. This 
includes the implementation of tracking systems, reporting of device malfunctions, 
serious injuries, or deaths, and registering the establishments where devices are 
produced or distributed with the FDA.  
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
127 
 
Figure 5-13: Activity A8 – market device  
 
5.2.3 Higher Level Context Activity of the EU Medical Devices 
Regulatory Approval Process Model 
The higher level context activity, represented by the IDEFØ technique, of a process 
model for regulating the approval of medical devices for the EU market is shown in 
Figure 5-14.  
 
 
Figure 5-14: Context activity of the EU medical devices regulatory approval process  
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The direct input into the context activity (A0) was the intended purpose of the medical 
device. This input was converted into the output – ‘Medical Device Certified and 
Approved for Intended Purpose in the EU’.  
 
As illustrated in Figure 5-14, there were five mechanisms or physical resources, and 
seven constraints (controls) required to regulate the approval of medical devices for the 
EU market. The context activity is shown decomposed in Figure 5-15.  
 
5.2.4 Decomposition of the EU Medical Devices Regulatory 
Approval Process Model  
The decomposition of the IDEFØ model for the EU medical devices regulatory 
approval process (Figure 5-15) commences with the classification of the medical device 
(A1).  
 
The activities that follow this are; implement quality management system (QMS) (A2), 
prepare technical documentation (A3), appoint EU notified body (A4), audit QMS 
including technical file (device documentation) and design dossier (A5), register device 
details (A6), and market device (A7).  
 
The activities are described in detail in the following subsections using the IDEFØ 
modelling tool constituents (inputs, controls, outputs, and mechanisms).  
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Figure 5-15: Decomposition of the EU medical devices regulatory approval process  
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5.2.4.1 Classify Device  
Figure 5-16 shows activity A1 – ‘Classify Device’. Medical device manufacturers’ are 
required to classify the device to be placed in the EU market using the classification 
rules defined in Annex IX of the Medical Device Directive (MDD) 93/42/EEC [6] 
(European Commission, 2007; 2010). This classifies a device according to its 
properties, function, and intended purpose (MHRA, 2008b).  
 
Devices that are covered by the MDD are grouped into four classes (MHRA, 2006c) 
designed to reflect the perceived risk associated with the devices (MHRA, 2008b). 
These classes are: class I (low-risk devices), class IIa (medium-risk devices), class IIb 
(medium-risk devices), and class III (high-risk devices). Devices classified as class I are 
grouped according to whether they are sterile and/or have a measuring function (s/mf) 
or they are non-sterile and/or have no measuring function (ns-nm). It is described by the 
Medicines and Healthcare products Regulatory Agency (MHRA) (MHRA, 2008b; 
2006c) that at this particular activity (A1), it is for the device manufacturers’ to 
determine the classification of the medical device to be placed on the market.  
 
 
Figure 5-16: Activity A1 – classify device  
 
5.2.4.2 Implement Quality Management System  
Activity A2 (Figure 5-17) requires for the device manufacturers’ to implement a quality 
management system (QMS) for the intended medical device to be placed on the EU 
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market. As illustrated in Figure 5-17, only medical devices that are classified as class I 
(s/mf), IIa, IIb and III are required to have a QMS implemented by the device 
manufacturers’. Manufacturers of devices classified as class I (ns-nm) are not required 
to implement a QMS.  
 
The QMS is to be implemented by the device manufacturer in accordance with the 
MDD [6-7] or the equivalent ISO 13485:2003 standard. Many companies in the EU 
apply the ISO 13485 standard to achieve QMS compliance [7]. As part of QMS 
compliance, device manufacturers are required to have their quality systems and 
technical documentation reviewed by an EU NB (A5) before they are able to place their 
products on the market [18].  
 
 
Figure 5-17: Activity A2 – implement QMS  
 
5.2.4.3 Prepare Technical Documentation  
At activity A3 (Figure 5-18), the device manufacturers’ are required to prepare the 
technical documentation for the medical devices to demonstrate the conformity of the 
device with the MDD [7]. Devices have to meet the essential requirements set out in the 
MDD taking account of the intended purpose of the devices concerned (MHRA, 2008a).  
 
Technical documentation has to cover the following aspects of the medical device: 
device description; raw materials and component documentation; intermediate product 
and sub-assembly documentation; final product documentation; packaging and labelling 
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documentation; and design verification which includes the results of qualifications tests 
and design calculations relevant to the intended use of the device (MHRA, 2008a). 
Clinical data and manufacturing testing records are also required as part of the technical 
documentation. Manufacturing and test records are required to show compliance with 
the defined procedures and specifications. It has been noted that many class I devices do 
not require a special clinical investigation to establish data on performance and safety or 
side effects (MHRA, 2008a). However, it is also noted that manufacturers should 
review the intended use of the medical device and any medical claims being made to 
ensure that there are adequate supporting test results.  
 
 
Figure 5-18: Activity A3 – prepare technical documentation  
 
5.2.4.4 Appoint EU Notified Body  
In activity A4 (Figure 5-19), device manufacturers are required to select and appoint an 
authorised representative to handle the regulatory issues regarding medical devices [7]. 
The EU location of the appointed notified body is controlling this activity (Figure 5-19). 
The appointed EU NB must be registered with an EU CA and located in the EU. 
Medical device manufacturers in the EU can register with any of the designated EU 
CA’s. Device manufacturers should use the website of an appointed EU CA to search 
and identify the available notified bodies to handle the regulatory issues under the MDD 
[17].  
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Figure 5-19: Activity A4 – appoint EU notified body  
 
5.2.4.5 Audit Quality Management System and Documentation  
At activity A5 (Figure 5-20), manufacturers’ of devices in class I (s/mf), IIa, IIb and III 
are required to have their technical files, device documentation, and QMS and/or design 
dossiers audited by the appointed EU NB. The device manufacturers should establish 
and maintain documented procedures and records at their premises for audit inspection 
by the EU NB. For manufacturers’ of devices that are classified as class I (ns/nm), 
auditing is not required. The audit is conducted by the EU NB according to MDD to 
ensure that the device, its documentation, technical file, and QMS show conformance to 
MDD.  
 
On successful completion of the audit by the EU NB, a CE certificate for the device is 
issued to the device manufacturer by the EU NB which performed the audit [7]. The 
issuing of the CE certificate indicates that the CE mark can now be placed on the device 
by the manufacturer. The CE mark means that a medical device manufacturer is 
satisfied that the device conformed to the relevant essential requirements in the MDD 
and that it is fit for its intended purpose (MHRA, 2007). This is a legal requirement for 
devices intended for the EU market and it also indicates that the medical device can be 
placed anywhere in the EU market without further control.  
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Figure 5-20: Activity A5 – audit QMS and documentation  
 
5.2.4.6 Register Device Details  
Activity A6 (Figure 5-21) requires the manufacturers’ of all class I (s/mf and ns/nm) 
devices to register the details of the devices and the manufacturing organisation with an 
EU CA [7]. This is to be completed in accordance to the MDD. For all medical devices 
of classes IIa, IIb and III, device manufacturers are not required to register the device 
and manufacturer details. The MDD states that any device manufacturer who, under 
their own name, places medical devices on the market shall inform the competent 
authorities of the member state in which they have their registered place of business of 
the address of the registered place of business and the description of the devices 
concerned (European Commission, 2007). 
 
 
Figure 5-21: Activity A6 – register device details  
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5.2.4.7 Market Device  
Activity A7 (Figure 5-22) is primarily for the device manufacturers’ to ‘place the 
medical device on the EU market’. The term ‘placing on the market’ has been defined 
by the EC (European Commission, 2007) to mean; ‘the first making available in return 
for payment or free of charge of a device other than a device intended for clinical 
investigation, with a view to distribution and/or use on the Community market, 
regardless of whether it is new or fully refurbished’.  
 
The MDD states that the manufacturer must draw up a written declaration of conformity 
(European Commission, 2007). This declaration of conformity must cover one or more 
medical devices manufactured, clearly identified by means of product name, product 
code, or other unambiguous reference, and must be retained by the manufacturer 
(European Commission, 2007). For implementing post market surveillance (PMS) for 
medical devices, it is described (MHRA, 2008a) that device manufacturers’ are to 
maintain a vigilance system to notify the regulatory authorities of incidents that might 
lead to serious health consequences, or to a systematic recall of a device.  
 
 
Figure 5-22: Activity A7 – market device  
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5.3 Discussion: Comparing the U.S. and EU Processes  
The decomposed activities and outputs for both the U.S. and EU regulatory approval 
processes for medical devices, represented by the IDEFØ technique, have been used as 
the initial point for comparison. Following this, the physical resources and factors 
controlling device approval for both processes are compared and contrasted.  
 
5.3.1 Decomposed Activities and Outputs  
Three pairs of activities in the U.S. and EU processes appeared to have identical goals. 
These activities are ‘Classify Device’ (U.S. A2 | EU A1), ‘Register Device Details’ 
(U.S. A7 | EU A6), and ‘Market Device’ (U.S. A8 | EU A7). The goals are: device 
manufacturers’ are to identify the device classification of their device intended for 
regulatory approval, device manufacturers’ are to register the device details with the 
necessary regulatory approval authorities, and the device manufacturers’ are to place the 
medical device in either the U.S. or EU market. However, the physical resources and 
factors controlling device approval for each of the activities differ.  
 
The device classification activity in U.S. process (U.S. A2) shows that device 
manufacturers’ are to utilise the CRDH device classification database to identify similar 
products that are regulated by the FDA. In the EU, device manufacturers’ are to use the 
website of the EU CA as an initial point of reference to identify the appropriate 
documentation relating to medical device classification.  
 
The registration of the device details in the U.S. process requires the device 
manufacturers’ to use the FDA’s website to register the details of the device and 
manufacturer. In the EU, only manufacturers of class I devices are required to register 
the details of the device and organisation with an EU CA.  
 
Placing of the medical device in the U.S. requires the device manufacturers’ to notify 
the FDA personnel that the device has been placed onto the market and that there is 
conformance with the post market requirements specified by the FDA. Device 
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manufacturers of class IIa, IIb and III in the EU are required to notify the EU NB that 
vigilance systems are in place before the device is placed onto the EU market.  
 
Two pairs of activities in the U.S. and EU processes appear to have similar goals. 
Similarity of these goals is evident within the two pairs of the U.S. and EU activities. 
The first pair is ‘Prepare Marketing Application’ and ‘Prepare Technical 
Documentation’ (U.S. A4 | EU A3), and the second pair is ‘Review Device Application’ 
and ‘Audit QMS and Documentation’ (U.S. A6 | EU A5).  
 
Preparation of the device marketing application in the U.S. (U.S. A4) requires the 
device manufacturers’ to ensure that clinical trials have been conducted, if necessary, 
any clinical performance data is collated, and that the quality management system is 
established within the manufacturing organisation.  
 
At the preparation of the technical documentation activity in the EU (EU A3), device 
manufacturers’ are required to have clinical data, if necessary, as part of the technical 
documentation. Outputs from both activities are the technical documentation of the 
devices. In the U.S., the output is specified as device data and documentation, and in the 
EU the output is specified as a technical file (applicable to devices in class: I (s/mf and 
ns/nm), IIa and IIb) or design dossier (applicable to class III devices only).  
 
Reviewing of the device application activity in the U.S. (U.S. A6) is similar to the 
auditing of the QMS and documentation activity in the EU (EU A5). At these activities, 
regulatory authorities in the U.S. (FDA) and in the EU (EU NB) are required to review 
the device documentation submitted by the device manufacturers’. However, the outputs 
from these activities differ. In the U.S. process, the output (U.S. A6) is a device 
approvable letter given by the FDA to the device manufacturer on successfully 
completing the review. In the EU, there are two outputs. These are a CE certificate for 
class I devices (s/mf) and a CE certificate for devices designated in classes IIa, IIb and 
III. CE certificates are issued by the EU NB to the device manufacturer on successful 
completion of the audit.  
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In contrast, several activities are uniquely found in either the U.S. or EU approval 
process. For the U.S. these are ‘Define Device’ (U.S. A1), ‘Select Marketing Process’ 
(U.S. A3), and ‘Submit Marketing Application’ (U.S. A5). For the EU process, 
activities that are unique are ‘Implement QMS’ (EU A2) and ‘Appoint EU NB’ (EU 
A4).  
 
In the U.S. process, device manufacturers’ are primarily required to ensure that their 
device intended for the U.S. market meets with the definition of a medical device as 
defined by the FDA. Selection of the marketing process by the device manufacturer in 
the U.S. is based on the classification of the device to be placed onto the U.S. market. 
The device marketing application is submitted to the FDA by the device manufacturer 
using the FDA website.  
 
In the EU process, the device manufacturers’ are required to implement a QMS which is 
in accordance to the MDD. It is this QMS which is then audited by the EU NB (EU 
A5). The appointing of the EU NB is a requirement for medical device manufacturers in 
the EU. The EU NB must be registered with an EU CA. This activity is not required in 
the U.S. process as the FDA is the principal regulatory authority responsible for 
regulating medical devices.  
 
5.3.2 Physical Resources Required for Device Approval  
Four physical resources required for device approval in the U.S. and EU processes 
appear to be similar. These are device manufacturers, clinical trials, and clinical data, 
the websites of the U.S. and EU regulatory authorities, and the regulatory authorities.  
 
Device manufacturers’ are required to undertake the majority of the activities when 
placing medical devices in the U.S. and EU markets. Clinical data from any clinical 
trials that are conducted by the device manufacturers’ are required by the regulatory 
authorities to establish if the device works well in people and is safe to use. The U.S. 
and EU medical device regulatory authority websites are specified for use by the FDA 
and the EU competent authorities at the initial activities of both the U.S. and EU 
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regulatory approval processes. Information relating to the regulatory approval of 
medical devices can be found at the websites by the device manufacturers’. Regulatory 
authorities in the U.S. and EU are required to review and audit the device approval 
applications and device documentation prior to the device being placed onto the market 
by the manufacturers, and also after the device has been marketed to ensure conformity 
to the post market regulations.  
 
However, there are two physical resources that are required for device approval in the 
U.S. which are unique to this process. These are the CDRH device classification 
database and quality management system. The CDRH device classification database is 
to be used by device manufacturers’ in order to identify predicate devices. This is 
specified by the FDA and remains unique to the U.S. process. In the U.S. process, the 
quality management system is a physical resource whereas in the EU, the 
implementation of the QMS is an individual activity (EU A2). Manufacturers’ in the 
U.S. are required to establish and follow the quality management systems according to 
the QSR to ensure that their devices meet the applicable requirements. In the EU, the 
QMS is to be implemented after the device classification activity (EU A1).  
5.3.3 Factors Controlling Device Approval  
Two factors controlling device approval in the U.S. and EU processes appear to be 
similar. These are medical device reporting regulations in the U.S. and post market 
surveillance in the EU.  
 
In the U.S., medical device reporting is a method for the FDA to receive medical device 
adverse events from medical device manufacturers’, importers and user facilities. This 
is so that adverse events that have occurred concerning the use of the medical device 
can be detected and corrected. In the EU, device manufacturers’ are required to 
implement a documented procedure to review the experience gained from devices on 
the market. Any necessary corrective actions that are required are to be recorded as part 
of the documentation.  
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Several factors controlling device approval are uniquely found in either the U.S. or EU 
processes. For the U.S. process these are; device definition, device classification 
criteria, regulatory controls, marketing clearance requirements, quality system 
regulations, application submission requirements, 510(k) or PMA requirements, 
premarket requirements, and post market requirements. For the EU process these are; 
MDD, ISO standard 2003:13485, risk management requirements, EU location, CE 
mark, and declaration of conformity.  
 
5.4 Chapter Summary  
Answers to the three research questions that were guiding this chapter are summarised 
followed by the fulfilment of the third research objective.  
 
Firstly, this chapter sought to identify what the U.S. and EU regulatory approval 
processes for medical devices entailed? In this chapter, models of the U.S. and EU 
regulatory approval processes for medical devices captured using the IDEFØ process 
modelling tool were presented. These models were created based on publicly available 
information which was obtained from the U.S. and EU medical device regulatory 
authorities.  
 
The second research question posed was; what are the different stages that constitute the 
U.S. and EU regulatory approval of medical devices? The models created in this chapter 
identified the individual activities of the U.S. and EU approval processes, the outputs 
from the activities performed, the physical resources required to perform the individual 
activities, and the factors which control the successful placement of the medical device 
on the intended market.  
 
The third research question posed was; what are the differences and similarities between 
the U.S. and EU regulatory approval processes? The U.S. and EU regulatory approval 
process models presented in this chapter were compared and contrasted using the 
modelling tool constituents as a basis for comparison. Comparison of the U.S. and EU 
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models revealed differences and similarities between the two processes, and identified 
the features that were unique to each process.  
 
Differences included the types of physical resources and factors controlling device 
approval for each activity that comprised both processes. The inputs and outputs from 
the activities in each process also differed. Primary input into the U.S. process focussed 
on the medical device intended for human use, whereas the input into the EU process 
focussed on the intended purpose of the medical device. The final output from the U.S. 
process was concerned with the registration and approval for the intended use of the 
device in the U.S. market. In contrast to this, the final output from the EU process 
concerned itself with the certification and approval for the intended purpose of the 
medical device in the EU market. Similarities included three pairs of activities in both 
the U.S. and EU processes which appeared to have identical goals. These goals 
primarily require medical device manufacturers’ to identify the device classification, 
register the details of the intended device for market with the designated regulatory 
authorities, and place the medical devices in either the U.S. or EU markets.  
 
This chapter has identified the existing processes for medical device approval in the 
U.S. and EU. Also, this chapter has revealed the different process activities that are 
currently required for placing medical devices in the U.S. and EU markets thereby 
fulfilling the third objective of the research. The following chapter investigates the 
utilisation of the design rationale capabilities identified in Chapter 2 with the U.S. and 
EU medical device regulatory approval process activities that have been revealed in this 
chapter.  
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6 Utilising Design Rationale with the Regulatory 
Approval of Medical Devices  
This chapter provides details of an analysis which investigates the possibilities of 
utilising design rationale with the U.S. and EU regulatory approval processes for 
medical devices.  
 
This chapter analyses the possibilities of utilising design rationale with the different 
activities that constitute both the U.S. and EU regulatory approval processes for medical 
devices. In this chapter, the design rationale capabilities that were derived from the 
literature reviewed in Chapter 2 are mapped with the U.S. and EU medical device 
regulatory approval process activities that were identified in the previous chapter 
(Chapter 5).  
 
This chapter identifies the relevant U.S. and EU regulatory approval process activities 
where design rationale could be utilised and outlines the benefits it could provide to 
medical device manufacturers and regulatory authorities. Additionally, this chapter 
provides the necessary basis for forming the guidelines presented in the following 
chapter (Chapter 7). The analysis reported in this chapter addresses the gaps in existing 
research (Chapter 2) by analysing ways in which design rationale could be utilised with 
the regulatory approval of medical devices. The fourth objective of the research is 
addressed in this chapter.  
 
This chapter is presented as follows. First of all, the methodology followed in order to 
identify and analyse the U.S. and EU regulatory approval process activities is presented. 
This is followed by the results from the analysis which identifies the relevant U.S. and 
EU regulatory approval process activities where design rationale could be utilised. 
Following this, the proposition of the regulatory approval of medical devices as a novel 
area of application is discussed which includes the implications that this could present 
on the future of design rationale research. Finally, this chapter is summarised.  
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6.1 Analysis Methodology  
6.1.1 Defining the Research Questions  
The analysis presented in this chapter is guided by the following research questions that 
have been defined:  
1) How could design rationale be utilised with the U.S. and EU regulatory approval 
processes for medical devices?  
2) What benefits could design rationale potentially provide for medical device 
manufacturers and regulatory authorities?  
 
6.1.2 Identifying U.S. and EU Regulatory Approval Process 
Activities  
Descriptive models developed using the IDEFØ process modelling technique have 
illustrated the individual activities and the physical resources required to perform those 
activities that are required for placing medical devices in the U.S. and EU markets.  
 
These process models have been used in this chapter to recognise the individual 
activities required for regulating the approval of medical devices in the U.S and EU. It 
is these individual activities that have been investigated to identify if design rationale 
could be utilised.  
 
The alphanumerical activity identifier (AX – whereby X denotes the activity number) 
and the names of the individual activities that comprise both the U.S. and EU regulatory 
approval processes for medical devices are listed in Table 6-1.  
 
As listed in Table 6-1, there are eight activities that comprise the U.S. process and seven 
activities that comprise the EU process for regulating the approval of medical devices.  
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Table 6-1: List of U.S. and EU medical device regulatory approval process activities  
Activity 
identifier  
U.S. process activity name  EU process activity name  
A1 Define Device  Classify Device  
A2 Classify Device  
Implement Quality 
Management System (QMS) 
A3 Select Marketing Process  
Prepare Technical 
Documentation  
A4 Prepare Marketing Application  Appoint EU Notified Body  
A5 Submit Marketing Application  Audit QMS and Documentation  
A6 Review Device Application  Register Device Details  
A7 Register Device Details  Market Device  
A8 Market Device  (Not applicable for EU process)  
 
6.1.3 Utilising Design Rationale  
Mechanisms are specified in the IDEFØ technique to represent the physical resources 
required to perform activities and can include software tools. Design rationale consists 
of methodological approaches and computational support tools based on those 
approaches. This chapter focuses specifically on the concept of design rationale as a 
physical resource that could be utilised with the activities that comprise both the U.S. 
and EU regulatory approval processes for medical devices.  
 
In order to utilise design rationale with the individual regulatory approval activities, it 
was considered essential to identify design rationale’s ability to perform actions that 
would be relevant and of benefit to the medical device manufacturers and regulatory 
authorities during the device approval process. These actions have been defined as 
capabilities of design rationale whereby thirteen capabilities have been identified. These 
thirteen capabilities of design rationale are listed in Table 6-2. Provided in Table 6-2 are 
the names of the DR capabilities and their identification labels (listed alphabetically 
from A to M).  
 
The individual activities comprising both the U.S. and EU regulatory approval 
processes for medical devices (Table 6-1) and the DR capabilities (Table 6-2) are the 
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datasets used in the analysis which is described in the following subsection of this 
chapter.  
 
Table 6-2: List of design rationale capabilities  
Capability 
identification label  
Design rationale 
capability name  
A Answer  
B Capture  
C Communicate  
D Design  
E Determine  
F Document  
G Explain  
H Justify  
I Provide  
J Represent  
K Structure  
L Support  
M Teach  
 
6.1.4 Analysing the Possibilities of Utilising Design Rationale with 
the U.S. and EU Regulatory Approval Process Activities  
The activities comprising both the U.S. and EU regulatory approval processes were 
individually tabulated according to each process. These activities for both the U.S. and 
EU processes (Table 6-1) were separately listed as rows in two tables beginning with 
the first activity (A1) continuing through to the final activity of that process (U.S. 
process | activity A8, and EU process | activity A7).  
 
The thirteen design rationale capabilities (Table 6-2) were listed as columns in each of 
the two corresponding tables representing the U.S. and EU processes and their 
constituent activities. These capabilities of design rationale were used to designate 
design rationale’s ability to perform specific actions and to map them against the 
regulatory approval activities.  
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Each of the thirteen design rationale capabilities was then mapped with the individual 
activities for both the U.S. and EU regulatory approval processes. This mapping 
addressed whether or not each capability of design rationale was applicable and could 
support each activity for per U.S. or EU process, and if it could, what were the available 
benefits of utilising design rationale at that particular activity? Evidence to provide the 
rationale for the resulting responses to the aforementioned questions has been 
established from the regulatory approval process activity description including the 
requirements for that activity, and the description of the design rationale capability 
stating the action that design rationale can perform.  
 
6.2 Results  
Results from the analysis of utilising the design rationale capabilities with the 
regulatory approval activities for medical devices in the U.S. and EU are presented in 
the following subsections of this chapter. Firstly, the process used for mapping the 
design rationale capabilities with the individual activities for both the U.S. and EU 
approval processes is described. This provides details on how the results from the 
analysis are presented.  
 
Secondly, the design rationale capabilities are mapped with both the U.S. and EU 
regulatory approval process activities respectively. The mapping identifies the 
individual activities where the capabilities of design rationale could be utilised. The 
activities where design rationale could be utilised are then individually analysed to 
identify which of the thirteen design rationale capabilities are applicable, how they 
could be utilised at a particular activity and the benefits that they could provide.  
 
6.2.1 Mapping Design Rationale Capabilities with the U.S. and EU 
Regulatory Approval Activities  
The names of the individual activities in both processes (eight activities in the U.S. 
process | A1 to A8; and seven activities in the EU process | A1 to A7) were separately 
tabulated individually by U.S. and EU process and mapped with the thirteen design 
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rationale capabilities. These tables are presented in the following sub-sections of this 
chapter.  
 
An example showing the mapping of the design rationale capabilities with the U.S. 
regulatory approval process activities is presented in Table 6-3. Table 6-3 shows that 
the regulatory approval process activities were alphanumerically listed as rows in the 
first column (activities A1 to A8). The design rationale capabilities were listed as 
columns beginning with capability ‘A’ (answer) incrementing alphabetically to 
capability ‘M’ (teach). Symbols were used to indicate the applicability of the design 
rationale capabilities at each activity. The ‘X’ symbol denotes that the design rationale 
capability was not applicable at the activity and the tick mark symbol indicates that the 
design rationale capability could be used at the activity.  
 
The example shown in Table 6-3 illustrates that capabilities ‘A’ (answer), ‘B’ (capture) 
and ‘M’ (teach) were not applicable for the first two activities (A1 and A2) in the U.S. 
regulatory approval process for medical devices. The table (Table 6-3) also shows that 
capability ‘B’ (capture) was not applicable at activity A8 but capabilities ‘A’ (answer) 
and ‘M’ (teach) were applicable at this activity.  
 
This mapping is performed for both the U.S. and EU regulatory approval processes and 
is presented in Table 6-4 and Table 6-5 in the following subsections of this chapter.  
 
Table 6-3: An example of the mapping of the design rationale capabilities with the U.S. 
regulatory approval process activities  
U.S. process 
activity name  
Design rationale capabilities  
A  B...  ... to M  
A1 – Define 
Device  
X  X  X  
A2 – Classify 
Device... 
X  X  X  
... to A8 – 
Market Device  
  X    
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6.2.2 Utilising Design Rationale Capabilities with the U.S. 
Regulatory Approval Process Activities  
The thirteen design rationale capabilities were mapped with the eight activities that 
comprise the U.S. medical devices regulatory approval process in Table 6-4.  
 
Results from the analysis highlight that there were there three main activities (A4 | 
Prepare Marketing Application; A6 | Review Device Application; and A8 | Market 
Device) in the U.S. regulatory approval process for medical devices where the 
capabilities of design rationale could be applicable. However, the results also indicate 
that not all of the design rationale capabilities were applicable at these three activities. 
The names of the capabilities that were applicable differed at these three activities.  
 
There were twelve out of the thirteen design rationale capabilities that were found to be 
applicable at activity A4 (Prepare Marketing Application). Eleven identical capabilities 
were found to be applicable at activities A6 (Review Device Application) and A8 
(Market Device).  
 
The three activities (A4, A6, and A8) where the capabilities of design rationale where 
found to be applicable are individually analysed in the following subsections. Benefits 
of utilising the applicable design rationale capabilities with the three activities in the 
U.S. process are also outlined.  
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Table 6-4: Utilising design rationale capabilities with the U.S. regulatory approval process for medical devices  
U.S. process  
activity 
name 
Design rationale capabilities  
A  B  C  D  E  F  G  H  I  J K L M 
A1 – Define 
Device  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A2 – 
Classify 
Device  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A3 – Select 
Marketing 
Process  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A4 – 
Prepare 
Marketing 
Application  
X    
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
A5 – Submit 
Marketing 
Application  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A6 – Review 
Device 
Application  
  
 
X    
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
X    
 
A7 – 
Register 
Device 
Details  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A8 – Market 
Device    
 
X    
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
X    
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6.2.2.1 Prepare Market Application  
At activity A4, medical device manufacturers could utilise design rationale as part of the 
marketing application to provide the regulatory authority in the U.S. (U.S. Food and 
Drug Administration – FDA) with explicit rationale behind the design and development 
of the medical device intended to be placed on the U.S. market.  
 
At this activity, the capabilities of design rationale could be utilised by device 
manufacturers in the following twelve ways: (1) to show how the reasoning, design 
knowledge and designers decisions were captured when designing a medical device; (2) 
to communicate the design aspects of the medical device such as the design 
relationships, design space, information and logical reasoning; (3) to make the 
reasoning behind the design of the medical device explicit for device application 
review; (4) to show how the reasoning underlying the design of the medical device was 
determined; (5) to show how the design decisions, design history, decision-making 
processes, design and logical reasoning that were made during the design of the medical 
device were documented; (6) to provide explanations of how the medical device was 
designed; (7) to provide justification of the argument behind the design decisions made 
during the design of the medical device; (8) to provide historical evidence of the 
medical device design process; (9) to represent the reasoning underlying the design of 
the medical device; (10) to show how the decision-making process and designers 
decisions were structured during the design of the medical device; (11) to show the 
reasoning and argumentation behind the design of the medical device by using a 
communication support system; and (12) to teach the FDA about how the medical 
device was designed using structured methods for capturing design knowledge as it is 
generated.  
 
6.2.2.2 Review Device Application  
When reviewing the device application at activity A6 (Review Device Application), the 
capabilities of design rationale could be utilised in the following eleven ways by the 
FDA: (1) to answers questions concerning the design of the medical device; (2) to 
understand and review the design relationships, design space, information and logical 
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reasoning; (3) to identify the explicit reasoning behind the design of the medical device; 
(4) to realise how the reasoning underlying the design of the medical device was 
determined; (5) to review how the design decisions, design history, decision-making 
processes, design and logical reasoning that were made during the design of the medical 
device were documented; (6) to examine explanations of how the medical device was 
designed; (7) to view the justification of the argument behind the design decisions that 
were made during the design of the medical device; (8) to review historical evidence of 
the medical device design process; (9) to view the representation of the reasoning 
underlying the design of the medical device; (10) to understand how the decision-
making process and designers decisions were structured during the design of the 
medical device; and (11) to gain knowledge of how the medical device was designed.  
 
6.2.2.3 Market Device  
Activity A8 (Market Device) was found to have eleven design rationale capabilities that 
could be applied at this activity which were identical to those capabilities applicable in 
activity A6. Although the identical design rationale capabilities were found to be 
applicable at both activities (A6 and A8), the manner in which they could be utilised at 
activity A8 differs from the way in which they could be applied at activity A6.  
 
At activity A8, the capabilities of design rationale could be utilised by both the medical 
device manufacturers and the FDA in the following eleven ways: (1) to answers 
questions concerning a device malfunction after the device has been placed on the 
market; (2) to communicate the design relationships, design space, information and 
logical reasoning for a medical device that has been recalled from the market; (3) to 
understand the reasoning behind the design of a medical device that has been recalled; 
(4) to determine the reasoning underlying the design of a medical device that has been 
recalled; (5) to understand the design history of a medical device that has been recalled; 
(6) to provide an explanation of how a medical device was designed in the event of a 
device recall; (7) to review the justification of the argument behind the design decisions 
that were made during the design of the medical device that has been recalled; (8) to 
view the historical evidence of a medical device that has been recalled; (9) to review the 
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representations of the reasoning underlying the design of a medical device that has been 
recalled; (10) to show how the decision-making processes and designers decisions were 
structured during the design of a medical device that has been recalled; and (11) to learn 
about the design and development of a medical device that has been recalled from the 
U.S. market after receiving regulatory approval.  
 
6.2.2.4 Benefits of Utilising Design Rationale with the U.S. Regulatory 
Approval Process Activities  
There are various possible benefits available to both the medical device manufacturers 
and the FDA for utilising design rationale and its existing capabilities with three of the 
regulatory approval process activities for medical devices in the U.S. (A4 | Prepare 
Marketing Application; A6 | Review Device Application; and A8 | Market Device). 
These postulated benefits have been derived from analysing the ways in which design 
rationale could be utilised with the three U.S. regulatory approval process activities for 
medical devices (A4, A6, and A8). The possible benefits are summarised as follows.  
 
The use of design rationale with the preparation of the marketing application (A4) could 
provide benefits to the device manufacturers. Device manufacturers could fully 
document the rationale of the design and development of the medical device that has 
been manufactured for regulatory approval in the U.S. This captured and documented 
design rationale for the medical device could be used by different personnel in the 
organisation who are involved with the development and regulatory approval aspects of 
the device before the marketing application is submitted to the FDA. Utilising the 
capabilities of design rationale with the marketing application could provide benefits to 
the device manufacturers and the FDA by communicating the final design of the 
medical device and its rationale. This rationale could be reused in the future by device 
manufacturers to diagnose a problem with an existing device and to identify possible 
solutions. If the design rationale is captured and documented in parallel with the design 
of the medical device, this could provide the medical device manufacturers with a 
method of addressing and resolving issues during the development stages of the device 
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prior to market approval which could provide significant cost savings due to device 
recalls, major rework, and possible litigation costs.  
 
Using documented design rationale as part of the device application review (A6) could 
benefit the FDA. The FDA could use the documented design rationale of the device as 
part of the device application to validate the device’s safety and effectiveness, to 
understand how the device was designed and to raise any queries related to the design of 
the device before it is approved for sale in the U.S. market. By utilising design rationale 
as a way to review the device application, the FDA could reduce the amount of time 
spent on reviewing vast device design documentation as this could be represented by 
design rationale. As a result, this could also decrease the time taken to approve a device 
and the overall time taken for manufacturers to place a medical device on the U.S. 
market. By querying the design rationale of a medical device during the application 
review, the FDA could also gain insight into the possible issues related with the device 
and to prevent them from occurring before the device has been placed on the market, 
thereby increasing the quality and safety of the device intended for the U.S. market.  
 
Design rationale could provide significant benefits once the device has been placed on 
the U.S. market (A8). A major benefit of utilising design rationale with activity A8 of 
the U.S. regulatory approval process for medical devices is to address design issues with 
a device that has been recalled from the U.S. market. This is where the reuse of design 
rationale could assist the medical device manufacturers and the FDA to promptly 
identify the root cause of the problems associated with the recalled device and to 
propose solutions that address the issues. The opportunities available for the reuse of a 
design documented using design rationale are significantly increased than compared to a 
device designed without utilising design rationale.  
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6.2.3 Utilising Design Rationale Capabilities with the EU Regulatory 
Approval Process Activities  
The thirteen design rationale capabilities were mapped with the seven activities that 
comprise the EU medical devices regulatory approval process in Table 6-5.  
 
There were there three activities in the EU process (A3 | Prepare Technical 
Documentation; A5 | Audit QMS and Documentation; and A7 | Market Device) which 
highlighted that design rationale could be utilised based on its current capabilities. 
Results from the analysis have indicated that not all of the thirteen design rationale 
capabilities were applicable at these three activities.  
 
There were twelve design rationale capabilities that were found to be applicable at 
activity A3 (Prepare Technical Documentation). Eleven capabilities were found to be 
identically applicable at activities A5 (Audit QMS and Documentation) and A7 (Market 
Device).  
 
The following subsections individually analyse the three activities (A3, A5, and A7) 
where the capabilities of design rationale where found to be applicable and presents the 
benefits of utilising design rationale with the three activities in the EU regulatory 
approval process.  
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Table 6-5: Utilising design rationale capabilities with the EU regulatory approval process for medical devices  
EU process  
activity 
name 
Design rationale capabilities  
A  B  C  D  E  F  G  H  I  J K L M 
A1 – 
Classify 
Device  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A2 – 
Implement 
QMS  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A3 – 
Prepare 
Technical 
Doc.  
X    
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
A4 – 
Appoint EU 
NB  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A5 – Audit 
QMS and 
Doc.  
  
 
X    
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
X    
 
A6 – 
Register 
Device 
Details  
X  X  X  X  X  X  X  X  X  X  X  X  X  
A7 – Market 
Device    
 
X    
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
X    
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6.2.3.1 Prepare Technical Documentation  
At activity A3, medical device manufacturers wanting to place their medical devices in 
the EU market could utilise design rationale when preparing the technical 
documentation.  
 
Twelve capabilities of design rationale could be utilised at activity A3 in the following 
ways: (1) to show how the reasoning, design knowledge and designers decisions were 
captured when designing a medical device; (2) to communicate the design aspects of the 
medical device; (3) to make the reasoning behind the design of the medical device 
explicit; (4) to show how the reasoning underlying the design of the device was 
determined; (5) to show how the design decisions, design history, decision-making 
processes that were made during the design of the medical device were documented; (6) 
to provide explanations of how the medical device was designed; (7) to provide 
justification of the argument behind the design decisions made during the design of the 
device; (8) to provide historical evidence of the device design process; (9) to represent 
the reasoning underlying the design of the device; (10) to show how the decision-
making process and designers decisions were structured during the design of the device; 
(11) to show the reasoning and argumentation behind the design of the device by using 
a communication support system; and (12) to teach the EU medical device regulatory 
authorities about how the device was designed using structured methods for capturing 
design knowledge.  
 
6.2.3.2 Audit Quality Management System and Documentation  
Eleven design rationale capabilities could be utilised in the following ways by the 
regulatory authorities for medical devices in the EU when auditing the QMS and device 
documentation at activity A5: (1) to answers questions concerning the design of the 
device; (2) to review the design relationships, design space, information and logical 
reasoning; (3) to identify the reasoning behind the design of the device; (4) to realise 
how the reasoning underlying the design of the device was determined; (5) to review 
how the design decisions, design history, decision-making processes, design and logical 
reasoning that were made during the design of the medical device were documented; (6) 
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to examine explanations of how the device was designed; (7) to view the justification of 
the argument behind the design decisions that were made during the design of the 
device; (8) to review historical evidence of the device design process; (9) to view the 
representation of the reasoning underlying the design of the device; (10) to understand 
how the decision-making process and designers decisions were structured during the 
design of the device; and (11) to gain knowledge of how the device was designed.  
 
6.2.3.3 Market Device  
Activity A7 was found to have eleven design rationale capabilities that could be applied 
when placing the medical device in the EU market.  
 
At this activity (A7), the eleven capabilities of design rationale could be utilised by both 
the device manufacturers and the medical device regulatory authorities in the EU in the 
following ways: (1) to answers questions concerning a device malfunction after the 
device has been placed on the EU market; (2) to communicate the design relationships, 
design space, information and logical reasoning for a device that has been recalled from 
the EU market; (3) to understand the reasoning behind the design of a device that has 
been recalled; (4) to determine the reasoning underlying the design of a device that has 
been recalled; (5) to understand the design history of a device that has been recalled; (6) 
to provide an explanation of how a device was designed in the event of a device recall; 
(7) to review the justification of the argument behind the design decisions that were 
made during the design of the medical device that has been recalled; (8) to view the 
historical evidence of a device that has been recalled; (9) to review the representations 
of the reasoning underlying the design of a device that has been recalled; (10) to show 
how the decision-making processes and designers decisions were structured during the 
design of a device that has been recalled; and (11) to learn about the design and 
development of a device that has been recalled from the EU market after receiving 
regulatory approval.  
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6.2.3.4 Benefits of Utilising Design Rationale with the EU Regulatory 
Approval Process Activities  
There are a range of benefits available to both the device manufacturers and the 
regulatory authorities in the EU for utilising design rationale with the three regulatory 
approval process activities for medical devices in the EU (A3 | Prepare Technical 
Documentation; A5 | Audit QMS and Documentation; and A7 | Market Device). These 
benefits are summarised as follows.  
 
Utilising design rationale with the preparation of the technical documentation (A3) 
could provide benefits to the device manufacturers. Device manufacturers could 
document the design rationale of the manufactured device as part of the technical 
documentation for regulatory approval in the EU. This could be used by personnel in 
the organisation who are involved with the development and regulatory approval 
aspects of the medical device before the technical documentation is submitted to the EU 
regulatory authorities. Utilising the design rationale capabilities with the preparation of 
the technical documentation could provide benefits to the device manufacturers and the 
EU regulatory authorities by communicating the final design of the device and its 
rationale. If required, this rationale could be reused by device manufacturers to diagnose 
a problem with an existing device and to identify possible solutions. Capturing and 
documenting design rationale in parallel with the design of the device could provide the 
device manufacturers with a way of addressing and resolving issues during the design 
and development stages of the device. This could provide significant cost savings due to 
device recalls, major device rework and any potential litigation costs.  
 
Utilising design rationale with the auditing of the QMS and device documentation (A5) 
could benefit the regulatory authorities in the EU. The EU medical device regulatory 
authorities could review the design rationale of the device as part of the device 
documentation to understand how the device was designed and to raise any queries 
related to its design before it is approved and certified for sale in the EU. Utilising 
design rationale as a way to audit the QMS and device documentation, the regulatory 
authorities could reduce the amount of time spent on auditing documentation. This 
could also decrease the time taken to approve and certify a device and also decrease the 
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overall time taken for manufacturers to place a device on the EU market. Querying the 
design rationale of a device during the audit could provide insight for the regulatory 
authorities into the possible issues related with the device. This could assist them in 
preventing them from occurring before the device has been placed on the EU market.  
 
Design rationale could provide significant benefits once the device has been placed on 
the EU market (A7). A major benefit of utilising design rationale with activity A7 of the 
EU regulatory approval process for medical devices is to address design issues with a 
device that has been recalled from the EU market. At this activity (A7), the reuse of 
design rationale could assist the device manufacturers and the regulatory authorities in 
the EU to identify the root cause of the issues that are associated with a device that has 
been recalled.  
 
6.3 Discussion  
The discussion is structured in two parts. Firstly, it discusses the proposition of the 
regulatory approval of medical devices as a novel area of application for design 
rationale. This is followed by a discussion on the implications that this could present on 
the future of design rationale research. Discussion on the novel area of application for 
design rationale addresses the possible utilisation of design rationale with the regulatory 
approval of medical devices and presents future challenges that need to be addressed by 
the design rationale research community. The prospective research that is required in 
order for design rationale to be utilised with the regulatory approval of medical devices 
is discussed.  
 
6.3.1 Novel Area of Application for Design Rationale  
Utilisation of design rationale methods and computational support tools to capture and 
represent the design decisions of medical devices, so that they can be used with 
regulatory approval, presents a novel area of application for design rationale, and in 
particular, the design rationale research community. Accessing a new application 
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domain for design rationale presents both challenges and benefits for the design 
rationale research and medical device communities.  
 
In order for medical device manufacturers and regulatory authorities to be able to utilise 
design rationale methods and tools with the regulatory approval of medical devices, 
there are several challenges that need to be overcome by the design rationale research 
community. These challenges include; identifying or developing the most appropriate 
design rationale methods or frameworks to capture and represent the design decisions of 
medical devices, integrating design rationale with existing medical device development 
and regulatory approval practices, identifying the utility and usability of design 
rationale with the medical device domain, identifying how well design rationale can be 
put to use with the regulatory approval of medical devices, understanding the 
requirements and problems currently faced by the medical device community, and 
providing evidence to the medical device community of the value of design rationale 
solutions through formal empirical evaluations.  
 
As well as the future challenges facing the design rationale research community, 
accessing a new application domain could potentially provide many benefits for design 
rationale research. These benefits are suggested and include; developing and applying 
dedicated design rationale methods and tools to a highly technical and heavily regulated 
application domain, dissemination of design rationale research within a new application 
domain, new opportunities for acquiring funding to advance design rationale research, 
opportunity for design rationale to have an impact on the way medical devices are 
currently developed and regulated in the U.S. and EU, and opportunities to liaise and 
work in conjunction with medical device manufacturers and regulatory authorities 
thereby disseminating design rationale research to a wider audience.  
 
6.3.2 Implications on Future Design Rationale Research  
Accessing a novel area of application such as the medical device domain has 
implications on future design rationale research. Firstly, design rationale researchers 
need to work closely with medical device manufacturers and regulatory authorities in 
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identifying design issues with medical devices that can have a negative impact on them 
being successfully approved for the U.S. and EU markets. Secondly, researchers need to 
identify the stakeholders who could benefit from using design rationale and classify 
how they could use design rationale and integrate it with their existing working 
practices. Further research needs to be conducted to identify how designers in the 
medical device domain retrieve and reuse design information and how this design 
information should be structured so that it can be used for regulatory approval purposes.  
 
Due to the highly technical and scientific nature of complex medical devices such as 
MRI scanners, researchers need to identify if the existing state-of-the-art in design 
rationale representation frameworks and tools are feasible for utilisation with such 
complex medical instrumentation. If not, this could lead to an area of new research in 
developing bespoke methods and tools or further extending existing ones that enable the 
capture and representation of the design decisions of medical devices so that it can be 
used with the regulatory approval activities as identified in this chapter.  
 
6.4 Chapter Summary  
This chapter identified the relevant U.S. and EU regulatory approval process activities 
where design rationale could be utilised and highlighted the potential benefits available 
to medical device manufacturers and regulatory authorities. This chapter has analysed 
each of the process activities that constitute the U.S. and EU regulatory approval 
processes for medical devices and identified the individual activities where design 
rationale could be utilised. The benefits that are offered to medical device 
manufacturers and regulatory authorities by utilising design rationale with the current 
regulatory approval processes for medical devices have been outlined.  
 
This chapter has fulfilled the fourth research objective by analysing how design 
rationale could be utilised with the regulatory approval of medical devices. Based on the 
results obtained from the analysis presented in this chapter, the following chapter 
presents the guidelines that have been developed.  
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7 Guidelines for Utilising Design Rationale with the 
Regulatory Approval of Medical Devices  
This chapter presents the guidelines that have been developed for utilising design 
rationale with the regulatory approval of medical devices.  
 
The regulatory approval process activities that were identified as applicable and 
proposed for utilisation in the previous chapter (Chapter 6), have formed the basis for 
developing the guidelines that are presented in this chapter. These guidelines provide a 
generic step-by-step approach for medical device manufacturers and regulatory 
authorities on how to use design rationale with three key regulatory approval activities.  
 
This chapter reports on the development of the guidelines that can be used by medical 
device manufacturers and regulatory authorities to capture, represent and review the 
design decisions in the case of a medical device. In this chapter, the fifth objective of 
the research is addressed.  
 
This chapter is structured and presented as follows. The focus and the context of the 
guidelines are firstly defined. Secondly, the methodology followed for developing the 
guidelines is described. This is followed by the guidelines themselves which present the 
different stages of the guidelines and the generic steps that have been defined. 
Following this, the chapter is summarised.  
 
7.1 Focus and Context of the Guidelines  
7.1.1 Guidelines Focus  
The focus of the guidelines is placed on three key activities that constitute the 
application of design rationale with the regulatory approval of medical devices. These 
three key activities were identified from the analysis performed in Chapter 6. In Chapter 
6, the analysis identified that design rationale could be utilised with the regulatory 
approval of medical devices in the following three ways:  
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1. When developing a medical device or preparing the designated marketing 
application (U.S.) and technical documentation (EU), medical device 
manufacturers could capture and represent the design decisions of a medical 
device.  
2. During the review of the marketing application (U.S.) or audit of the quality 
management system and technical documentation (EU), the regulatory 
authorities could review the rationale underlying the design decisions that were 
undertaken during the development of a medical device.  
3. Once the medical device has been placed onto the market, design rationale could 
be used by medical device manufacturers to resolve and/or prevent design issues 
with a device that has been recalled.  
Figure 7-1 illustrates the integration of design rationale and the interconnections of the 
three key activities addressed by the guidelines presented in this chapter.  
 
 
Figure 7-1: Focus of design rationale integration with the designated medical device 
regulatory approval activities  
 
The guidelines are primarily intended for medical device regulatory authorities in the 
U.S. and EU, medical device manufacturers, in particular, designers, engineers, 
regulatory approval specialists, and project managers involved in the development and 
regulatory approval of medical devices. However, other technical specialists, such as 
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those involved in device research and development, quality management, and 
manufacturing, could find the guidelines of use.  
 
It is anticipated that manufacturers involved in medical device development will benefit 
by adopting the guidance provided by the guidelines in order to incorporate design 
rationale with their existing working practices.  
 
The guidelines may also be particularly useful for designers and researchers in other 
application domains, where little guidance exists on the utilisation of design rationale to 
communicate design decisions.  
 
7.1.2 Goal of the Guidelines  
The goal of the guidelines is to provide guidance and support in order to communicate 
design decisions in the case of a medical device.  
 
7.1.3 Guidelines Intentions  
The intentions of the guidelines are to:  
1. Provide a descriptive step-by-step approach on how to utilise design rationale to 
capture and represent the design decisions of a medical device.  
2. Describe the factors that need to be considered when reviewing the design 
decisions of a medical device.  
3. Explain the steps necessary in order to utilise design rationale to resolve and/or 
prevent a design issue with a medical device.  
 
Having defined the focus, goal and intentions of the guidelines in this section, the 
following section describes the steps that have been followed in order to develop the 
guidelines.  
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7.2 Guidelines Development Methodology  
The methodology followed for developing the guidelines to utilise design rationale with 
the regulatory approval of medical devices is presented in this section as follows. First 
of all, the constituents that have formed the basis for the guidelines are described. This 
is followed by a description of how the structure of the guidelines has been 
fundamentally created.  
 
7.2.1 Forming the Guidelines  
There are two main constituents that have formed the basis for developing the 
guidelines. The first is the regulatory approval process activities that were identified 
from the analysis presented in Chapter 6 and discussed in section 7.1.1.  
 
The analysis in Chapter 6 investigated the possibilities of utilising design rationale with 
the U.S. and EU regulatory approval processes for medical devices and identified three 
key activities where design rationale could be utilised and the intended users who would 
benefit from its utilisation. Significantly, the analysis also identified how design 
rationale could be utilised at each of the three activities and how it could be integrated 
into the existing working practices by medical device manufacturers and regulatory 
authorities in the U.S. and EU.  
 
In addition, the second constituent that has been used to form the guidelines is published 
literature in the areas of design rationale and medical device practices. Descriptions 
regarding design rationale capture and representation, issue resolution, solution 
synthesis, and reviewing argumentation-based notations for medical device 
applications, have been extracted directly from the literature and synthesised to form the 
guidelines.  
 
The literature used and referenced in this chapter was identified and reviewed in 
Chapter 2 of this thesis. Data was extracted from the literature listed in Table 7-1. The 
authors, the title of the published article and a description of the articles are provided 
(Table 7-1).  
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Table 7-1: List of identified literature that has been used to form the guidelines  
Authors (date)  Article title  Description of articles  
Bracewell et al. 
(2009) 
Capturing design 
rationale 
Provided descriptions of how design 
rationale can be captured & 
represented.  
Weinstock and 
Goodenough (2009)  
Towards an 
Assurance Case 
Practice for Medical 
Devices 
Explored the use of assurance cases 
for justifying claims of medical 
device safety.  
 
The process of extracting and synthesising the data from the literature involved the 
following stages. Firstly, the articles were fully examined as described in Chapter 2 
(section 2.1.3). The parts of the articles that were considered relevant in supporting the 
formation of the guidelines were manually highlighted so that they could be referred to 
as and when necessary without repeating the process of fully examining them.  
 
Secondly, the highlighted texts were then extracted from the articles and categorised 
into three categories, each representative of the three key activities and goals that are the 
focus of the guidelines. The categories (activity names), guidelines goals, and the 
reference to the literature indicating the data source that has been used to address each 
of the objectives is listed in Table 7-2.  
 
Table 7-2: List of derived categories  
Category name  Guidelines goals (no.) Authors (date)  
Device Development  
Capture and represent the 
design decisions of a 
medical device (1)  
Bracewell et al. (2009)  
Regulatory Approval  
Factors that need to be 
considered when 
reviewing medical devices 
(2)  
Weinstock and 
Goodenough (2009)  
Market Device  
(Device Recall)  
Utilising design rationale 
to resolve and/or prevent a 
design issue (3)  
Bracewell et al. (2009)  
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The published literature was selected and used as a basis to form the guidelines based 
on, firstly, the information relevant to development of the guidelines that the articles 
offer, and secondly, the success of the DRed design rationale tool developed and 
employed into industrial practice and the FDA’s recent recommendations to use 
assurance case practices to demonstrate the safety of medical devices. Figure 7-2 
illustrates an actual representation of captured rationale using the DRed tool in the 
aerospace industry.  
 
 
Figure 7-2: DRed representation of captured rationale (Bracewell et al., 2009)  
 
The descriptions extracted from the literature (Bracewell et al., 2009; Weinstock and 
Goodenough, 2009) have been adapted and generically arranged in order for them to be 
applicable for forming the guidelines which are mainly aimed at medical device 
manufacturers and regulatory authorities, who are the intended users. For example, 
Bracewell et al. (2009) have presented an account of how design rationale was routinely 
captured in the aerospace industry. From the literature itself, this account has been 
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extracted, arranged, and written in the form of what a designer needs to do in order to 
capture the design rationale of a generic product, in the instance of the guidelines 
presented in this chapter, a medical device.  
 
The guidelines themselves do not make reference to the extracted descriptions or the 
literature that they were extracted from, however the explicit listing of the literature 
referenced (Table 7-1) and derivation of the categories (Table 7-2) indicates how the 
guidelines have been formed. The referenced literature can be referred to for more 
information.  
 
On completion of the data extraction and categorisation, a structure for the guidelines 
was created and is described in the following subsection.  
 
7.2.2 Creating the Guidelines Structure  
In order for the guidelines to be developed so that they can be followed by medical 
device manufacturers and regulatory authorities, a coherent structure containing 
different stages has been created to illustrate who should utilise design rationale (user) 
and where (activity) it is to be utilised. This structure is founded on the three key 
activities, the intended users of the guidelines, and the goal and intentions of the 
guidelines.  
 
The guidelines have been structured and defined into the following three stages:  
 Stage 1: describes the approach in which to capture and represent the design 
decisions of a medical device. This initial stage of the guidelines is intended for 
medical device manufacturers.  
 Stage 2: outlines the factors that need to be considered when reviewing the 
design decisions of a medical device. This stage is intended for the regulatory 
authorities.  
 Stage 3: explains how to utilise design rationale to resolve and/or prevent a 
design issue with a medical device that has been recalled from the market. This 
final stage of the guidelines is intended for medical device manufacturers.  
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• Device 
Development 
• Device 
Manufacturers 
Stage 1 
• Regulatory 
Approval 
• Regulatory 
Authorities  
Stage 2 
• Market Device 
(Device Recall) 
• Device 
Manufacturers 
Stage 3 
The three stages that comprise the guidelines are illustrated in Figure 7-3. Figure 7-3 
shows how the guidelines are structured into three sequential stages. These sequential 
stages emphasize that there is directionality offered by the guidelines which is 
representative of the regulatory approval processes which were modelled in Chapter 5. 
In Figure 7-3, the three key activities which have formed the basis for the guidelines are 
named and highlighted and the intended users of the guidelines are listed.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7-3: Stages comprising the guidelines structure  
 
Within the three separate stages, each of which reflects the key activities and goals 
addressed by the guidelines, the guidelines themselves have been structured (written) as 
‘steps’. The steps indicate the actions that are required by the intended user of the 
guidelines in order to utilise design rationale to either; capture and represent the design 
decisions of a medical device, review the design decisions of a medical device, diagnose 
a problem with a device, and design a solution to resolve and/or prevent the problem 
from reoccurring.  
 
Each of the steps within the individual three stages is labelled (named to indicate the 
action that is to be undertaken) and assigned a numerical identifier beginning with the 
number 1 and ending with the final number in the sequence of steps (Step 1 to Step ‘n’). 
For ease of clarity, the guidelines have been written and complied using bullet points 
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and indentation to show the numerous steps that comprise each stage. The three stages 
have also been individually named as follows:  
Stage 1 -  Capturing and Representing the Design Decisions of a Medical Device  
Stage 2 -  Reviewing Design Decisions  
Stage 3 -  Diagnosing a Problem and Designing a Solution  
In order to illustrate how the guidelines have been structured according to the 
development approach presented in this section, an example is provided below:  
 Stage 1: Capturing and Representing the Design Decisions of a Medical Device  
o Step 1: Identify design rationale representation framework  
 [Description of how medical device manufacturers are to identify 
the state-of-the-art in design rationale representation frameworks]  
o Step 2: [Name of guidance step]  
 [Description of how medical device manufacturers are to perform 
the necessary action required at this step]  
This section has presented the methodology that has been developed and followed in 
order to develop the guidelines that are to be used for utilising design rationale with the 
regulatory approval of medical devices. The following section in this chapter presents 
the guidelines.  
 
7.3 The Guidelines  
In this section, the guidelines that have been developed for utilising design rationale 
with the regulatory approval of medical devices are presented. The guidelines consist of 
three stages, each describing the individual steps necessary in order to utilise design 
rationale to capture and represent the design decisions in the case of medical devices. 
These guidelines are primarily intended for medical device manufacturers and 
regulatory authorities.  
 
The guidelines are presented as follows. An overview of the guidelines is initially 
provided which describes the intent of the guidelines. This is followed by a description 
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on how to use the guidelines with existing working practices. Following this, the three 
stages of the guidelines are presented in the following order. Firstly, Stage 1 of the 
guidelines provides guidance on how to capture and represent the design decisions of a 
medical device. Secondly, Stage 2 of the guidelines describes the steps necessary in 
order to review the design decisions of a medical device. Finally, Stage 3 of the 
guidelines provides details on how to utilise design rationale to resolve and/or prevent a 
design issue with a device that has been recalled from the market.  
 
7.3.1 An Overview of the Guidelines  
The guidelines provide a generic top-level approach to utilising design rationale with 
the regulatory approval of medical devices. This top-level approach does not provide a 
detailed description (how to use specific representation frameworks and computational 
support tools), but instead provides a generic step-by-step approach in which the 
intended users of the guidelines can follow in order to gain an understanding of how the 
concept of design rationale can be utilised with three key activities that constitute the 
regulatory approval processes for medical devices in the U.S. and EU.  
 
The guidelines are divided into the three numerical stages, each of which targets the 
following three key regulatory approval activities: (Stage 1) Device Development; 
(Stage 2) Regulatory Approval; and (Stage 3) Market Device (Device Recall). Each of 
the stages is intended for the following users: (Stage 1) Medical Device Manufacturers; 
(Stage 2) Regulatory Authorities; and (Stage 3) Medical Device Manufacturers 
(Regulatory Authorities). The individual stages of the guidelines incorporate the use of 
primary ‘guidance steps’ which are sequenced in numerical order. These indicate the 
order in which to perform the necessary actions in order to: (Stage 1) Capture and 
Represent the Design Decisions of a Medical Device; (Stage 2) Review Design 
Decisions; and (Stage 3) Diagnose a Problem and Design a Solution.  
 
A schematic illustrating the overview of the guidelines is presented in Figure 7-4. In the 
schematic (Figure 7-4), the 3 stages that are the focus of the guidelines are presented 
(stages 1, 2 and 3). The schematic details the stage number and name, activity name, 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
177 
and implementation responsibility (designated personnel required to perform the 
activity – medical device manufacturers and/or regulatory authorities). Figure 7-4 shows 
that the stages are to be sequentially performed beginning at stage 1 and it also 
illustrates the interrelationships between the three stages and their crossover elements.  
 
Firstly, the design decisions for a medical device are to be captured and represented by 
the device manufacturers during its development by using stage 1 of the guidelines. 
These captured design decisions are then to be submitted by the device manufacturers 
with the existing device documentation to the relevant regulatory authorities (directional 
arrow labelled | 1-2).  
 
Secondly, these design decisions along with the appropriate device documentation are 
to be reviewed by the regulatory authorities (stage 2). If the regulatory authorities are 
not satisfied with any aspect of the captured and represented design decisions, or if there 
is any dispute with any of the decisions made by device manufacturers, the regulatory 
authorities can request that device manufacturers make the necessary changes to satisfy 
regulatory requirements (arrow | 2-1).  
 
The two directional arrows between stages 1 and 2 (arrows | 1-2 and | 2-1) indicate that 
iterations could occur when regulatory authorities are reviewing the design decisions. 
The primary implementation responsibility at stage 2 is directed at the regulatory 
authorities. However the device manufacturers will be notified of any inconsistencies 
with the design decisions by the regulatory authorities at this stage. Once the device has 
been approved for market, the device manufacturers can then place the device onto the 
market (arrow | 2-3).  
 
Once placed onto the market, if a problem is identified with the device or it is recalled 
from the market by the regulatory authorities and/or device manufacturers, both device 
manufacturers and regulatory authorities could reuse the previously captured design 
decisions to identify the root cause of the problem for which the device was recalled 
(stage 3 of the guidelines). Primarily at stage 3, it is the responsibility of the device 
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manufacturers to diagnose a problem and to design the corrective solution to resolve the 
issue surrounding the device recall.  
 
Once the problem has been diagnosed and a solution has been designed and the new 
design decisions have been captured and represented, the device manufacturers can then 
submit the updated design decisions to the regulatory authorities notifying them of the 
changes made to the devices design (arrow | 3-2). The regulatory authorities can then 
review the design decisions (stage 2) before either reapproving the device for market, or 
rejecting it from further market access.  
 
 
Figure 7-4: Schematic of the guidelines for utilising design rationale with the regulatory 
approval of medical devices  
 
7.3.2 How to Use the Guidelines  
It is intended that the guidelines be used by medical device manufacturers and 
regulatory authorities in conjunction with existing working practices and in addition to 
the different regulatory approval routes for medical devices in the U.S. and EU. It 
should be noted that as a consequence, the extent with which and the approach in which 
the guidelines are to be adopted is very much at the user’s discretion.  
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The generic practice of capturing and representing the design decisions of a medical 
device is explained step-by-step in Stage 1 of the guidelines. This should be of general 
interest as well as of use for understanding how to generically capture and represent the 
design decisions of an artefact or product.  
 
The steps specified in Stage 2 of the guidelines give details on the actions required in 
order to review the design decisions of a medical device. The steps defined in Stage 2 
will help to assure that the regulatory authorities can understand the structure by which 
the design decisions of a medical device have been represented.  
 
Stage 3 of the guidelines details the steps necessary in order to utilise design rationale to 
diagnose a problem with a medical device that has been recalled from either the U.S. or 
EU markets. This stage of the guidelines also presents the different steps required to 
design a solution.  
 
7.3.3 Stage 1 of the Guidelines – Capturing and Representing the 
Design Decisions of a Medical Device  
Stage 1 of the guidelines provides the steps necessary for medical device manufacturers 
to capture and represent the design decisions that were undertaken during the 
development stages of a medical device.  
 
It is intended that these captured design decisions could be structured by using a design 
rationale representation framework and be used as part of the device documentation 
required for regulatory approval in the U.S. and EU. Once captured, this rationale for 
the developed device could be referred to in the future as and when necessary by the 
medical device manufacturers. The guidelines presented in Stage 1 provide the basic 
guidance steps in order for medical device manufacturers to capture and represent the 
design decisions of a medical device.  
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Stage 1:  
Capturing and Representing the Design Decisions of a Medical Device 
 
o Step 1: Select the product or device that has been, or is currently being developed.  
 To begin the process of capturing and representing the design decisions for a 
medical device, first select the specific device that is being developed or has 
been developed and requires regulatory approval in order to be placed onto 
the market.  
o Step 2: Identify the team members that are/were involved in the design and 
development of the product or device.  
 Collect the names and details of all the personnel involved in the 
development of the device. Each of the personnel involved during the design 
and development stages of the medical device will have data or access to the 
data concerning the design and development stages of the device. This data 
will have the rationale underlying the design and development of the device.  
o Step 3: Organise a team of personnel (ideally, the team members that are/were 
involved in the design and development of the product or device) to perform the 
task of capturing and representing the design decisions.  
 In order to capture and represent the design decisions for a medical device, 
there needs to be an individual or a group of people in order to perform the 
task. Team members should ideally consist of designers, engineers, and 
project managers who were involved during the device’s development stages.  
o Step 4: Gather all of the design data concerning the product or device from the 
team members in ‘Step 2’and any other identifiable data sources.  
 The rationale underlying the design and development of the device can be 
found in and sourced from engineering drawings, documents, emails, models, 
databases, including colleagues.  
o Step 5: Organise the design data into different categories, each category reflecting 
an integral part (component, module) of the product or device.  
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 Once the design data has been gathered, divide the datasets into categories 
which highlight the different integral parts of the device. This is to simplify 
the design decisions into key parts of the device that will make it easier for 
reviewers to follow and analyse. Also, this makes it useful for traceability at a 
later date if the design on a particular part of the device is altered. The 
rationale for this particular change can be amended without having to alter the 
entire design argument.  
o Step 6: Identify and classify the design decisions undertaken during product or 
device development according to the designated categories defined in ‘Step 5’. 
 Go through the design data of the device to identify the design decisions that 
were taken during the device’s development and classify each of the decisions 
based on an integral part of the device. This classification helps to determine 
which decisions were made regarding each unique part of the device.  
o Step 7: Identify the available design rationale representation frameworks and 
computational support tools.  
 There are a variety of state-of-the-art design rationale representation 
frameworks available and subsequent computational support tools based on 
the representation notations. Information of these frameworks can be found in 
the literature and online (WWW). The representation frameworks that are 
widely used are: Issue-Based Information System (IBIS), Procedural 
Hierarchy of Issues (PHI), Questions, Options, and Criteria (QOC), and 
Decision Representation Language (DRL).  
o Step 8: Select the relevant design rationale representation framework and 
computational support tool to represent the design decisions of the selected product 
or device.  
 Once the state-of-the-art in design rationale representation frameworks have 
been identified, a selection of the most relevant framework is required. The 
selection can be made based on the current domain coverage of the 
frameworks or by identifying the structure that is most relevant to represent 
the design decisions for a medical device.  
o Step 9: Select one of the designated categories which reflect an integral part of the 
product or device.  
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 This is to be used in the following step for representing the design decisions 
of the integral part of the device.  
o Step 10: Identify the initial steps in representing the design argument and 
subsequent decisions as suggested by the underlying theory of the selected design 
rationale representation framework.  
 To represent the design decisions for a medical device by using design 
rationale, the theory of the representation framework needs to be understood. 
Different frameworks begin the representation in their own unique ways and 
follow a structure that is bespoke. For example, the IBIS methodology 
requires the definition of a top-level issue. Each framework has its own way 
of constructing and representing a design argument.  
o Step 11: Construct the design argument, directly with the computational support 
tool, according to the structure of the selected design rationale representation 
framework by using the design decisions that were extracted from the available 
design data.  
 More recently, computational support tools based on existing representation 
framework notations are available on the WWW and can be downloaded. 
These tools can be used to directly construct a design argument which shows 
the design decisions taken during the development of a medical device 
without having to use a paper-based system. This saves time and effort on the 
part of the team who are performing the task of design decision capture and 
representation.  
o Step 12: Repeat ‘Step 11’ for the different categories which are related to the 
different integral parts of the product or device.  
 This step is to be repeated for each of the different integral parts of the device 
so as to capture and represent the different parts that constitute the whole 
device.  
o Step 13: Verify the design decisions for each of the integral parts of the product or 
device.  
 On completion of capturing and representing the design decisions for the 
medical device, these decisions require verification before they are to be used 
and submitted with the device documentation for regulatory approval. To 
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accomplish the verification of the design decisions, show the captured design 
decisions to the team involved in the development of the device to confirm 
the decisions before being released to the regulatory authorities. This could be 
considered to be an internal verification process within the medical device 
manufacturing company.  
o Step 14: Save and retain all soft copies and hard copies of the captured design 
decisions that have been represented using design rationale.  
 Use the computational support tool to save and print the captured design 
decisions and keep all copies for future use, as they may be required at a later 
time, for example, if the design changes or the device is recalled from the 
market.  
o Step 15: Compile and add the design rationale documentation (design decisions 
represented by utilising design rationale) with the existing design documentation 
required for regulatory approval purposes.  
 Embed the captured and represented design decisions within the existing 
documentation required for regulatory approval as additional information for 
the regulatory authorities.  
o Step 16: Submit all relevant product or device documentation to the required 
regulatory authorities as specified in the regulatory requirements.  
 All device documentation required for regulatory approval should be 
submitted to the regulatory authorities as specified.  
 
7.3.4 Stage 2 of the Guidelines – Reviewing Design Decisions  
Stage 2 of the guidelines details the individual steps required for the regulatory 
authorities, in particular of medical devices, to review the design decisions that were 
captured by the medical device manufacturers and represented using design rationale 
representation frameworks.  
 
The steps presented in this stage of the guidelines outline the factors that need to be 
considered when reviewing the design decisions of a medical device. In order for design 
rationale to be utilised with the regulatory approval of medical devices, adopting design 
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rationale to represent the design decisions of a medical devices necessarily requires that 
there be way to review them. In order to accept design rationale documentation as part 
of the regulatory approval documentation and practices for medical devices, the 
reviewer must be able to understand it, be convinced that the design decisions are 
concise, and supported by the necessary evidence.  
 
The guidelines in Stage 2 provide the fundamental steps in order for the regulatory 
authorities in the U.S. and EU to review the design decisions that were undertaken by 
medical device manufacturers during the development of a medical device.  
 
 
Stage 2:  
Reviewing Design Decisions 
 
o Step 1: Verify that the design rationale documentation is structurally complete and 
that the node phrasing in each representation is correct.  
 Check to see that every node can be traced back to the top-level claim and 
that each ‘leaf’ node is either evidence or reference to some previously 
reviewed design rationale documentation.  
o Step 2: Validate the claims being made.  
 Ensure that the claims are expressed as simple predicates and that evidence is 
a noun phrase (not stated as a claim). Checking that claims and evidence 
nodes are correctly phrased guards against confusion when later considering 
the substance of the design rationale documentation.  
o Step 3: Review the design arguments and design decisions for all of the integral 
parts and components of the medical device.  
 Review the design rationale documentation to consider whether the design 
decisions and resulting arguments are persuasive. An argument is persuasive 
if each claim follows from the claims or evidence supporting it. 
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Persuasiveness is best achieved when the associations between claims are 
made obvious.  
o Step 4: Check for the incompleteness of design arguments, design decisions, and 
supporting evidence.  
 Ensure that the design argument and design decisions, including the claims 
and evidence are complete. If a design argument breaks claims into sub-cases 
and argues each of the sub-cases separately, the design argument is defective 
if all the sub-cases are not actually addressed.  
o Step 5: Check the design rationale for robustness.  
 Verify if a claim is supported by independent arguments/evidence (e.g., by 
test results and by modelling analysis). If so, the claim is more likely to hold, 
since a defect in one branch of the supporting argument will not impair the 
validity of the other branches. To the extent that proposed supporting 
arguments are not independent, the claim is more weakly supported than it 
might at first appear.  
 
7.3.5 Stage 3 of the Guidelines – Diagnosing a Problem and 
Designing a Solution  
Stage 3 of the guidelines describes the steps necessary in order to utilise design 
rationale to diagnose a problem with a medical device that has been recalled from either 
the market. This stage of the guidelines also presents the different steps required to 
design a solution in order to resolve the identified problem and/or prevent the problem 
from reoccurring.  
 
The guidelines in Stage 3 provide the essential steps for medical device manufacturers 
to utilise design rationale to identify a problem with a medical device, resolve the issue 
so that it does not reoccur, and demonstrate to the regulatory authorities that the device 
is safe and effective for use.  
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Stage 3:  
Diagnosing a Problem and Designing a Solution 
o Step 1: Define the problem focus that is associated with the product or device.  
 First step in diagnosing the problem associated with the device that has been 
recalled is to define the problem statement. This statement should specify the 
exact nature of the device recall. The problem can be identified from the 
reason behind the recall of the device from the market by the regulatory 
authorities or actual users of the device, i.e. from the public domain or 
clinicians and physicians.  
o Step 2: Identify personnel involved in the design and development of the product or 
device that has been recalled from the market.  
 Collect the names and details of all the personnel involved in the 
development of the device. Each of the personnel involved during the design 
and development stages of the medical device will have data or access to the 
data concerning the design and development stages of the device. This data 
will have the rationale underlying the design and development of the device.  
o Step 3: Select personnel to perform the task of diagnosing the problem and 
designing a solution.  
 In order to diagnose the reported problem and design a solution for the 
recalled medical device, there needs to be an individual or a group of people 
in order to perform the task. Team members should ideally consist of 
designers, engineers, and project managers who were involved during the 
device’s development stages. 
o Step 4: Prepare a problem report which describes the problems associated with the 
recalled product or device.  
 The problem report should explicitly state the exact nature of the problem 
associated with the device that has been recalled from the market. This report 
should provide details such as; reason for recall, when and how the problem 
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was identified, how many products have been affected, any serious injuries as 
a result of the device recall, and list any possible causes for the problem.  
o Step 5: Retrieve all design documentation and any previously captured rationale of 
the product or device that has been recalled.  
 Gather all of the necessary documentation that is associated with the recalled 
device and any previously captured rationale as this is to be used to trace the 
history of the design and development of the device.  
o Step 6: Review the design documentation and any previously captured rationale.  
 Perform a thorough review and analysis of the design documentation to 
identify the design decisions that were made during the development stages. 
Extract these decisions from the design documentation during the review. 
Segregating the design decisions for the different parts that comprise the 
device is a useful way to organise the decisions based on individual parts or 
components.  
o Step 7: Identify the available design rationale representation frameworks and 
computational support tools.  
 There are a variety of state-of-the-art design rationale representation 
frameworks available and subsequent computational support tools based on 
the representation notations. Information of these frameworks can be found in 
the literature and online (WWW). The representation frameworks that are 
widely used are: Issue-Based Information System (IBIS), Procedural 
Hierarchy of Issues (PHI), Questions, Options, and Criteria (QOC), and 
Decision Representation Language (DRL).  
o Step 8: Select the relevant design rationale representation framework and 
computational support tool to represent the design decisions (diagnosis of the 
problem and design of the solution) of the selected product or device. 
 Once the state-of-the-art in design rationale representation frameworks have 
been identified, a selection of the most relevant framework is required. The 
selection can be made based on the current domain coverage of the 
frameworks or by identifying the structure that is most relevant to represent 
the design decisions taken to diagnose a problem and to design a solution for 
a medical device.  
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o Step 9: Form theories about the potential causes of the problem and highlight all 
known design issues.  
 Begin to form some theories about what some of the potential causes of the 
problem could be and list them in an order of likelihood. Start searching for 
evidence to support or refute the theories. Make a list of the known design 
issues with the devices, if any are known and made available.  
o Step 10: Depending on the selected design rationale representation framework, 
define the top-level issue to be resolved – for example, “What is causing the issue 
of…”  
 To represent the design decisions for a medical device by using design 
rationale, the theory of the representation framework needs to be understood. 
Different frameworks begin the representation in their own unique ways and 
follow a structure that is bespoke. For example, the IBIS methodology 
requires the definition of a top-level issue. Each framework has its own way 
of constructing and representing a design argument. At this step, define the 
top-level issue, i.e. what is causing the reported problem.  
o Step 11: Construct the design argument, using the formed theories as an initial 
basis, directly with the computational support tool according to the structure of the 
selected design rationale representation framework.  
 Use the computational support tool, which is based on an existing design 
rationale representation framework to directly construct a design argument 
showing the design decisions taken to diagnose the reported problem with the 
recalled.  
o Step 12: Generate the various hypotheses regarding the diagnosis of the problem 
(top-level issue).  
 Use the representation frameworks structure in order to construct the 
argument showing the various hypotheses that have been generated regarding 
the diagnosis of the problem.  
o Step 13: Develop the respective pro and con statements to support or refute each of 
the generated hypotheses providing adequate evidence in support of each 
statement.  
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 Build the design argument showing the process of diagnosing the problem 
using answers and pro and con statements to either support or refute each of 
the generated hypotheses.  
o Step 14: Resolve all issues with an answer and/or pro and con statements.  
 Do not leave any unresolved issues. Ensure all issues are resolved with either 
an answer that is linked with a pro or con statement.  
o Step 15: Verify the diagnosis of the problem with the recalled product or device.  
 Go through each of hypotheses and resultant decisions to verify that all raised 
issues have been resolved and that the top-level issue has been resolved. In 
the case of the diagnosis, the question as to what has caused the design 
problem has been answered using evidence in support.  
o Step 16: Highlight that the top-level issue is resolved or it is insoluble.  
 If the top-level issue cannot be resolved for any reason, label it as insoluble. 
This will provide indication that further studies need to be conducted to 
address the issue.  
o Step 17: To design a solution in order to resolve the diagnosed problem, define a 
new top-level issue – for example, “How to stop…”  
 Raise a top-level issue that aims to address the questions of how to solve the 
reported problem. The solution is directly related to the reported problem, in 
that it aims to solve the problem that has been identified and diagnosed with 
the device.  
o Step 18: Generate various hypotheses regarding the possible resolution of the 
defined top-level issue.  
 Use the representation frameworks structure in order to construct the 
argument showing the various hypotheses that have been generated regarding 
possible solutions to address the diagnosed problem.  
o Step 19: Develop the respective pro and con statements to support or refute each of 
the generated hypotheses providing adequate evidence in support of each 
statement.  
 Build the design argument showing the process of diagnosing the problem 
using answers and pro and con statements to either support or refute each of 
the generated hypotheses.  
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o Step 20: Verify the solution.  
 Go through each of hypotheses and resultant decisions to verify that all raised 
possible solutions have been address and that the top-level issue has been 
resolved. In the case of designing a solution, the question as to how to stop 
the problem from reoccurring has been answered using evidence in support. 
o Step 21: Prepare a narrative description of the solution, complete with details such 
as rework procedures required to apply the solution to the device(s) or products 
that have been recalled from the market.  
 Being narrative, these descriptions are best written as standard word-
processed reports.  
o Step 22: Inform the regulatory authorities of the changes made to the product or 
device and submit the generated rationale documentation of the diagnosis and 
solution with the any other documentation as required by the regulatory 
authorities.  
 Inform the regulatory authorities that the problem with the recalled device has 
been diagnosed and a solution has been designed and implemented so the 
problem will not reoccur again.  
 
7.4 Discussion  
This section presents a discussion on the descriptive guidelines that have been 
developed and presented in the preceding section this chapter.  
 
The descriptive guidelines have been structured into three stages and consist of 
numerous guidance steps for each of the three stages. There are sixteen steps present in 
stage 1 of the guidelines, five steps for stage 2, and a total of twenty-two steps which 
comprise stage 3 of the guidelines. These steps have been derived from the literature 
and present the necessary actions required by medical device manufacturers and 
regulatory authorities to utilise design rationale with the regulatory approval of medical 
devices. Each of the three stages has been specifically structured and defined according 
to the findings of the research presented in Chapter 6.  
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Stage 1 of the guidelines has been developed to provide the steps necessary for medical 
device manufacturers to capture and represent the design decisions that were undertaken 
during the development stages of a medical device. Stage 2 of the guidelines details the 
individual steps required for the regulatory authorities to review the design decisions of 
a medical device that have been represented using design rationale. Stage 3 of the 
guidelines describes the steps necessary in order to utilise design rationale to diagnose a 
problem with a medical device that has been recalled from the market.  
 
The three stages of the guidelines all correspond with the activities that were identified 
in the analysis (Chapter 6) which investigated where in the regulatory approval process 
for medical devices design rationale could be utilised. These three stages of the 
guidelines were particularly structured according to the activities identified from the 
analysis and aimed at the target users who were to undertake those activities, i.e. 
medical device manufacturers and regulatory authorities.  
 
The structure of the guidelines has been illustrated using a schematic diagram which 
shows; the medical device activity that each stage of the guidelines is targeted at 
addressing, the guidance provided at each activity, and who the guidance is intended 
for. Each stage addresses the necessary actions required from medical device 
manufacturers and regulatory authorities.  
 
7.5 Chapter Summary  
In order to address the gaps identified in existing knowledge from the literature 
reviewed in Chapter 2 and the aim and fifth objective of the research, a descriptive set 
of guidelines for utilising design rationale with the regulatory approval of medical 
devices have been developed and presented in this chapter.  
 
These guidelines provide a generic step-by-step approach for medical device 
manufacturers and regulatory authorities on how to use design rationale with three key 
regulatory approval process activities; device development, regulatory approval, and 
market device (device recall). The guidelines consist of three stages, each of which 
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targets a key regulatory approval process activity. Each of the three stages is comprised 
by a number of descriptive steps which uniquely detail the requisite actions necessary 
from both medical device manufacturers and regulatory authorities in order to utilise 
design rationale.  
 
The guidelines presented in this chapter are the result from the research that has been 
systematically conducted and presented throughout the chapters of this thesis. The 
findings from the research presented in the different chapters have been synthesised in 
order to form the guidelines, thereby partially fulfilling the aim of the research. 
Validation of the guidelines is required to fully address the aim of the research.  
 
The following chapter describes the adopted approach taken by the author to validate 
the guidelines that were presented in this chapter.  
 
  
CHAPTER 8  
 
 
 
 
 
 
 
 
 
 
VALIDATION  
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8 Validation  
This chapter presents the validation of the research based on the opinions of 
researchers and experts from a variety of design contexts. The guidelines developed in 
the previous chapter have been validated to present a comprehensive understanding on 
the steps required to capture, represent and review the design decisions in the case of 
medical devices. This chapter addresses the final objective of the research.  
 
The previous chapter (Chapter 7) developed and presented a set of guidelines that were 
to be followed in order to capture, represent and review the design decisions in the case 
of medical devices.  
 
The guidelines were targeted at three key medical device activities, consisted of three 
separate stages, each of which were dedicated to a particular activity, and were 
comprised of a series of descriptive guidance steps. This chapter presents the approach 
taken to validate the guidelines that were developed and presented in Chapter 7.  
 
In this chapter, the guidelines that have been developed are validated. The validation of 
the guidelines has been performed by academics, researchers and medical device 
experts.  
 
This chapter is presented as follows. First of all, the methodology followed for 
validating the guidelines is described. This is followed by the presentation and a 
detailed analysis of the results which have been obtained from the validation process. 
Additional information obtained during the validation process is presented in 
conjunction with the analysis of the results. Following this, the results obtained from the 
validation are discussed. Finally, this chapter is summarised.  
 
The structure of this chapter is illustrated in Figure 8-1.  
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Figure 8-1: Structure of validation chapter  
 
8.1 Validation Methodology  
The methodology developed and followed for validating the guidelines is presented in 
this section. The methodology utilises academics, researchers, and medical device 
experts to perform the validation of the guidelines. This approach ensures the validity of 
the guidelines by obtaining the opinions and feedback from the experts and researchers.  
 
Details of the methods followed for the stages in validating the guidelines are presented 
in the following subsections as follows. Firstly, the method and underlying rationale 
behind the participant selection to validate the guidelines is explained. This is followed 
 
8.1 
• Validation Methodology 
 
8.2 
• Validation Results 
 
8.3 
• Discussion 
 
8.4 
• Chapter Summary 
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by a description of how the participants (academics, researchers, and medical device 
experts) opinions and feedback is to be obtained. Following this, the approach taken to 
analyse the feedback and opinions from the experts is outlined. This is followed by the 
utilisation of the guidelines to capture and represent the design decisions of medical 
devices.  
 
8.1.1 Participant Selection  
The initial stage of the approach taken to validate the guidelines required participants to 
answer the questions in the validation questionnaire. This was performed to ensure that 
the guidelines could be understood and followed by practitioners. Ten participants were 
invited to attend a validation workshop which was held on the 21
st
 of September 2012 at 
Cranfield University, U.K. Further details on the delivery of the questionnaire and 
completion can be found in section 8.1.2.2.  
 
The participants that were invited to attend the validation workshop were from different 
schools and departments within Cranfield University. The rationale for this selection is 
based on the different perspectives and differing core competencies that each of the 
participants has acquired in the various research and application domains. Also, some of 
the invited participants have experience in developing medical devices. Participants 
were invited from the following schools: School of Applied Sciences, School of 
Engineering, and School of Health.  
 
It is anticipated that the intended users of the guidelines (medical device manufacturers 
and regulatory authorities) may come from a professional background that has been 
focussed on applied sciences, engineering and the medical domain. By using 
participants from divergent backgrounds during the validation process, it is intended 
that their diverse opinions and feedback would enrich the validation process and 
provide useful information regarding the guidelines themselves.  
 
By using researchers and academics to validate the guidelines, this provides information 
regarding future research possibilities or a basis for further investigation. Out of the ten 
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invited participants, seven attended the workshop. From the seven participants who 
attended, there was one research fellow and six PhD researchers from different 
academic backgrounds including; design, computer sciences, engineering, management, 
physics, chemistry, and biology.  
 
8.1.2 Obtaining Participants Opinions and Feedback  
In order to establish whether the proposed guidelines could be used in practice, it was 
necessary to design an approach to measure the attributes of the guidelines. The 
attributes of the guidelines were captured and analysed using a validation questionnaire 
which has been designed and utilised to validate the guidelines with the participants.  
 
The concept of the structured questionnaire to validate the guidelines was selected by 
the author to formalise the validation process whereby the results obtained could be 
measured and analysed in an organised and consistent manner, thus eliminating any 
bias. Details on the design of the questionnaire and the attributes of the guidelines are 
provided in the following subsection.  
 
8.1.2.1 Questionnaire Design  
The questionnaire has been designed to incorporate the questions among the defined 
sections to reflect the different attributes of the guidelines. The questionnaire has been 
developed based on previous work published by Younis (2010), Chandraprakaikul 
(2008) and Platts (1994). The questions have been established to investigate the 
feedback of the participants at a high-level of abstraction. The intention of the 
questionnaire design was to give both a detailed analysis of the guidelines and to 
consider them from the following perspectives:  
 Feasibility  
 Usability  
 Usefulness  
 Design Features  
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
199 
Based on the aforementioned perspectives, the questionnaire has been divided into the 
following sections, each section containing a set of different attributes:  
Section A - Feasibility  
The first section in the questionnaire addresses the feasibility of the guidelines. This 
section is intended to gather feedback regarding the practicability of the proposed 
guidelines. The questions in this section focus on the following attributes:  
 Completeness  
o The guidelines consist of relevant steps in order to capture and represent 
the design decisions of a medical device.  
 Consistency  
o The stages and sequences of steps within the guidelines are consistent 
with one another.  
 Applicability  
o The guidelines could be successfully adopted in other similar contexts, 
i.e. where product development, approval, and post market play a vital 
role in placing a product onto the market.  
 Contingency  
o The guidelines provide the intended users with alternative solutions on 
how to utilise design rationale with the regulatory approval of medical 
devices.  
Section B - Usability  
The second section in the questionnaire has been developed to address the usability of 
the guidelines. The questions defined in this section focus on the following attributes:  
 Time  
o The time required to follow and understand the guidelines is within 
desirable limits (between 15 minutes to 30 minutes).  
 Ease of Use  
o The structure of the guidelines is easy to follow.  
 Understanding  
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o The goals and intentions of the guidelines are clear and concise.  
 Flexibility  
o The guidelines are sufficiently flexible in application.  
Section C - Usefulness  
The third section of the questionnaire addresses the usefulness of the guidelines. This 
section intends to understand the effectiveness of the proposed guidelines and whether 
or not they would be likely to be of use. The questions defined in this section are related 
to the following attributes:  
 Satisfaction  
o The guidelines meet the expectations of utilising design rationale with 
the regulatory approval of medical devices.  
 Success  
o The guidelines were successful in meeting their stated goals and 
intentions.  
 Practicality  
o The guidelines are practical for application.  
 Benefit  
o The guidelines could provide essential benefits to medical device 
practitioners and regulatory authorities.  
Section D - Design Features  
The fourth section of the validation questionnaire identifies the associative design 
features of the guidelines. This section of the questionnaire addresses the 
methodological attributes of the guidelines. The questions defined in this section of the 
questionnaire address the following eight attributes:  
 Strategic Link  
o The guidelines provide an essential link between device development 
and regulatory approval.  
 Key Activities  
o The guidelines successfully target key medical device activities.  
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 Novel Approach  
o The guidelines provide a novel approach in capturing and representing 
design decisions, and resolving design issues and/or preventing design 
issues with a medical device.  
 Continuous Improvement  
o The guidelines can be used as part of a continuous improvement 
programme for medical devices.  
 Structure  
o The guidelines are well defined, in a step-by-step approach.  
 Documentation  
o The guidelines provide a well-documented set of steps to be used with 
key medical device activities.  
 Participation  
o The intended users of the guidelines are appropriate.  
 Deliverables  
o The product/outcome is useful for practitioners.  
Section E - Any Other Comments  
The validation questionnaire concluded by providing the participants with an additional 
page to make any comments they felt that were necessary in order to provide feedback 
in an unstructured way. A further space below each question was made available in the 
questionnaire for the participants to make any additional comments related to the 
individual questions.  
 
In order to answer the questions in each of the sections of the validation questionnaire, a 
standardised scale (Likert scale) for considering each attribute of the developed 
guidelines was employed. This scale is often used in research that employs 
questionnaires. It is the most widely used approach to scaling responses in survey 
research. The standardised scale was used in order to answer all of the twenty questions 
(4 questions each in sections - A to C, and eight questions in section D). The 
incorporation of a standardised scale presents a structure with which the participants can 
select a predefined answer based on the scale, and it also offers the opportunity to assign 
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numerical values to the responses which can then be used for a complete analysis and 
cross-comparison of the results. This is described in section 8.1.3. An image of the 
standardised scale used in the validation questionnaire is illustrated in Figure 8-2.  
 
Strongly 
Disagree 
Disagree Neither Agree 
Nor Disagree 
Agree Strongly Agree 
     
Figure 8-2: Standardised scale  
 
The version of the validation questionnaire that has been used to validate the guidelines 
with the participants can be found in Appendix D: Validation Questionnaire.  
 
8.1.2.2 Questionnaire Delivery and Completion  
The process of validating the guidelines was conducted on the 21
st
 of September 2012 at 
Cranfield University, U.K. The duration of the validation workshop was one hour. 
Participants were invited to attend for the whole hour due to the format of the workshop 
which is presented as follows:  
1. Introduction to the research (5mins)  
2. Presentation (10mins)  
3. Explanation of the guidelines (5mins)  
4. Complete validation questionnaire (30mins)  
5. Questions and answers (5mins)  
6. Discussion and feedback regarding the validation process (5mins)  
Details on the format of the workshop consisted of the following. An introduction to the 
research was presented due to the limited knowledge of the participants regarding both 
design rationale research and the regulatory approval of medical devices. This included 
the context of the research and the developed guidelines. This was incorporated into the 
presentation by providing essential background information. A copy of the validation 
presentation can be found in Appendix C: Validation Presentation.  
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An explanation of the guidelines was provided due to the limited time available and 
limited knowledge of the participants regarding the utilisation of design rationale with 
the regulatory approval of medical devices. This minimised time used to validate the 
guidelines and provided focus for the participants on aspects which they were 
competent to validate.  
 
The participants were then asked to complete the validation questionnaire in the 
structured format provided by the questionnaire. A separate sheet with the attached 
guidelines was provided to each of the participants so that they could view the structure 
of the guidelines and follow them independently within the allotted time frame. A 
questions and answers session with the participants was arranged within the workshop 
as to allocate time in order to explain any issues with the validation process itself that 
required clarification. This was arranged in case the participants did not feel that they 
could ask questions during the presentation. Finally, a time was allotted for discussion 
and feedback regarding the specifics of the validation process. Section E on the 
questionnaire was referred to by the participants in order to provide feedback on the 
questionnaire, and so that any comments could be addressed at the end of the validation 
workshop. This part of the workshop captured the feedback of the participants regarding 
the guidelines and captured any additional improvements to the guidelines which could 
then be incorporated.  
 
8.1.3 Analysing the Participants Feedback  
In order to analyse the responses to the questionnaires from the participants, the 
questionnaires were gathered upon completion from each of the participants and all of 
their responses were coded into a spread sheet using Microsoft Excel 2007 edition. The 
coding of the responses was based on the standardised scale:  
 Strongly Disagree  
 Disagree  
 Neither Agree Nor Disagree  
 Agree  
 Strongly Agree  
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By using the standardised scale, it has been possible to assign numerical values to each 
individual response in the scale, thereby measuring each of the participant’s responses 
to each of the questions answered. The following list shows the numerical value that has 
been assigned to represent each of the responses in the scale:  
 Strongly Disagree = -2  
 Disagree = -1  
 Neither Agree Nor Disagree = 0  
 Agree = +1  
 Strongly Agree = +2  
In assigning the numerical values to each of the responses (zero, positive and negative 
values), this allowed for the comparison of the results for the individual participants, 
questionnaire sections, and questions, in order to identify the strengths and weaknesses 
of the guidelines attributes.  
 
Each of the responses from the participants was tabulated into a spread sheet and tables 
were created for each of the sections (Sections A to D), four in total. These four tables 
were firstly sorted by the guidelines attributes in each section of the questionnaire, then 
by the participants (labelled P1 to Pn to preserve the anonymity of the participants), and 
then by the average values of the responses for each attribute. The actual values given 
for the responses are also provided in the columns reflecting the response to each 
question answered in the questionnaire. An example of the table that is to be used to 
represent the responses is provided in Table 8-1.  
 
Table 8-1: An example of the responses coded for Section A of the questionnaire  
Attribute  P1  P2  P3  P4… Pn  
Participant 
Average  
Completeness  2 1 1 2 - 1.5 
Consistency  2 2 1 0 - 1.25 
Applicability  2 0 1 2 - 1.25 
Contingency  2 1 2 1 - 1.5 
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The data input from the tables (four tables in total) have been used to create radar charts 
using Microsoft Excel 2007 edition to illustrate the findings from the validation process. 
These radar charts are then analysed to identify the strengths and weaknesses of the 
guidelines attributes. A radar chart plots the values of each category along a separate 
axis that starts in the centre of the chart and ends on the outer ring. Data that is arranged 
in columns or rows on a worksheet (spread sheet) can then be plotted directly onto the 
chart. Radar charts compare the aggregate values of multiple data series. Each data 
series in a chart has a unique colour or pattern and is represented in the chart legend. An 
example of a radar chart using the data provided in Table 8-1 is illustrated in Figure 8-3.  
 
 
Figure 8-3: An example of a radar chart used for analysing the participants feedback  
 
8.1.4 Utilising the Guidelines to Capture and Represent the Design 
Decisions of an Infusion Pump  
In order to validate the guidelines for use in a medical device industrial setting, a 
member of the research and development department at a leading international medical 
device company based in the U.K. was contacted by email and asked to participate in 
validating the guidelines by using them in order to; capture and represent the design 
decisions of a medical device, diagnose a well-documented problem with an infusion 
pump, and design a solution. The validation participant has over sixteen years of 
-2
-1
0
1
2
Completeness
Consistency
Applicability
Contingency
Section A - Feasibility 
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experience as a principal research and development engineer developing medical 
devices such as airways assisted products, diagnostic and monitoring equipment and 
therapeutic devices. Due to confidentiality, the principal engineer omitted certain 
aspects of the guidelines, however followed them to diagnose an issue regarding the 
battery of the infusion pump and designed a possible solution. Decisions were firstly 
captured and represented on paper by the principal engineer according to the chosen 
design rationale methodology. These were illustrated by the researcher using the 
designVUE tool. Illustrations of the decisions were shown to the principal engineer who 
verified them by checking the semantics of the decisions and corresponding arguments.  
 
8.2 Validation Results  
Results that have been obtained from the validation process as presented in this section. 
The validation results follow the order of the sections defined in the questionnaire and 
are presented as follows. Firstly, the results regarding the feasibility of the guidelines 
are presented. This is followed by the results for usability, usefulness, and design 
features. Following this, the average results for four of the sections in the questionnaire 
(A – Feasibility | B – Usability | C – Usefulness | D – Design Features) are analysed. 
Finally, the comments and feedback that were noted by the participants on the 
questionnaire are summarised.  
 
8.2.1 Feasibility  
The results obtained from the validation process regarding the feasibility of the 
guidelines, according to the defined scale and numerical values, is presented in Table 
8-2 and represented by the radar chart illustrated in Figure 8-4.  
 
Table 8-2: Section A – Feasibility results  
Attribute Name P1 P2 P3 P4 P5 P6 P7 Attribute Average 
Completeness 2 1 1 2 1 2 2 2 
Consistency 2 2 1 2 2 2 2 2 
Applicability 1 1 2 0 2 2 1 1 
Contingency 1 0 1 1 2 2 2 1 
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
207 
 
Figure 8-4: Radar chart showing the average results for feasibility  
 
From the results obtained and shown in Table 8-2 and Figure 8-4, the experts and 
researchers considered ‘completeness’ and ‘consistency’ to be the strongest attributes of 
the feasibility of the guidelines. By analysing the results further for these two attributes, 
it is noticed that the consistency of the guidelines ranks higher than completeness. The 
attributes ‘applicability’ and ‘contingency’ were equally ranked behind ‘completeness’.  
 
8.2.2 Usability  
Results that have been obtained regarding the usability of the guidelines are presented in 
Table 8-3 and Figure 8-5. Both Table 8-3 and Figure 8-5 show that the experts and 
researchers considered the attribute ‘understanding’ to be the most favourable attribute.  
 
Table 8-3: Section B – Usability results  
Attribute Name P1 P2 P3 P4 P5 P6 P7 Attribute Average 
Time -1 1 2 2 0 1 1 1 
Ease of Use 1 0 1 2 1 1 2 1 
Understanding 2 1 2 1 2 2 2 2 
Flexibility 0 0 2 0 0 1 1 1 
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Figure 8-5: Radar chart showing the average results for usability  
 
As it is listed in Table 8-3 and illustrated in Figure 8-5, the attribute ‘understanding’ 
was followed by ‘ease of use’. This indicates that the experts and researchers considered 
the ease of use of the guidelines to be favourable behind understanding. This was thirdly 
followed by the ‘time’ required to understand the guidelines. The attribute that was 
ranked the lowest by the experts and researchers was ‘flexibility’.  
 
8.2.3 Usefulness  
Results regarding the usefulness of the guidelines are presented in Table 8-4 and 
illustrated by the radar chart in Figure 8-6.  
 
Table 8-4: Section C – Usefulness results  
Attribute Name P1 P2 P3 P4 P5 P6 P7 Attribute Average 
Satisfaction 2 2 1 2 1 2 0 1 
Success 1 1 1 2 2 2 2 2 
Practicality 1 1 2 2 1 1 2 1 
Benefit 2 2 2 2 1 1 1 2 
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As shown in Table 8-4 and Figure 8-6, the experts and researchers considered the 
attributes ‘success’ and ‘benefit’ to be the highest and of equal importance regarding the 
usefulness of the guidelines. They also considered the attributes ‘satisfaction’ and 
‘practicality’ to be equally important but not as favourable when compared to the 
attributes ‘success’ and ‘benefit’.  
 
 
Figure 8-6: Radar chart showing the average results for usefulness  
 
8.2.4 Design Features  
Results for the evaluation of the design features and corresponding attributes as 
assessed by the experts and researchers is presented in Table 8-5 and shown in Figure 
8-7.  
 
Table 8-5: Section D – Design features results  
Attribute Name P1 P2 P3 P4 P5 P6 P7 
Attribute 
Average 
Strategic Link 2 1 1 2 2 2 2 2 
Key Activities 1 1 2 2 2 0 2 1 
Novel Approach 0 0 2 1 1 1 1 1 
Continuous Improvement 2 1 2 2 2 2 2 2 
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Structure 2 1 1 2 2 2 2 2 
Documentation 2 2 2 2 2 1 2 2 
Participation 2 1 2 2 2 1 2 2 
Deliverables 2 1 2 2 1 2 1 2 
 
The radar chart (Figure 8-7) and the results from the assessment presented in Table 8-5 
highlight that the experts and researchers favourably evaluated the attributes of the 
guidelines design features. This is clearly shown in the radar chart and indicated by the 
high ranking attribute averages as shown in Table 8-5. Out of the eight attributes that 
comprise the design features of the guidelines, six of the attributes have been ranked 
with an attribute average of 2. This numerical value signifies that the experts and 
researchers highly favoured most of the attributes which comprise the design features of 
the guidelines. The attributes for design features were ranked by the experts and 
researchers as follows. The attributes ‘continuous improvement’ and ‘documentation’ 
were equally ranked the highest and considered to be most favourable. This was 
followed by the attributes ‘strategic link’, ‘structure’, and ‘participation’ which were 
also equally ranked. The ranking of the attributes that followed were; ‘deliverables’, 
‘key activities’, and finally, ‘novel approach’.  
 
 
Figure 8-7: Radar chart showing the average results for design features  
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8.2.5 Final Ranking for Sections A, B, C and D  
The average results for each of the responses from the experts and researchers were 
calculated and combined to provide an overall average for each of the comprising 
sections of the questionnaire. These results are provided in Table 8-6 and Figure 8-8.  
 
Table 8-6: Average results for sections A to D  
All Sections P1 P2 P3 P4 P5 P6 P7 
Section 
Average 
Section A - Feasibility 2 1 1 1 2 2 2 2 
Section B - Usability 1 1 2 1 1 1 2 1 
Section C - Usefulness 2 2 2 2 1 2 1 2 
Section D - Design Features 2 1 2 2 2 1 2 2 
 
 
Figure 8-8: Radar chart showing the average results for sections A to D  
 
From the radar chart (Figure 8-8) and the ranking of the coded responses (Table 8-6), 
the following three sections of the questionnaire (perspectives of the guidelines) were 
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ranked and considered of equal importance by the experts and researchers: feasibility 
(Section A), usefulness (Section C), and design features (Section D).  
 
The results from the validation process indicate that the usability of the guidelines was 
ranked lower by the experts and researchers as compared to the feasibility, usefulness, 
and design features of the guidelines.  
 
8.2.6 Participants Comments and Feedback  
In addition to the results obtained from the questionnaire and presented in the tables and 
radar charts in the previous five subsections (sections 8.2.1 to 8.2.5), the comments and 
feedback that were provided by the experts and researchers at the end of the validation 
questionnaire (Section E) have been detailed in this subsection as follows.  
 
 Participant No. 1 (P1):  
 The guidelines are useful as a Kaizen method which is important in 
product development.  
 The guidelines can also be considered to be a knowledge management 
tool, which is also important in lean product development.  
 The guidelines encourage people to capture, store and share product 
development knowledge, which are key activities in product 
development.  
 
 Participant No. 3 (P3):  
 All questions arising in my mind were answered in each of the steps, no 
vital steps were missing.  
 Guidelines are truly generic, easily applicable and adoptable for other 
similar products.  
 Guidelines are easily understandable for new or inexperienced users.  
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 Schematic presentation of the guidelines is clearly understandable.  
 Since the high-level of steps have been explained without describing 
specifics, these steps are flexible in terms of use.  
 The guidelines are also applicable to other similar products.  
 The three stage approach in the guidelines appears to be novel.  
 The novel guidelines will help designers / practitioners to improve their 
products.  
 
 Participant No. 6 (P6):  
 I think that the guidelines are generic.  
 
8.2.7 Utilising the Guidelines to Capture the Design Decisions of a 
Medical Device  
The principal engineer at a leading medical device company in the U.K. utilised the 
guidelines to capture the design decisions of a medical device. Decisions were captured 
in order to diagnose a documented problem (chapter 2) with an infusion pump and to 
design a solution. This is detailed in sections 8.2.7.2 and 8.2.7.3.  
 
The engineer was shown several design rationale representation frameworks, as 
described in chapter 2, and their underlying principles were explained. The principal 
engineer selected the IBIS-based methodology used by the current DRed tool 
(Bracewell et al., 2009).  
 
This selection was based on the relevance of the DRed methodology to engineering 
design and that engineering design methods are widely used during the design and 
development of medical devices.  
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8.2.7.1 Capturing and Representing the Design Decisions of an Infusion 
Pump  
The documented problem was shown to the principal engineer who then followed the 
DRed methodology to diagnose the problem with the infusion pump and mapped the 
decisions onto a sheet of A4 plain paper according to the DRed elements (Figure 8-9). 
On a different sheet of paper, the engineer then documented his decisions on designing 
a possible solution to resolve the problem.  
 
On completion of capturing the design decisions from the principal engineer, the 
decisions for both the diagnosis and solution design were then illustrated using the 
designVUE software tool by the researcher.  
 
 
Figure 8-9: DRed elements (Kim et al., 2007)  
 
Figure 8-10 shows a screenshot of the IBIS nodes used in designVUE as arranged 
according to the DRed elements illustrated in Figure 8-9.  
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Figure 8-10: IBIS node types in designVUE arranged according to the elements defined 
by the DRed methodology and tool (Kim et al., 2007)  
 
The designVUE software tool is an open source tool and was downloaded from the 
internet (http://www3.imperial.ac.uk/designengineering/tools/designvue). Its 
functionality includes support for IBIS argumentation and bi-directional hyperlinking 
between designVUE files. This tool was selected by the researcher to illustrate the 
design decisions based on its availability and ability to support IBIS-based 
argumentation structures. As shown in Figure 8-10, the different IBIS nodes are 
illustrated as follows: question mark – issue node; light bulb – answer; plus symbol – 
pro argument; and minus symbol – con argument.  
 
8.2.7.2 Diagnosing a Problem  
The principal engineer was asked to diagnose the following design issue identified with 
the battery of an infusion pump (details provided in chapter 2):  
 Battery failures:  
o A design issue causes over-heating of the battery and leads to premature 
battery failure. See Figure 8-11.  
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Figure 8-11: Image showing sealed lead-acid battery damage [23]  
 
In order to diagnose the issue with the battery, firstly, the top-level issue was defined by 
the principal engineer according to the selected design rationale methodology (Kim et 
al., 2007) – ‘What is causing the overheating of the infusion pump battery?’ The 
possible answers were then listed and linked to the top-level issue and their 
corresponding arguments (pro and con) were presented. The representation of the design 
decisions taken by the principal engineer to resolve the top-level issue is illustrated 
using the designVUE tool in Figure 8-12.  
 
 
Figure 8-12: Representing the design decisions concerning the diagnosis of battery 
related issues with the infusion pump 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
217 
8.2.7.3 Designing a Solution  
In order to design a solution to resolve the overheating issue with the infusion pump 
battery, the principal engineer defined the following top-level issue: ‘How to stop the 
overheating of the infusion pump battery?’ The possible solutions (answers) were listed 
along with their corresponding arguments and further sub-questions were also raised. 
The design decisions for designing a solution as captured by the principal engineer are 
illustrated using the designVUE tool in Figure 8-13.  
 
 
Figure 8-13: Representing the design decisions of possible solutions to resolve the 
battery related issues with the infusion pump  
 
8.3 Discussion  
This section discusses both the quantitative and qualitative results obtained from 
validation process.  
 
The experts and researchers who were invited to the validation workshop in order to 
perform the validation of the guidelines provided important feedback regarding the 
guidelines from the following four perspectives: feasibility, usability, usefulness, and 
design features. These perspectives were structured as part of the validation 
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questionnaire that was used to obtain responses to twenty questions from the experts 
and researchers, each of these questions highlighting a different attribute of the 
guidelines and linked to the individual sections of the questionnaire.  
 
Comments were also provided by three of the seven participants who attended the 
validation workshop. These comments were noted and found to be representative of the 
guidelines that have been developed. For the remaining four participants that did not 
make any further comments regarding the guidelines on the questionnaires, the informal 
discussion and feedback session at the end of the validation workshop was used to 
obtain their opinions. From this informal discussion, all of the seven participants found 
the guidelines to be feasible and useful. This was reflected in the quantitative results 
that were represented by the radar charts and corresponding ranking of the attributes in 
the respective tables of results.  
 
In comparison, the quantitative results obtained for the feasibility and usefulness of the 
guidelines showed that the experts and researchers did not consider the guidelines to be 
as usable as much as they are feasible and useful. The highest ranked attribute of the 
usability of the guidelines was the understanding that the guidelines provided, i.e. the 
goals and intentions of the guidelines are clear and concise. The attribute 
‘understanding’ was ranked higher in comparison to the other three attributes (time, 
ease of use, and flexibility) that comprised the usability of the guidelines.  
 
Out of the four attributes comprising the usability of the guidelines, the lowest ranked 
attribute as shown in the results was – flexibility. A possible reason for this is that the 
validation participants were validating the logic and rationale underlying the guidelines 
development rather than in actual application. The attribute ‘flexibility’ is aimed at 
evaluating if the guidelines are sufficiently flexible in application. The term application 
was understood by the participants to mean – in actual application when developing and 
regulating the approval of medical devices. This was raised during the discussion and 
feedback session by the participants at the end of the validation workshop. After this 
informal discussion, it was suggested to the author by the participants that greater 
clarification was required regarding this particular attribute that was being measured 
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(flexibility). In contrast, one of the participants (P3) considered the guidelines to be 
flexible in terms of use and noted that since the generic steps have been explained 
without describing specifics, these steps are flexible in terms of use.  
 
An interesting point that was noticed from the results obtained for the design features of 
the guidelines was the low ranking given by the participants for the attributes ‘key 
activities’ and ‘novel approach’. A possible explanation regarding this is that the 
participants were not familiar with the areas of research concerning design rationale and 
the regulatory approval of medical devices. Therefore, they were unaware of the novelty 
of the guidelines that have been developed by the author due which target the key 
activities. However, the author did make it clear during the presentation that the 
guidelines were targeted at three key activities of the regulatory approval processes for 
medical devices, and the guidelines themselves were structured in three stages based on 
the three key activities that they intended to address. Conversely, one of the participants 
(P3) did comment that the three stages underlying the structure of the guidelines 
appeared to be novel. It was further commented by this particular participant (P3) that 
the novel guidelines could help designers and practitioners to improve their products.  
 
The outcome from the validation process reported in this chapter has verified that the 
guidelines are indeed feasible, usable, and useful and comprise of a unique set of design 
features. Examples of design decisions for an infusion pump have been captured from a 
medical device expert, working in a leading medical device company in the U.K, and 
represented using an open source rationale capture computational support tool. As a 
result, this signifies that the guidelines can be used by medical device practitioners in 
industry to diagnose a problem and to design a solution in the case of a medical device. 
This chapter is summarised in the following section.  
 
8.4 Chapter Summary  
This chapter has presented the results from the final stage of the research that has been 
systematically followed by the author, the validation of the guidelines. The validation of 
the guidelines presented in this chapter has been performed by a number of experts and 
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researchers who have assessed the guidelines from the following four perspectives: 
feasibility, usability, usefulness, and design features.  
 
Core attributes of the four guidelines perspectives were defined by the author and a 
methodology to assess these attributes was established. A structured questionnaire 
consisting of twenty questions was designed by the author and used as an essential part 
of the validation process to obtain the experts and researchers opinions and feedback 
regarding the attributes of the guidelines. Seven out of the ten invited experts and 
researchers attended a validation workshop and completed the validation questionnaires, 
thereby providing the vital feedback regarding the feasibility, usability, usefulness, and 
design features of the guidelines. Additional comments and feedback provided by the 
experts and researchers were also detailed. Results obtained from the validation process 
have highlighted that the guidelines are equally strong from the following three 
perspectives; feasibility, usefulness and design features. However, the results also 
showed that the usability of the guidelines was not ranked as highly by the experts and 
researchers.  
 
The guidelines have been used by a principal engineer from a leading medical device 
company based in the U.K. to capture the design decisions for an infusion pump. 
Guidelines were followed in order to diagnose a known problem with the battery of an 
infusion pump and to design a solution to resolve the problem. The design decisions 
were captured by the medical device expert using a design rationale representation 
framework. These decisions and their underlying arguments were illustrated using the 
designVUE open source computational support tool dedicated for rationale capture. 
This signifies that the guidelines can be used in an industrial context to capture and 
represent the design decisions in the case of medical devices.  
 
This chapter has fulfilled the final objective of this research, to validate the guidelines. 
The following chapter of this thesis provides a discussion on the different stages of the 
research, and presents the main contributions to knowledge made by this research.  
 
  
CHAPTER 9  
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION AND CONCLUSIONS  
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Can Design Rationale be used with the regulatory approval of medical devices?  
9 Discussion and Conclusions  
This chapter provides a comprehensive understanding surrounding the process of 
capturing and representing the design decisions in the case of medical devices. The 
author’s reflection regarding the research process is provided, the main contributions 
to knowledge are outlined, and recommendations for future research are proposed.  
 
Conclusions to the thesis are provided in this chapter with a discussion of the findings 
that have emerged throughout this research investigation. This chapter consolidates the 
findings of the research and directly addresses the primary research question that has 
been guiding this research.  
 
Section 9.1 describes how the primary research question has been answered. Section 9.2 
highlights how the aim and objectives of the research have been addressed and fulfilled. 
Section 9.3 outlines the key contributions to existing knowledge made by this research. 
Section 9.4 provides the authors own reflection on the research investigation which 
details the strengths and limitations of the research. Section 9.5 presents the 
recommendations for future research and further advancement based on the findings 
that have emerged. Section 9.6 concludes with a final summary of the research 
presented in this thesis.  
 
9.1 Addressing the Primary Research Question  
The primary research question that was defined in Chapter 1 was:  
 
 
This was addressed in the following two stages. The first stage of the research, detailed 
in Chapters 4, 5 and 6, undertook multiple case studies which identified, compared and 
analysed design rationale and the regulatory approval processes for medical devices, in 
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particular, how design rationale methods and tools could be utilised with the medical 
device domain. A flexible methodology was undertaken consisting of:  
 a comparison of the state-of-the-art in design rationale research with the state-of-
the-art in medical device design,  
 a comparative analysis of the U.S. and EU regulatory approval processes for 
medical devices, and  
 an analysis of the possibilities for utilising design rationale to capture and 
represent the design decisions in the case of medical devices.  
This resulted in a multitude of qualitative data which was systematically synthesised to 
form the guidelines that were presented in Chapter 7. The second stage of the research, 
detailed in Chapters 7 and 8, developed and validated a set of descriptive guidelines. 
The researcher organised and undertook a validation workshop with 7 participants. All 
of the participants were from an academic background. The data obtained from the 
validation process was then analysed. The analysis revealed that the guidelines were 
feasible, usable, and useful and consisted of novel design features. The result of this was 
a set of guidelines that have been validated by academic experts and researchers. 
Further validation was performed with a research and development professional from a 
leading medical device company based in the U.K. This highlighted that the guidelines 
could be used in an industrial environment in order to capture and represent the design 
decisions of medical devices.  
 
Finally, the research investigation has therefore addressed and answered the primary 
research question and has provided validated results to support this. In summary, design 
rationale can be used with the regulatory approval of medical devices.  
 
9.2 Addressing the Research Aim and Objectives  
This section now details the aim and objectives on which the research was based. 
Evidence is provided of how the research investigation has addressed each objective, 
and subsequently, fulfilled the aim of the research. The following six research 
objectives have been addressed:  
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Obj. 1. Understand the state-of-the-art in design rationale research and medical 
device design.  
Evi. 1 This research objective was met by conducting a comprehensive review 
of current and relevant literature related to the area of design rationale research 
and medical device design (Chapter 2). The review presented and discussed the 
state-of-the-art design rationale research and identified the current capabilities 
it has to offer, and identified the state-of-the-art in medical device design. 
Synthesis of the literature resulted in identifying thirteen capabilities of design 
rationale, each capability representing design rationale’s ability to perform a 
specific action. These capabilities were presented in Table 2-7. These 
capabilities were addressed in detail, compared to the capabilities of the best 
practices in medical device design, and were utilised to form the basis of the 
guidelines.  
 
Obj. 2. Compare the state-of-the-art in design rationale research with the current 
state-of-the-art in medical device design.  
Evi. 2 This research objective was met by identifying the state-of-the-art in 
design rationale methods and tools and comparing these with the current state-
of-the-art in medical device design (Chapter 4). Results from the comparison 
presented several offerings for the possible utilisation of design rationale with 
the medical device domain. The strengths of design rationale as compared to 
the existing best practices in medical device design were also highlighted. 
Fulfilment of this objective formed the basis for the need of a systematic 
research approach in order to further investigate how design rationale could be 
utilised with the medical device domain.  
 
Obj. 3. Identify the individual activities that constitute the U.S. and EU regulatory 
approval processes for medical devices.  
Evi. 3 This research objective was met by developing, comparing and analysing 
a set of descriptive process models which uniquely illustrated the individual 
activities that constitute the U.S. and EU regulatory approval processes for 
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medical devices (Chapter 5). Data was identified, collected, analysed, and 
process models were developed using the IDEFØ process modelling tool. The 
modelling tool constituents were used as an initial basis for comparison. The 
comparison identified the differences and similarities between the U.S. and EU 
processes. The process models illustrated; the regulatory approval processes as 
a sequence of activities with an input and output connecting the individual 
activities, mechanisms to indicate the physical resources required at each 
activity, and the factors controlling the successful outcome of each activity.  
 
Obj. 4. Analyse the possibilities of utilising design rationale with the U.S and EU 
regulatory approval process activities.  
Evi. 4 This research objective was met by utilising the design rationale 
capabilities that were identified in Chapter 2 and independently mapping these 
with the individual process activities that constitute that U.S. and EU 
regulatory approval processes that were defined in Chapter 5. The analysis 
(Chapter 6) identified a set of possibilities for utilising the current capabilities 
that comprise design rationale with three regulatory approval processes 
activities for both the U.S. and EU processes. The analysis also suggested the 
possible benefits offered to both medical device manufacturers and regulatory 
authorities. As a result of the analysis, three key medical device regulatory 
approval activities were identified where design rationale methods and tools 
could be utilised.  
 
Obj. 5. Develop a set of descriptive guidelines.  
Evi. 5 This research objective was met through synthesising the key findings 
from stage one of the research (Chapters 4, 5, and 6). In stage two of the 
research, a novel set of descriptive guidelines were presented (Chapter 7) and 
validated (Chapter 8). It is intended that the guidelines be used in conjunction 
with existing working practices. The guidelines are structured into three stages, 
each stage targeting one of the three key regulatory approval process activities 
that were identified from the analysis in Chapter 6. Each of the stages 
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respectively describes; the generic practice of capturing and representing the 
design decisions of a medical device, the factors that need to be considered in 
order to review the design decisions of a medical device, and the steps 
necessary in order to diagnose a problem with a medical device that has been 
recalled and to design a solution in order to resolve the problem.  
 
Obj. 6. Validate the proposed guidelines.  
Evi. 6 This research objective was met by organising and conducting a 
validation workshop with experts and researchers from academia who were 
invited to participate in the process of validating the guidelines (Chapter 8). A 
brief presentation on the research presented in this thesis was given to the 
participants by the author. This presentation highlighted how the guidelines 
have been developed, described the intended aim and objectives of the 
guidelines and introduced the guidelines themselves. The process required to 
validate the guidelines was explained. Participants were asked to complete a 
structured questionnaire consisting of twenty questions which specifically 
addressed the four different perspectives of the guidelines, namely; feasibility, 
usability, usefulness, and design features. The participants were additionally 
asked to provide their feedback at the end of the questionnaire. This method 
was successful in validating the guidelines and verifying the kernel of the 
research investigation. A research and development professional from the 
medical device industry validated the use of the guidelines in an industrial 
context by using the guidelines to diagnose a problem with an infusion pump 
and to design a solution. Design decisions were captured and represented using 
an open source rationale capture tool.  
 
The aim of the research was is to develop a set of guidelines which detail the steps 
required to capture and represent the design decisions in the case of a medical device. 
This aim has been addressed by the fulfilment of the six objectives of the research.  
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9.3 Contribution to Knowledge  
The contribution to knowledge made by this research is twofold as follows; firstly, 
through the implementation of this research investigation, and secondly, through the 
findings of the research that have been generated throughout the research itself. 
Implementation of the research investigation allowed the author to create a study which 
focussed on amalgamating two diverse areas of research and application. This 
amalgamation resulted in the realisation of a novel contribution to knowledge. As a 
result, the findings that have been generated throughout the research are also considered 
to be a contribution to existing knowledge. Since a similar study which focuses on 
utilising design rationale with medical devices has not been identified prior to 
commencing this research investigation or during its completion, a significant 
contribution to knowledge has been indicated.  
 
The main contributions to knowledge are summarised as follows:  
 Showed that design rationale has additional capabilities compared to the existing 
best practices in medical device design  
 Showed the current processes required for regulating the approval of medical 
devices in the U.S. and EU as a set of descriptive activities  
 Showed how design rationale could be utilised with key medical device 
regulatory approval activities  
 Showed the sequential steps necessary to capture and represent the design 
decisions in the case of medical devices  
The guidelines proposed in this thesis provide guidance in order to communicate design 
decisions in the case of medical devices. Currently, the guidelines provide generic steps 
dedicated for medical device professionals to follow in order to capture and represent 
the design decisions undertaken during the development and regulatory approval of a 
medical device.  
 
The contribution of the guidelines is divided into three separate stages which consist of 
a series of generic guidance steps each detailing the necessary actions required to utilise 
design rationale. The guidelines describe the actions that are required by medical device 
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manufacturers and regulatory authorities during the process of developing a medical 
device, reviewing a device application, and diagnosing a problem and designing a 
solution for a device that has been recalled.  
 
The descriptive guidelines directly address the gaps in existing knowledge where, 
currently, there is a lack of information which; details the utilisation of design rationale 
methods and tools with medical devices, addresses its feasibility for use with the 
regulatory approval of medical devices, explains how design rationale could be utilised 
with the development of medical devices for regulatory approval and the benefits it 
could provide, and defines the individual steps required for medical device 
manufacturers and regulatory authorities to capture, represent and review design 
decisions.  
 
The design, production and presentation of the research investigation presented in this 
thesis has significantly added to and built upon existing research. Furthermore, the 
research has contributed to knowledge and understanding within the area of design 
rationale research and medical device regulatory approval.  
 
9.4 Reflecting Upon the Research  
In this section, the author’s reflections upon the limitations that were encountered 
during the research are discussed including how these challenges were addressed. 
Specific consideration is paid to the research methodology, the resultant data that was 
collected, and the findings of the research. The suitability of the multiple case studies is 
also considered. Strengths and weaknesses of the methodology followed by research 
were previously discussed in Chapter 3 (see section 3.6). The main limitations of the 
research were encountered during the following phases:  
 Comparing the state-of-the-art in design rationale with the state-of-the-art in 
medical device design.  
o This phase of the research aimed to compare design rationale with the existing 
best practices available in the literature concerning medical device design. In 
order to make a direct comparison between design rationale and medical device 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
230 
design, one document was identified which described the use of assurance case 
practices for medical devices. Due to the limited availability of documentation, 
the assurance case practice was the only available documentation that was used 
in the comparison. However, this seminal document has received much 
coverage in the form of being referred to by researchers and the regulatory 
approval authority for medical devices in the U.S. (FDA).  
 
 Identifying the regulatory approval processes for medical devices.  
o Details regarding the U.S. and EU regulatory approval processes for medical 
devices were captured from the websites and documentation published by the 
U.S. and EU regulatory authorities. There was a lack of process models 
available in the wider literature which illustrated both the U.S. and EU 
practices for regulating the approval of medical devices as a set of process 
models labelling each unique activity. This limitation was addressed by the 
author by developing a set of descriptive models which represented the 
individual activities that constitute both the U.S. and EU medical device 
regulatory approval processes.  
o As a consequence of developing the process models, another limitation 
encountered was that these models have not been directly validated by medical 
device manufacturers or the U.S. and EU regulatory authorities. To address this 
issue, the author has submitted an article to a peer-review scientific journal 
(Proceedings of the Institution of Mechanical Engineers, Part H: Journal of 
Engineering in Medicine) in order to validate the findings from this research 
activity.  
 Validating the guidelines.  
o The main limitations surrounding the validation of the guidelines were the lack 
of available medical device experts and practitioners including members of 
organisations which govern the regulatory approval of medical device in the 
U.S. and EU. Due to the time constraints of the research itself, the author 
validated the theoretical framework of the guidelines with experts and 
researchers from academia. However, one medical device expert from industry 
was contacted and the guidelines were validated using the infusion pump as a 
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case study. By using the guidelines, the medical device expert was able to 
capture and represent the design decisions for an infusion pump which were 
then illustrated using an open source rationale capture tool. Another limitation 
was the overall number of participants that attended the validation workshop. 
However, their contribution to the validation process has proved effective and 
useful, and shows that the developed guidelines are feasible, usable, and useful. 
One of the invited participants had previous experience in developing medical 
devices but was not familiar with regulatory approval. The participant’s 
unfamiliarity with the regulatory approval processes for medical devices also 
provided some limitations during the validation process.  
 
9.5 Recommendations for Future Research  
This research investigation has concluded that there is a need for further research within 
the area of design rationale and additionally the utilisation of methods and 
computational support tools with the development and the regulatory approval of 
medical devices in general.  
 
The research provided its target audience with a set of guidelines that have been 
developed to provide support in capturing and representing the design decisions of 
medical devices. The research does not claim, however, that these guidelines are fully 
complete. As a result, further research is required to evaluate these guidelines in 
application, to liaise with medical device manufacturers and regulatory authorities to 
develop the existing framework of the guidelines into a more comprehensive set of 
detailed steps using real-life medical devices that are currently in development as 
examples. Additionally, the findings of the research, the guidelines, provide a set of 
generic steps for device manufacturers and regulatory authorities but they are not 
necessarily fully complete. Research needs to investigate whether the guidelines, 
presented within this thesis, can be used in practice or if there is further additional 
development or modification required in order for the guidelines to be adopted by 
device manufacturers and regulatory authorities in everyday practice.  
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Findings of the research indicate that design rationale, even after more than forty years 
of research contribution, still needs to address a wider audience in order for design 
rationale tools to be used and understood by personnel other than designers. Future 
research needs to address how the methods and tools can be more successfully 
integrated within a product development and/or regulatory approval process and how 
personnel other than designers can benefit from using and implementing a design 
rationale practice. Currently, there are no dedicated design rationale methods and 
computational support tools that have been extended or specifically developed for 
application in the medical device domain. This identifies a considerable gap in research 
and a significant opportunity for future research that needs to be addressed by both the 
design rationale research and medical device communities. Future research should 
involve the collaboration of researchers and practitioners in both domains to develop 
tools that are customised and bespoke for use in the medical device domain.  
 
9.6 Conclusions and Final Thesis Summary  
This research investigation intended to enhance existing knowledge and understanding 
and generate new knowledge surrounding the utilisation of design rationale with the 
regulatory approval of medical devices. This was achieved by developing and proposing 
a novel set of guidelines that are to be used by medical device manufacturers and 
regulatory authorities in order to capture and represent design decisions in the case of a 
medical device. The guidelines consist of three stages, each of which targets a key 
regulatory approval process activity for medical devices. Each individual stage of the 
guidelines presents the steps necessary in order to; capture and represent the design 
decisions of a medical device during device development, review the design decisions 
of a medical device, and diagnose a problem and design a solution for a device that has 
been recalled from the market. The findings of the research, in particular the guidelines 
that have been developed based on the emergent research findings, provide medical 
device manufacturers and medical device regulatory authorities with support and 
guidance concerning the integrative steps necessary to capture and represent the design 
decisions of medical devices.  
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Appendix A: List of Compiled Design Rationale Capabilities  
 
Actions  Descriptions  Reference  Outcomes  
Extracted  
Verb 
Capability  
Names  
Capability Sub-
Category Names  
Capability  
Identifier  
To answer 
design 
questions.  
Design rationale can 
answer questions about 
why a given design takes 
the form that it does.  
(Haynes et al., 
2008) 
Questions 
concerning a 
particular design 
are answered.  
Answer Answer Design Questions A 
To solve 
design 
problems.  
Design rationale is a 
methodology for problem 
solving and decision 
making in a design 
context.  
(Li et al., 2002) 
Available 
method for 
problem solving 
in a design 
context.  
Solve Answer Design Problems A 
To capture 
design 
knowledge.  
Design rationale is a 
method of capturing the 
knowledge and reasoning 
that justify the resulting 
design.  
(Tang et al., 
2006) 
Design 
knowledge and 
reasoning 
captured.  
Capture Capture Design Knowledge B 
To capture 
designers 
decisions.  
Design rationale captures 
the reasons why 
designers make the 
design decisions that they 
do, how they moved 
through a design space to 
identify questions and the 
answers to solutions to 
those questions, and the 
criteria they used to 
(Haynes et al., 
2008) 
Designer’s 
decisions and 
reasoning are 
captured.  
Capture Capture Designers Decisions B 
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determine that a 
particular solution will 
work, or will work better 
than other possible 
alternatives.  
To express 
the design 
relationships.  
Design rationale is an 
expression of the 
relationships between a 
designed artefact, its 
purpose, the designer’s 
conceptualisation, and the 
contextual constraints on 
realising the purpose.  
(Moran and 
Carroll, 1996) 
Design 
relationships are 
expressed.  
Express Communicate  Design Relationships C 
To describe 
the design 
space.  
Design rationale is a 
description of the design 
space.  
(MacLean et al., 
1989) 
Description of 
the design space 
is provided.  
Describe Communicate  Design Space C 
To transmit 
information.  
The intent of design 
rationale is to transmit 
information from a 
designer working at one 
time and in one context to 
another designer working 
in another time and 
context.  
(Atwood and 
Horner, 2007) 
Information 
transmitted from 
one designer to 
another.  
Transmit Communicate  Information  C 
To note 
logical 
reasoning.  
Design rationale is a 
notation for the logical 
reasons for a designed 
artefact.  
(Moran and 
Carroll, 1996) 
Logical 
reasoning is 
noted.  
Note Communicate  Logical Reasoning C 
To design an 
artefact with 
Design rationale is a 
method of designing an 
(Moran and 
Carroll, 1996) 
Reasoning 
behind the 
Design Design Artefact D 
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explicit 
reasoning.  
artefact whereby the 
reasons for it are made 
explicit.  
design is made 
explicit.  
To determine 
the reasoning 
behind a 
design.  
Design rationale is the 
reasoning that goes into 
determining the design of 
the artefact.  
(Dutoit et al., 
2006) 
Reasoning 
underlying a 
design is 
determined.  
Determine Determine Reasoning E 
To document 
the design 
decisions.  
Design rationale 
documents more than the 
results of each decision: it 
documents what the 
decisions were, what 
alternatives were 
considered and rejected, 
and what arguments were 
used in making the 
alternative selections.  
(Burge and 
Brown, 2008) 
Design 
decisions are 
documented.  
Document Document Design Decisions F 
To list the 
design 
decisions and 
reasoning.  
Design rationale is the 
explicit listing of 
decisions made during a 
design process and the 
reasons why those 
decisions were made.  
(Jarczyk et al., 
1992) 
Design 
decisions are 
explicitly listed.  
List Document Design Decisions F 
To record the 
design 
history.  
Design rationale is a 
historical record of the 
reasons for the choice of 
an artefact.  
(Yakemovic and 
Conklin, 1990) 
Historical 
evidence of the 
reasoning is 
provided.  
Record  Document Design History F 
To document 
the design 
history.  
Design rationale is a 
documentation of: (a) the 
reasons for the design of 
(Moran and 
Carroll, 1996) 
Historical 
evidence of the 
design process 
Document Document Design History F 
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an artefact, (b) the stages 
or steps of the design 
process, and (c) the 
history of the design and 
its context.  
is provided.  
To document 
the decision-
making 
processes.  
Design rationale can 
serve as a memory aid for 
those who have 
participated in the 
decision-making and the 
other is to inform those 
who did not participate in 
the decision-making 
process but are affected 
by the decisions.  
(Burge et al., 
2008) 
Decision-
making 
processes are 
documented.  
Document Document 
Decision-Making 
Processes 
F 
To document 
the design 
reasoning.  
Design rationale 
framework explicitly 
documents the reasoning 
and argumentation 
occurring in design.  
(MacLean et al., 
1991) 
Design 
reasoning is 
documented.  
Document Document Design Reasoning F 
To record 
logical 
reasoning.  
Design rationale presents 
the logical reasons given 
to justify a designed 
artefact.  
(Moran and 
Carroll, 1996) 
Logical 
reasoning of a 
designed 
artefact is 
recorded.  
Record Document Logical Reasoning F 
To explain 
the reasoning 
behind the 
designed 
artefact.  
Design rationale is an 
explanation of why the 
designed artefact (or 
some feature of an 
artefact) is the way it is.  
(Moran and 
Carroll, 1996) 
Explanation of 
the designed 
artefact is 
provided.  
Explain Explain Design  G 
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To explain 
the reasoning 
behind the 
design.  
Design rationale is an 
explanation of how and 
why an artefact, or some 
portion of it, is designed 
the way it is.  
(Gruber and 
Russell, 1996) 
Explanation of 
the designed 
artefact is 
provided.  
Explain Explain  Reasoning G 
To justify the 
argument 
behind the 
design 
decisions 
made.  
Design rationale can 
include not only the 
reasons behind a design 
decision but also the 
justification for it, the 
other alternatives 
considered, the trade-offs 
evaluated, and the 
argumentation that led to 
the decision.  
(Lee, 1997) 
Justification of 
the design 
decisions is 
provided.  
Justify Justify Argument  H 
To provide 
historical 
evidence.  
Design rationale provides 
a history of the design 
process as well as 
capturing the intent 
behind the decisions 
made.  
(Burge and 
Bracewell, 
2008) 
Historical 
evidence of the 
design process 
is provided.  
Provide Provide  Historical Evidence I 
To represent 
the design 
reasoning.  
Design rationale is a 
representation of the 
reasoning behind the 
design of an artefact.  
(Shum, 1996) 
Reasoning 
underlying the 
designed 
artefact is 
represented.  
Represent Represent Design Reasoning J 
To illustrate 
rationale 
behind the 
artefact.  
Design rationale is a set 
of psychological claims 
embodied by an artefact.  
(Carroll and 
Rosson, 1990) 
Rationale is 
embodied 
within the 
artefact.  
Illustrate Represent Rationale J 
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To represent 
the reasoning 
of design 
solutions.  
Design rationale is an 
approach to design which 
emphasises working with 
explicit representations 
not only of possible 
design solutions, but also 
of the reasons and 
processes behind them.  
(McKerlie and 
MacLean, 1994) 
Representation 
of the design 
solutions.  
Represent Represent Reasoning J 
To expose 
the reasoning 
underlying an 
artefact.  
Design rationale helps to 
expose the underlying 
propositions and 
mechanics of a given 
theoretical position by 
exposing the otherwise 
invisible reasoning that 
unifies a theoretical 
construct with a 
constructed object.  
(Haynes et al., 
2008) 
Rationale for a 
constructed 
artefact is 
exposed.  
Expose Represent Reasoning J 
To structure 
designers 
decisions.  
A design rationale system 
intends to let designers 
think and discuss design 
within a certain 
knowledge framework.  
(Regli et al., 
2000) 
Designer’s 
decisions 
structured to a 
given 
framework.  
Structure Structure  Designers Decisions K 
To structure 
designers 
decisions.  
Design rationale is a type 
of argumentation that is 
structured according to a 
given schema.  
(Dutoit et al., 
2006) 
Designer’s 
decisions 
structured to a 
given schema. 
Structure Structure  Designers Decisions K 
To assist 
designers in 
Design rationale could 
help designers follow the 
(Lee, 1997) 
Structured 
decision-making 
Assist Support Designers L 
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decision-
making.  
issues and alternatives 
being explored including 
their evaluations, which 
in turn clarified the 
overall structure of the 
reasoning process and 
supported decision 
making.  
process.  
To support 
designers.  
One of the goals of 
design rationale systems 
is to support designers by 
providing a means to 
record and communicate 
the argumentation and 
reasoning behind the 
design process.  
(Atwood and 
Horner, 2007) 
Reasoning and 
argumentation 
communication 
support system 
is established.  
Support Support Designers L 
To teach 
others about 
design.  
Design rationale is a 
helpful aid for teaching 
students or inexperienced 
designers; because it 
provides an explanation 
for why particular design 
components or features 
were chosen.  
(Moran and 
Carroll, 1996) 
Explanation of 
the designed 
artefact is 
provided. 
Teach Teach Design M 
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Appendix B: Tabulation of Activities and Their Controls, Mechanisms and Outputs for 
the U.S. and EU Processes  
 
Activity 
No.  
U.S. Process Activity Name U.S. Process Controls U.S. Process Mechanisms U.S. Process Outputs 
A1 Define Device Device Definition 
FDA Website;  
Device Manufacturer 
Defined Medical Device 
A2 Classify Device 
Device Classification Criteria;  
Regulatory Controls 
Device Manufacturer;  
CDRH Classification Database 
Classified Device: Class I;  
Classified Devices: Classes II 
and III 
A3 Select Marketing Process 
Device Classification Criteria;  
Regulatory Controls;  
Marketing Clearance Requirements 
FDA Website;  
Device Manufacturer 
Premarket Notification 510(k) 
Requirements and Premarket 
Approval Application (PMA) 
Requirements 
A4 Prepare Marketing Application 
Marketing Clearance Requirements;  
Quality System Regulation (QSR) 
Device Manufacturer;  
Clinical Trials;  
Clinical Performance Data;  
Quality Management System 
(QMS) 
Device Data and 
Documentation 
A5 Submit Marketing Application Application Submission Requirements 
FDA Website;  
Device Manufacturer 
Device Marketing Application 
A6 Review Device Application 
Premarket Approval Application (PMA) Regulations; 
Premarket Notification 510(k) Regulations 
FDA Personnel Device Approvable Letter 
A7 Register Device Details 
Premarket Requirements; 
Marketing Clearance Requirements 
FDA Website;  
Device Manufacturer 
Medical Device Registered with 
the FDA 
A8 Market Device 
Marketing Clearance Requirements;  
Quality System Regulation (QSR) 
Postmarket Requirements 
Medical Device Reporting Regulations (MDR) 
Device Manufacturer;  
FDA Personnel 
Medical Device Registered and 
Approved for Intended Use in 
the U.S. 
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Activity No.  EU Process Activity Name EU Process Controls EU Process Mechanisms EU Process Outputs 
A1 Classify Device Medical Device Directive (MDD) 
Device Manufacturer;  
EU CA Website 
Classified Device: Class I (ns/nm); 
Classified Devices: Classes I 
(s/mf), IIa, IIb and III 
A2 Implement QMS 
Medical Device Directive (MDD);  
ISO Standard 13485:2003 
Device Manufacturer QMS Compliance 
A3 Prepare Technical Documentation 
Medical Device Directive (MDD);  
Risk Management Requirements 
Device Manufacturer;  
Clinical Data 
Technical File or Design Dossier 
A4 Appoint EU NB EU Location 
Device Manufacturer;  
EU CA Website 
Appointed EU REP for Classified 
Device: Class I (ns/nm);  
Appointed EU REP for Classified 
Devices: Classes I (s/mf), IIa, IIb 
and III 
A5 Audit QMS and Documentation Medical Device Directive (MDD) EU Notified Body 
CE Certificate for Class I Devices 
(s/mf);  
CE Certificate for Class IIa, IIb and 
III Devices 
A6 Register Device Details Medical Device Directive (MDD) 
Device Manufacturer;  
EU CA 
Registered All Class I Medical 
Devices 
A7 Market Device  
Medical Device Directive (MDD);  
CE Mark;  
Postmarket Surveillance (PMS);  
Declaration of Conformity 
Device Manufacturer;  
EU NB 
Medical Device Certified and 
Approved for Intended Purpose in 
the EU 
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Appendix C: Validation Presentation  
 
 
 
 
 
 
 
 
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
263 
 
 
 
 
 
 
 
 
 
 
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
264 
 
 
 
 
 
 
 
 
 
 
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
265 
 
 
 
 
 
 
 
 
 
 
 
Design Rationale for the Regulatory Approval of Medical Devices 
 
 
266 
Appendix D: Validation Questionnaire  
 
 
 
 
 
 
Guidelines for Utilising Design Rationale with the 
Regulatory Approval of Medical Devices  
 
Validation Questionnaire  
 
 
 
The purpose of this validation questionnaire is to capture the opinions of 
academics/researchers on the guidelines that have been developed for utilising 
design rationale with the regulatory approval of medical devices. This process 
of capturing the opinions forms an integral part of the validation process. 
Results from the validation process are to be analysed and presented in the 
final thesis.  
 
 
Complete sections A to D of this validation questionnaire. Please feel free to 
make additional comments as required, supplementary space is provided below 
each of the questions.  
 
 
Name:   .................................................................. 
Organisation:  .................................................................. 
Job Title: ............................................................................. 
 
 
 
 
PhD: Design Rationale for the Regulatory Approval of Medical Devices  
Researcher: Jeevan Sagoo  
Supervisors: Professor A. Tiwari and Dr. J. Alcock  
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Section A. Feasibility  
1. (Completeness) The guidelines consist of relevant steps in order to capture 
and represent the design decisions of a medical device.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
2. (Consistency) The stages and sequences of steps within the guidelines flow 
sequentially without missing any vital steps in between.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
3.  (Applicability) The guidelines could be successfully adopted in other 
similar contexts, i.e. where product development, approval, and post market 
play a vital role in placing a product onto the market.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
4.  (Contingency) The guidelines provide the intended users with solutions on 
how to utilise design rationale with the regulatory approval of medical 
devices.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
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Section B. Usability  
5. (Time) The time required to follow and understand the guidelines is within 
desirable limits (between 15 minutes to 30 minutes).  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
6. (Ease of Use) The structure of the guidelines is easy to follow.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
7. (Understanding) The goals and intentions of the guidelines are clear and 
concise.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
8. (Flexibility) The guidelines are sufficiently flexible in application.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
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Section C. Usefulness  
9.  (Satisfaction) The guidelines meet the expectations of utilising design 
rationale with the regulatory approval of medical devices.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
10. (Success) The guidelines were successful in meeting the goal and intended 
purpose.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
11. (Practicality) The guidelines are practical for application.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
12. (Benefit) The guidelines could provide essential benefits to medical device 
practitioners and regulatory authorities.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
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Section D. Design Features  
13. (Strategic Link) The guidelines provide an essential link between device 
development and regulatory approval.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
14. (Key Activities) The guidelines successfully target key medical device 
activities.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
15. (Novel Approach) The guidelines provide a novel approach to capturing and 
representing design decisions, and resolving design issues and/or 
preventing design issues with a medical device.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
16.  (Continuous Improvement) The guidelines can be used as part of a 
continuous improvement programme for medical devices.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
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17. (Structure) The guidelines are well defined, in a step-by-step approach.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
18. (Documentation)  The guidelines provide a well-documented set of steps to 
be used with key medical device activities.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
19.  (Participation) The intended users of the guidelines are appropriate.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ............................................................................................................................................... 
20.  (Deliverables) The product/outcome is useful for practitioners.  
 
 
Strongly Disagree Disagree Neither Agree Nor 
Disagree 
Agree Strongly Agree 
     
Comments: ................................................................................................................... ............................ 
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